k141_52900_2	megares|MEG_1180|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|ASMA_1	99.0	617	618	617	0.0	1186
k141_52900_2	megares|MEG_1179|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|ASMA_1	62.2	609	618	607	3.49e-273	759
k141_8284_52	SARG|gi|500194536|ref|WP_011867743.1|	30.6	222	344	306	6.81e-28	109
k141_29805_2	SARG|gi|447057510|ref|WP_001134766.1|	28.7	230	511	309	7.36e-22	95.1
k141_29805_2	SARG|gi|488120365|ref|WP_002191762.1|	28.3	230	511	309	1.83e-21	94.0
k141_29805_2	SARG|gi|507055561|ref|WP_016126482.1|	28.3	230	511	309	2.48e-21	93.6
k141_29805_2	SARG|gi|488067981|ref|WP_002139378.1|	28.7	230	511	309	3.36e-21	93.2
k141_29805_2	SARG|gi|507023808|ref|WP_016095885.1|	28.7	230	511	309	3.36e-21	93.2
k141_29805_2	SARG|gi|487936534|ref|WP_002010000.1|	28.7	230	511	309	3.36e-21	93.2
k141_29805_2	SARG|gi|507050365|ref|WP_016121371.1|	28.3	230	511	309	6.15e-21	92.4
k141_29805_2	SARG|gi|488130770|ref|WP_002201978.1|	28.7	230	511	309	6.15e-21	92.4
k141_29805_2	SARG|gi|488053456|ref|WP_002124853.1|	28.3	230	511	309	1.13e-20	91.7
k141_29805_2	SARG|gi|488068784|ref|WP_002140181.1|	27.8	230	511	309	1.52e-20	91.3
k141_47947_1	CARD|gb|BAB35162.1|ARO:3000676|H-NS	60.0	135	135	137	2.42e-41	133
k141_8309_15	SARG|BAB59035	32.1	137	183	154	2.87e-07	47.0
k141_8309_15	SARG|Q8DF90	33.9	115	183	154	3.95e-07	46.6
k141_8309_15	SARG|YP_002418004	31.4	137	183	154	5.44e-07	46.2
k141_8309_15	SARG|ZP_01813310	31.4	137	183	154	7.49e-07	45.8
k141_8309_15	SARG|ZP_00990220	31.4	137	183	154	7.49e-07	45.8
k141_8309_15	SARG|BAC58936	33.0	115	183	154	1.03e-06	45.4
k141_8309_15	SARG|YP_001444376	29.9	137	183	154	5.05e-06	43.5
k141_8309_15	SARG|YP_002666586	29.9	137	183	154	5.05e-06	43.5
k141_8309_15	SARG|ZP_02197344	31.3	115	183	154	6.92e-06	43.1
k141_8309_17	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	29.9	308	309	343	1.39e-39	140
k141_8309_17	SARG|gi|542061059|gb|ERI11611.1|	31.2	311	309	316	8.98e-37	132
k141_8309_17	SARG|gi|447057509|ref|WP_001134765.1|	32.7	306	309	309	4.12e-36	130
k141_8309_17	SARG|YP_001373621	32.7	306	309	318	1.37e-35	129
k141_8309_17	SARG|gi|445996708|ref|WP_000074563.1|	31.8	311	309	309	1.58e-35	129
k141_8309_17	SARG|ZP_04081918	32.1	315	309	306	2.07e-35	129
k141_8309_17	SARG|gi|488130770|ref|WP_002201978.1|	33.0	306	309	309	2.20e-35	129
k141_8309_17	SARG|gi|507035724|ref|WP_016107411.1|	32.0	306	309	309	3.08e-35	128
k141_8309_17	SARG|gi|445996697|ref|WP_000074552.1|	32.0	306	309	309	4.31e-35	128
k141_8309_17	SARG|gi|447195835|ref|WP_001273091.1|	30.2	318	309	306	5.64e-35	127
k141_5073_11	SARG|gi|534805066|gb|EQP57070.1|	100	18	96	419	7.35e-06	41.6
k141_5073_11	SARG|gi|323960204|gb|EGB55847.1|	100	18	96	419	7.35e-06	41.6
k141_5073_11	SARG|gi|323939655|gb|EGB35859.1|	100	18	96	419	7.35e-06	41.6
k141_5073_11	SARG|ZP_03030716	100	18	96	419	7.35e-06	41.6
k141_13310_10	CARD|gb|AAK37618.1|ARO:3005008|TxR	41.1	319	593	318	2.60e-63	210
k141_13310_49	SARG|YP_002333394	30.5	262	316	323	1.99e-28	110
k141_13310_49	SARG|gi|552942232|ref|WP_023043160.1|	29.4	272	316	323	1.92e-26	105
k141_13310_49	SARG|gi|746609237|ref|WP_039635344.1|	29.6	253	316	322	1.32e-25	103
k141_13310_49	SARG|AY082011.1.gene6.p01	29.0	272	316	323	1.34e-25	103
k141_13310_49	NCBI|WP_063856705.1|1|1|vanH-D|vanH-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-D|AMR|glycopeptide	31.1	235	316	323	1.86e-25	102
k141_13310_49	SARG|gi|740152780|ref|WP_037997109.1|	28.7	275	316	322	3.49e-25	102
k141_13310_49	SARG|gi|737310392|ref|WP_035293250.1|	28.1	253	316	323	4.90e-25	101
k141_13310_49	SARG|AF155139.2.gene6.p01	31.0	242	316	322	6.67e-25	101
k141_13310_49	SARG|DQ018711.1.gene4.p01	28.1	253	316	322	9.22e-25	100
k141_13310_49	SARG|FJ349556.1.gene5.p01	28.1	253	316	326	3.55e-24	99.4
k141_72830_2	SARG|gb|AAC75271.1|ARO:3003952|yojI	28.3	198	276	547	2.24e-10	59.7
k141_72830_2	SARG|gi|491465657|ref|WP_005323423.1|	50.8	59	276	513	5.24e-10	58.5
k141_72830_2	SARG|gi|489438834|ref|WP_003344330.1|	27.0	196	276	492	6.88e-10	58.2
k141_72830_2	SARG|gi|171851258|emb|CAQ04234.1|	50.8	59	276	483	1.22e-09	57.4
k141_72830_2	SARG|gi|550167391|ref|WP_022586684.1|	26.7	195	276	492	2.97e-09	56.2
k141_72830_2	SARG|gi|736993687|ref|WP_034989673.1|	49.2	59	276	513	3.03e-09	56.2
k141_72830_2	SARG|AF024666.2.gene6.p01	49.2	59	276	513	3.03e-09	56.2
k141_72830_2	SARG|gi|915546417|ref|WP_050844389.1|	25.1	195	276	492	3.97e-09	55.8
k141_72830_2	SARG|gi|445983948|ref|WP_000061803.1|	24.4	197	276	492	3.97e-09	55.8
k141_72830_2	SARG|gi|496784101|ref|WP_009371362.1|	25.0	208	276	493	3.98e-09	55.8
k141_10008_2	SARG|gb|AAS79458.1|ARO:3001302|chrB	36.9	241	270	280	7.88e-41	141
k141_10008_2	SARG|gb|AJD73064.1|ARO:3001301|RlmA(II)	33.2	241	270	282	3.11e-36	129
k141_10008_2	megares|MEG_4106|Drugs|MLS|23S_rRNA_methyltransferases|MYRA_1	32.3	260	270	295	2.40e-34	124
k141_10008_2	SARG|gb|BAA03674.1|ARO:3001300|myrA	32.3	260	270	295	2.40e-34	124
k141_10008_2	SARG|gb|CAB37345.2|ARO:3004592|erm(32)	31.8	245	270	280	1.38e-32	119
k141_10008_2	SARG|gb|AAD12162.1|ARO:3001299|tlrB	31.4	245	270	280	1.45e-31	117
k141_54679_28	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	36.7	240	231	252	8.63e-45	149
k141_54679_28	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	31.6	228	231	232	3.57e-35	124
k141_54679_28	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	31.6	225	231	232	7.08e-35	123
k141_54679_28	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	32.3	229	231	239	1.67e-34	122
k141_54679_28	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	31.9	226	231	225	6.50e-34	120
k141_54679_28	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	33.3	225	231	231	6.38e-32	115
k141_54679_28	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	30.7	228	231	231	6.38e-32	115
k141_54679_28	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	30.3	228	231	231	1.77e-31	114
k141_54679_28	CARD|gb|AAD51348.1|ARO:3003066|smeR	34.8	224	231	229	1.30e-30	112
k141_54679_28	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	31.1	228	231	231	1.36e-30	112
k141_34860_11	CARD|gb|BAE77778.1|ARO:3000508|gadX	36.8	193	254	274	6.40e-36	127
k141_34860_13	SARG|gb|BAE78116.1|ARO:3003576|eptA	96.3	547	548	547	0.0	1058
k141_34860_13	NCBI|WP_181726036.1|1|1|mcr-8.5|mcr-8||2|||phosphoethanolamine--lipid_A_transferase_MCR-8.5|AMR|peptide	43.7	531	548	565	1.33e-147	435
k141_34860_13	NCBI|WP_072310976.1|1|1|mcr-8.2|mcr-8||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-8.2|AMR|peptide	43.5	531	548	565	1.06e-146	432
k141_34860_13	SARG|gb|AVX52225.1|ARO:3004516|MCR-8	43.5	531	548	565	1.50e-146	432
k141_34860_13	NCBI|WP_118860654.1|1|1|mcr-8.4|mcr-8||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-8.4|AMR|peptide	43.5	531	548	565	3.01e-146	431
k141_34860_13	NCBI|WP_150823497.1|1|1|mcr-8.3|mcr-8||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-8.3|AMR|peptide	43.3	531	548	565	1.20e-145	430
k141_34860_13	NCBI|WP_094308975.1|1|1|mcr-3.22|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.22|AMR|peptide	41.5	496	548	541	8.99e-145	427
k141_34860_13	SARG|gb|AUN87920.1|ARO:3004500|MCR-3.11	41.5	496	548	541	1.27e-144	426
k141_34860_13	SARG|WP_065804663.1	41.5	496	548	541	1.80e-144	426
k141_34860_13	NCBI|WP_136512112.1|1|1|mcr-3.29|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.29|AMR|peptide	41.5	496	548	541	1.80e-144	426
k141_34860_14	CARD|gb|ATC67679.1|ARO:3000838|arlR	39.5	220	223	219	5.96e-41	138
k141_34860_14	CARD|gb|AAG06465.1|ARO:3005063|cprR	37.2	218	223	223	6.51e-38	130
k141_34860_14	NCBI|WP_011029105.1|1|1|vanR-Sc|vanR-Sc|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-Sc|AMR|glycopeptide	35.5	217	223	231	2.74e-35	124
k141_34860_14	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	35.4	223	223	225	9.26e-35	122
k141_34860_14	CARD|gb|AAC73788.1|ARO:3003841|kdpE	35.4	223	223	225	9.26e-35	122
k141_34860_14	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	32.6	218	223	228	1.10e-33	119
k141_34860_14	NCBI|WP_063856729.1|1|1|vanR-O|vanR-O|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-O|AMR|glycopeptide	33.2	217	223	233	2.46e-33	119
k141_34860_14	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	35.4	226	223	229	6.21e-33	117
k141_34860_14	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	32.4	225	223	232	1.20e-29	109
k141_34860_14	CARD|gb|AAD51348.1|ARO:3003066|smeR	34.4	218	223	229	1.39e-26	101
k141_34860_17	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	35.0	432	501	429	2.80e-80	255
k141_34860_22	SARG|gi|671541568|ref|WP_031525212.1|	38.4	219	263	648	7.36e-32	122
k141_34860_22	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	32.2	239	263	255	9.73e-32	116
k141_34860_22	SARG|gi|746482713|ref|WP_039520502.1|	34.4	250	263	648	5.71e-28	111
k141_34860_22	SARG|gi|555268367|ref|WP_023249730.1|	34.4	250	263	648	5.71e-28	111
k141_34860_22	SARG|gi|1027935297|ref|WP_063809363.1|	34.4	250	263	648	5.71e-28	111
k141_34860_22	SARG|gi|555258323|ref|WP_023240896.1|	34.4	250	263	648	5.71e-28	111
k141_34860_22	SARG|gi|685236936|ref|WP_031605176.1|	34.4	250	263	648	7.76e-28	110
k141_34860_22	SARG|gi|959866458|ref|WP_058145168.1|	34.4	250	263	648	7.76e-28	110
k141_34860_22	SARG|gi|555246906|ref|WP_023230855.1|	34.4	250	263	648	1.06e-27	110
k141_34860_22	SARG|gi|554958661|ref|WP_023203683.1|	34.4	250	263	648	1.06e-27	110
k141_34860_30	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	31.1	225	253	343	4.00e-22	92.4
k141_34860_30	megares|MEG_2670|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|DRRA_1	31.9	216	253	293	3.58e-19	83.6
k141_34860_30	SARG|gb|AAA26793|ARO:3003748|oleC	27.5	229	253	325	4.79e-18	80.9
k141_34860_30	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	27.5	229	253	325	6.58e-18	80.5
k141_34860_30	megares|MEG_4383|Drugs|Tetracycline|Tetracycline_resistance_ABC_efflux_pumps|OTRC_1	26.6	233	253	351	2.76e-11	61.6
k141_34860_30	SARG|gb|AAR96051.1|ARO:3002894|otrC	26.6	233	253	351	3.72e-11	61.2
k141_34860_31	SARG|gb|AAK76137.1|ARO:3000024|patA	27.8	205	227	564	7.20e-12	63.2
k141_34860_31	SARG|gi|817122037|ref|WP_046494699.1|	33.7	205	227	613	1.35e-11	62.4
k141_34860_31	SARG|gi|662175949|ref|WP_030118884.1|	32.2	214	227	605	2.45e-11	61.6
k141_34860_31	SARG|gi|663155409|ref|WP_030194633.1|	32.2	214	227	605	2.45e-11	61.6
k141_34860_31	SARG|gi|664538723|ref|WP_031054357.1|	32.2	214	227	605	2.45e-11	61.6
k141_34860_31	SARG|gi|663330365|ref|WP_030329892.1|	32.2	214	227	607	2.45e-11	61.6
k141_34860_31	SARG|gi|664170108|ref|WP_030704355.1|	32.2	214	227	603	3.30e-11	61.2
k141_34860_31	SARG|gi|490068471|ref|WP_003970646.1|	32.2	214	227	603	3.30e-11	61.2
k141_34860_31	SARG|gi|926286457|ref|WP_053623344.1|	32.2	214	227	605	3.30e-11	61.2
k141_34860_31	SARG|gi|1045390184|ref|WP_065479071.1|	32.2	214	227	605	3.30e-11	61.2
k141_23267_13	SARG|gi|486419929|ref|WP_001612272.1|	100	410	411	410	6.53e-288	779
k141_23267_13	SARG|Q8XB84	98.8	410	411	410	5.14e-285	772
k141_23267_13	SARG|gi|487742839|ref|WP_001825915.1|	98.5	410	411	410	5.14e-285	772
k141_23267_13	SARG|YP_002405849	99.0	409	411	410	7.30e-285	771
k141_23267_13	SARG|gi|487403919|ref|WP_001672347.1|	98.8	410	411	410	7.30e-285	771
k141_23267_13	SARG|gi|447059726|ref|WP_001136982.1|	98.5	410	411	410	7.30e-285	771
k141_23267_13	SARG|gi|742863377|ref|WP_038994632.1|	98.8	409	411	410	1.04e-284	771
k141_23267_13	SARG|YP_002389784	98.8	409	411	410	1.04e-284	771
k141_23267_13	SARG|gi|487406742|ref|WP_001674825.1|	99.0	409	411	422	1.15e-284	771
k141_23267_13	SARG|gi|447059754|ref|WP_001137010.1|	98.5	409	411	410	1.47e-284	771
k141_41423_2	SARG|AUI09862.1	39.8	269	283	287	2.29e-62	197
k141_41423_2	SARG|AJ459418.gene.p01	35.1	259	283	263	2.37e-46	155
k141_41423_2	SARG|gi|970263436|ref|WP_058647620.1|	35.1	259	283	263	4.71e-46	154
k141_41423_2	SARG|gi|553729091|ref|WP_023063817.1|	32.8	259	283	271	3.19e-37	132
k141_41423_2	NCBI|WP_001043265.1|1|1|sul2|sul2|insensitivity|2|sulfonamide|sulfonamide|sulfonamide-resistant_dihydropteroate_synthase_Sul2|AMR|sulfonamide	32.8	259	283	271	4.47e-37	131
k141_41423_2	SARG|gi|485778844|ref|WP_001402002.1|	32.8	259	283	271	6.28e-37	131
k141_41423_2	SARG|gi|638947703|ref|WP_024439711.1|	32.8	259	283	271	8.81e-37	130
k141_41423_2	SARG|gi|503278284|ref|WP_013512945.1|	33.1	266	283	271	8.81e-37	130
k141_41423_2	SARG|gi|916164813|ref|WP_050960181.1|	32.8	259	283	271	8.81e-37	130
k141_41423_2	SARG|gi|486033774|ref|WP_001505252.1|	32.8	259	283	271	8.81e-37	130
k141_41423_5	NCBI|WP_407792291.1|1|1|mcr-12.1|mcr-12||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-12.1|AMR|peptide	31.1	257	506	548	9.24e-19	88.2
k141_41423_5	SARG|gb|WP_001572373.1|ARO:3004684|MCR-9	22.9	449	506	539	8.82e-18	85.1
k141_41423_5	NCBI|QKF95689.1|1|1|mcr-9.3|mcr-9||1|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-9.3|AMR|peptide	22.9	449	506	539	8.82e-18	85.1
k141_41423_5	NCBI|MBO4175406.1|1|1|mcr-9.2|mcr-9||1|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-9.2|AMR|peptide	22.9	449	506	540	8.84e-18	85.1
k141_41423_5	NCBI|WP_094308975.1|1|1|mcr-3.22|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.22|AMR|peptide	24.7	470	506	541	6.27e-16	79.3
k141_41423_5	SARG|gb|ATQ63376.1|ARO:3004504|MCR-3.10	24.3	470	506	541	1.95e-15	77.8
k141_41423_5	SARG|WP_065804663.1	24.5	470	506	541	1.95e-15	77.8
k141_41423_5	NCBI|WP_136512112.1|1|1|mcr-3.29|mcr-3||2|COLISTIN|COLISTIN|phosphoethanolamine--lipid_A_transferase_MCR-3.29|AMR|peptide	24.5	470	506	541	1.95e-15	77.8
k141_41423_5	SARG|gb|AST36144.1|ARO:3004508|MCR-3.9	24.0	470	506	541	2.58e-15	77.4
k141_41423_5	SARG|gb|AUN87920.1|ARO:3004500|MCR-3.11	24.5	470	506	541	3.43e-15	77.0
k141_8478_9	CARD|gb|AAL19308.1|ARO:3000504|golS	42.1	126	136	154	5.75e-31	107
k141_47985_21	SARG|gi|912614197|ref|WP_050196089.1|	35.7	221	372	648	2.25e-28	115
k141_47985_21	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	30.5	220	372	343	2.89e-23	98.2
k141_47985_21	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	28.8	219	372	307	6.09e-23	96.7
k141_47985_21	SARG|gi|953808775|ref|WP_058042812.1|	33.3	222	372	608	3.78e-21	94.0
k141_47985_21	SARG|gb|AAK76137.1|ARO:3000024|patA	27.5	233	372	564	2.43e-16	79.3
k141_47985_21	SARG|gb|NP_388442.1|ARO:3004476|vmlR	29.3	208	372	547	2.45e-13	70.1
k141_47985_21	NCBI|WP_011116970.1|1|1|tetAB_B|tetAB_B|efflux|2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_TetAB_subunit_B|AMR|tetracycline	28.2	209	372	528	3.83e-08	53.9
k141_23287_10	CARD|gb|AAK37618.1|ARO:3005008|TxR	32.4	315	514	318	9.87e-48	167
k141_23287_24	NCBI|CAQ45063.1|1|1|emrA-sm|emrA-sm||1|EFFLUX|EFFLUX|multidrug_efflux_MFS_transporter_periplasmic_adaptor_subunit_EmrA|AMR|efflux	34.5	322	343	393	2.92e-50	171
k141_23287_24	SARG|gi|1012702223|ref|WP_062814406.1|	33.0	348	343	391	6.83e-46	159
k141_23287_24	SARG|CP004022.1.gene547.p01	33.0	348	343	391	6.83e-46	159
k141_23287_24	SARG|gi|896186420|ref|WP_049196554.1|	32.8	348	343	391	9.56e-46	159
k141_23287_24	SARG|gi|896193189|ref|WP_049201850.1|	33.0	348	343	391	1.34e-45	159
k141_23287_24	SARG|gi|490366423|ref|WP_004246087.1|	33.0	348	343	391	1.34e-45	159
k141_23287_24	SARG|gi|896217236|ref|WP_049220241.1|	33.0	348	343	391	1.34e-45	159
k141_23287_24	SARG|gi|896195525|ref|WP_049203604.1|	33.0	348	343	391	1.87e-45	158
k141_23287_24	SARG|gi|742671087|ref|WP_038976864.1|	31.7	341	343	387	2.40e-45	158
k141_23287_24	SARG|gi|545297559|ref|WP_021577764.1|	31.7	341	343	387	4.70e-45	157
k141_23287_25	SARG|gi|739061055|ref|WP_036932467.1|	28.7	380	390	505	2.30e-54	186
k141_23287_25	SARG|gi|739101602|ref|WP_036972253.1|	28.4	380	390	505	8.72e-54	184
k141_23287_25	SARG|gi|739067217|ref|WP_036938624.1|	28.7	380	390	505	1.22e-53	184
k141_23287_25	SARG|gi|896193191|ref|WP_049201851.1|	28.7	380	390	505	1.70e-53	184
k141_23287_25	SARG|CP004022.1.gene546.p01	28.4	380	390	505	2.37e-53	183
k141_23287_25	SARG|gi|983379651|ref|WP_060556945.1|	28.4	380	390	512	2.70e-53	183
k141_23287_25	SARG|gi|739012928|ref|WP_036894398.1|	28.4	380	390	512	2.70e-53	183
k141_23287_25	SARG|gi|983377615|ref|WP_060555304.1|	28.4	380	390	512	3.77e-53	183
k141_23287_25	SARG|gi|857587974|emb|CRL59874.1|	28.3	381	390	505	6.43e-53	182
k141_23287_25	SARG|gi|857775940|emb|CRL64641.1|	28.4	380	390	505	8.97e-53	182
k141_46446_17	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	31.9	235	299	346	4.71e-20	87.8
k141_46446_34	NCBI|WP_063856705.1|1|1|vanH-D|vanH-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-D|AMR|glycopeptide	32.1	224	411	323	1.54e-24	102
k141_46446_34	SARG|gi|746609237|ref|WP_039635344.1|	29.6	257	411	322	2.85e-24	101
k141_46446_34	SARG|gi|740152780|ref|WP_037997109.1|	30.1	226	411	322	4.78e-23	97.8
k141_46446_34	SARG|DQ018711.1.gene4.p01	29.2	257	411	322	6.53e-23	97.4
k141_46446_34	SARG|gi|738848198|ref|WP_036737307.1|	31.3	262	411	323	1.69e-22	96.3
k141_46446_34	NCBI|WP_063856698.1|1|1|vanH-Ac1|vanH-Ac1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ac1|AMR|glycopeptide	31.7	227	411	351	8.43e-22	94.7
k141_46446_34	SARG|gi|737310392|ref|WP_035293250.1|	28.8	257	411	323	1.09e-21	94.0
k141_46446_34	SARG|AF155139.2.gene6.p01	28.6	255	411	322	1.46e-21	93.6
k141_46446_34	SARG|gi|749574782|ref|WP_040203616.1|	32.2	233	411	323	3.75e-21	92.4
k141_46446_34	SARG|FJ349556.1.gene5.p01	29.6	247	411	326	3.90e-21	92.4
k141_46446_37	CARD|gb|CAA79966.1|ARO:3003665|NmcR	30.1	113	298	295	6.19e-07	48.9
k141_72900_14	SARG|gi|896514456|ref|WP_049420414.1|	28.4	116	454	387	1.47e-09	58.5
k141_72900_14	SARG|gi|881042407|ref|WP_048761349.1|	28.4	116	454	387	1.47e-09	58.5
k141_72900_14	SARG|gi|518673227|ref|WP_019834920.1|	28.4	116	454	387	1.47e-09	58.5
k141_72900_14	SARG|gi|896507999|ref|WP_049415454.1|	28.4	116	454	387	1.47e-09	58.5
k141_72900_14	SARG|gi|896534839|ref|WP_049437516.1|	28.4	116	454	387	3.45e-09	57.4
k141_72900_14	SARG|gi|739700146|ref|WP_037554487.1|	28.4	116	454	387	3.45e-09	57.4
k141_72900_14	SARG|ZP_04060517	28.4	116	454	387	3.45e-09	57.4
k141_72900_14	SARG|gi|896396316|ref|WP_049335029.1|	28.4	116	454	387	3.45e-09	57.4
k141_72900_14	SARG|gi|313655620|gb|EFS19365.1|	28.4	116	454	390	3.49e-09	57.4
k141_72900_14	SARG|ZP_03592168	29.4	119	454	389	6.13e-09	56.6
k141_72903_5	CARD|gb|AEX49906.1|ARO:3003583|basS	27.4	350	481	477	5.73e-34	132
k141_72903_5	CARD|gb|AAD51347.1|ARO:3003067|smeS	29.8	289	481	467	2.24e-28	116
k141_72903_5	CARD|gb|AAC75429.1|ARO:3000833|evgS	24.8	226	481	1197	4.55e-14	73.9
k141_72903_6	CARD|gb|ATC67679.1|ARO:3000838|arlR	40.2	219	228	219	1.37e-49	160
k141_72903_6	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	41.1	224	228	228	6.39e-47	154
k141_72903_6	CARD|gb|AAG06465.1|ARO:3005063|cprR	38.2	220	228	223	2.49e-45	149
k141_72903_6	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.5	222	228	219	3.95e-43	144
k141_72903_6	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.0	222	228	219	1.57e-42	142
k141_72903_6	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.0	222	228	220	1.62e-42	142
k141_72903_6	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.0	222	228	220	1.62e-42	142
k141_72903_6	NCBI|WP_063856729.1|1|1|vanR-O|vanR-O|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-O|AMR|glycopeptide	36.8	228	228	233	1.64e-42	142
k141_72903_6	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.0	222	228	220	2.28e-42	142
k141_72903_6	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	34.4	227	228	229	4.04e-39	134
k141_72903_7	NCBI|AAD15665.1|1|1|tbtM|tbtM||1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_outer_membrane_channel_subunit_TbtM|AMR|efflux	43.7	465	461	476	3.19e-107	325
k141_72903_7	NCBI|AAY90615.1|1|1|emhC|emhC||1|EFFLUX|EFFLUX|efflux_RND_transporter_outer_membrane_subunit_EmhC|AMR|efflux	42.7	461	461	486	3.82e-105	320
k141_72903_7	SARG|CAG34266	43.5	455	461	474	2.12e-104	318
k141_72903_7	NCBI|WP_003152694.1|1|1|toprJ1|toprJ||2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_transporter_outer_membrane_subunit_TOprJ1|AMR|tetracycline	41.1	462	461	477	4.62e-104	317
k141_72903_7	NCBI|WP_088903432.1|1|1|toprJ2|toprJ||2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_transporter_outer_membrane_subunit_TOprJ2|AMR|tetracycline	41.1	462	461	477	4.62e-104	317
k141_72903_7	SARG|CAC14596	43.2	461	461	466	6.63e-104	316
k141_72903_7	SARG|CAG34251	43.0	461	461	466	1.87e-103	315
k141_72903_7	SARG|YP_002706078	43.0	461	461	481	2.91e-103	315
k141_72903_7	SARG|gi|544780240|ref|WP_021203903.1|	42.7	461	461	461	9.03e-103	313
k141_72903_7	SARG|gb|BAM10414.1|ARO:3003039|oprA	42.7	461	461	467	1.08e-102	313
k141_72903_9	CARD|gb|AAL14439.1|ARO:3000774|adeA	24.0	317	408	396	9.40e-11	62.0
k141_72903_10	SARG|gi|499256187|ref|WP_010953727.1|	25.6	1044	1048	1042	6.28e-69	249
k141_72903_10	SARG|YP_001668663	24.5	1051	1048	1043	5.09e-68	246
k141_72903_10	SARG|YP_608682	25.3	1048	1048	1042	2.23e-67	244
k141_72903_10	SARG|gi|1011729993|ref|WP_062573631.1|	24.6	1051	1048	1042	4.04e-67	244
k141_72903_10	SARG|gi|496339859|ref|WP_009049037.1|	24.9	1053	1048	1043	4.08e-67	244
k141_72903_10	SARG|gi|852273548|ref|WP_048328542.1|	24.5	1045	1048	1043	4.35e-66	241
k141_72903_10	SARG|gi|757680562|ref|WP_042911120.1|	24.8	1059	1048	1043	1.06e-65	239
k141_72903_10	SARG|gi|759350549|ref|WP_043081214.1|	24.8	1059	1048	1043	1.06e-65	239
k141_72903_10	SARG|gi|553756961|ref|WP_023089641.1|	24.8	1059	1048	1043	1.06e-65	239
k141_72903_10	SARG|gi|489226605|ref|WP_003134989.1|	24.8	1059	1048	1043	1.42e-65	239
k141_72903_13	megares|MEG_8662|Drugs|Metronidazole|rdxA_nitroimidazole_reductase|RDXA_1	29.6	159	218	210	1.12e-12	63.5
k141_36653_12	CARD|gb|CAA79966.1|ARO:3003665|NmcR	27.6	145	309	295	3.64e-12	64.7
k141_529_6	SARG|gi|803568669|ref|WP_046077412.1|	46.5	200	232	648	2.57e-52	177
k141_529_6	SARG|gi|446110352|ref|WP_000188207.1|	46.5	200	232	648	2.57e-52	177
k141_529_6	SARG|YP_002382193	46.5	200	232	648	2.57e-52	177
k141_529_6	SARG|gi|803575554|ref|WP_046081557.1|	46.5	200	232	648	2.57e-52	177
k141_529_6	SARG|gi|446110351|ref|WP_000188206.1|	46.5	200	232	648	2.57e-52	177
k141_529_6	SARG|gi|749017716|ref|WP_040076354.1|	45.5	202	232	646	2.50e-51	175
k141_529_6	SARG|gi|694064328|ref|WP_032410816.1|	47.0	202	232	646	9.29e-51	173
k141_529_6	SARG|gi|751930065|ref|WP_041144773.1|	45.5	202	232	648	4.89e-50	171
k141_529_6	SARG|gi|446110305|ref|WP_000188160.1|	45.0	200	232	648	6.78e-50	171
k141_529_6	SARG|gb|ADZ12699.1|ARO:3005091|RanA	32.5	197	232	258	1.73e-25	99.4
k141_28415_1	CARD|gb|AEX49906.1|ARO:3003583|basS	29.3	222	269	477	9.53e-21	90.1
k141_28415_3	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	36.4	242	239	252	5.67e-48	157
k141_28415_3	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	36.1	227	239	229	5.83e-42	141
k141_28415_3	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	35.2	227	239	231	1.07e-39	135
k141_28415_3	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	34.8	227	239	231	1.07e-39	135
k141_28415_3	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	34.4	227	239	231	8.41e-39	133
k141_28415_3	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	33.9	230	239	239	1.46e-38	133
k141_28415_3	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	32.6	227	239	231	6.58e-38	131
k141_28415_3	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	32.6	227	239	231	6.58e-38	131
k141_28415_3	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	32.5	234	239	231	7.25e-37	128
k141_28415_3	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	32.3	226	239	228	1.87e-36	127
k141_31606_9	CARD|gb|AIA35096.1|ARO:3005059|LptD	82.1	786	785	782	0.0	1347
k141_31606_12	SARG|AY234334.1.orf0.gene.p01	24.6	260	274	281	2.67e-16	75.9
k141_31606_12	SARG|NC_007792.3912746.p01	29.1	182	274	244	1.92e-14	70.1
k141_31606_12	SARG|NP_040462	28.6	182	274	244	1.27e-13	67.8
k141_31606_12	SARG|P13978	28.6	182	274	244	1.73e-13	67.4
k141_31606_12	NCBI|WP_011276921.1|1|1|erm(C)|erm(C)|target_modification|2|CLINDAMYCIN/ERYTHROMYCIN/STREPTOGRAMIN_B/TYLOSIN|LINCOSAMIDE/MACROLIDE/STREPTOGRAMIN|23S_rRNA_(adenine(2058)-N(6))-methyltransferase_Erm(C)|AMR|multidrug	28.6	182	274	244	1.73e-13	67.4
k141_31606_12	SARG|gi|157058876|gb|ABV03165.1|	28.6	182	274	244	1.73e-13	67.4
k141_31606_12	SARG|NC_010686.6295746.p01	28.6	182	274	244	1.73e-13	67.4
k141_31606_12	SARG|gi|353127769|gb|AEQ67361.1|	28.6	182	274	244	1.73e-13	67.4
k141_31606_12	SARG|NC_007209.3523503.p01	28.6	182	274	244	1.73e-13	67.4
k141_31606_12	SARG|gi|700659240|gb|AIU96746.1|	28.6	182	274	253	1.93e-13	67.4
k141_31606_17	SARG|gb|AAA25550.1|ARO:3003105|dfrA3	51.3	160	197	162	1.83e-52	164
k141_31606_17	SARG|gb|ABO40886.1|ARO:3004645|dfrI	40.7	162	197	191	2.63e-40	134
k141_31606_17	NCBI|WP_434062363.1|1|1|dfrA53|dfrA53|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrA53|AMR|diaminopyrimidine	41.9	160	197	166	1.02e-39	132
k141_31606_17	SARG|gb|CBL80435.1|ARO:3002869|dfrK	40.9	159	197	163	2.66e-39	131
k141_31606_17	NCBI|WP_031775848.1|1|1|dfrK|dfrK|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrK|AMR|diaminopyrimidine	40.9	159	197	163	2.66e-39	131
k141_31606_17	SARG|gb|BAE15963.1|ARO:3002868|dfrG	40.3	159	197	165	2.81e-39	131
k141_31606_17	NCBI|WP_012779617.1|1|1|dfrK|dfrK|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrK|AMR|diaminopyrimidine	40.9	159	197	163	1.06e-38	129
k141_31606_17	SARG|gb|ASF80997.1|ARO:3005164|dfrA35	41.0	139	197	170	6.65e-36	122
k141_31606_17	SARG|gb|AAA85213.1|ARO:3002866|dfrD	39.2	158	197	162	4.76e-34	117
k141_31606_17	megares|MEG_2575|Drugs|Trimethoprim|Dihydrofolate_reductase|DFRD_1	39.2	158	197	162	4.76e-34	117
k141_31606_18	SARG|gi|740410309|ref|WP_038243756.1|	28.8	518	621	563	7.94e-46	169
k141_31606_18	SARG|ZP_04615639	28.7	512	621	543	1.10e-45	169
k141_31606_18	SARG|ZP_04631861	29.1	512	621	543	1.51e-45	168
k141_31606_18	SARG|YP_001007250	29.0	518	621	563	3.82e-45	167
k141_31606_18	SARG|ZP_04623897	28.9	512	621	543	5.33e-45	167
k141_31606_18	SARG|ZP_04635128	28.9	512	621	543	5.33e-45	167
k141_31606_18	SARG|gi|318604694|emb|CBY26192.1|	28.9	509	621	540	6.97e-45	166
k141_31606_18	SARG|gi|1001786599|ref|WP_061324791.1|	28.2	517	621	563	1.34e-44	166
k141_31606_18	SARG|ZP_04612557	28.8	511	621	543	3.51e-44	164
k141_31606_18	SARG|gi|544012122|gb|ERK10884.1|	28.8	534	621	541	4.66e-44	164
k141_71383_5	SARG|gb|APB03219.1|ARO:3003986|TaeA	44.9	385	399	648	6.17e-100	309
k141_71383_5	megares|MEG_4322|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	35.1	376	399	655	1.30e-60	206
k141_71383_5	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.8	376	399	655	2.52e-60	205
k141_71383_5	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.8	376	399	655	2.52e-60	205
k141_71383_5	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.8	376	399	655	2.52e-60	205
k141_71383_5	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.8	376	399	655	2.52e-60	205
k141_71383_5	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.8	376	399	655	2.52e-60	205
k141_71383_5	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.8	376	399	655	2.52e-60	205
k141_71383_5	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.8	376	399	655	2.52e-60	205
k141_71383_5	SARG|gb|AKA86814|ARO:3003746|optrA	34.8	376	399	655	2.52e-60	205
k141_1873_1	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	53.2	380	353	374	1.50e-121	354
k141_1873_1	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	49.9	359	353	357	2.20e-109	322
k141_39984_1	NCBI|WP_050824634.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	32.9	82	92	639	6.16e-08	47.4
k141_49896_3	NCBI|WP_172065992.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	24.0	192	226	461	1.24e-07	50.4
k141_49896_3	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	24.0	192	226	461	1.32e-06	47.4
k141_49896_8	SARG|gi|835330218|ref|WP_047457825.1|	42.9	219	229	648	8.42e-56	187
k141_49896_8	SARG|YP_001453760	42.9	219	229	648	8.42e-56	187
k141_49896_8	SARG|gi|992390012|ref|WP_061077002.1|	42.9	219	229	648	1.17e-55	186
k141_49896_8	SARG|gi|754927849|ref|WP_042284850.1|	42.9	219	229	648	1.17e-55	186
k141_49896_8	SARG|gi|1017028727|ref|WP_063163394.1|	44.3	219	229	646	1.59e-55	186
k141_49896_8	SARG|gi|695731408|ref|WP_032657917.1|	44.3	219	229	646	2.21e-55	186
k141_49896_8	SARG|gi|896088003|ref|WP_049126277.1|	44.3	219	229	646	2.21e-55	186
k141_49896_8	SARG|gi|1028180030|ref|WP_063927084.1|	44.3	219	229	646	2.21e-55	186
k141_49896_8	SARG|gi|749017716|ref|WP_040076354.1|	43.8	219	229	646	2.21e-55	186
k141_49896_8	SARG|gi|798862580|ref|WP_045895455.1|	44.3	219	229	646	2.21e-55	186
k141_20276_26	CARD|gb|BAA16344.1|ARO:3000491|acrD	99.9	1037	1038	1037	0.0	1966
k141_20276_26	CARD|gb|AAC73564.1|ARO:3000216|acrB	66.0	1036	1038	1049	0.0	1295
k141_20276_26	SARG|gi|447196024|ref|WP_001273280.1|	64.1	1032	1038	1037	0.0	1249
k141_20276_26	SARG|gi|817600095|ref|WP_046594084.1|	64.0	1032	1038	1037	0.0	1249
k141_20276_26	SARG|gi|487663012|ref|WP_001752778.1|	64.0	1032	1038	1037	0.0	1248
k141_20276_26	SARG|gi|817604860|ref|WP_046598079.1|	64.0	1032	1038	1037	0.0	1248
k141_20276_26	SARG|gi|817600173|ref|WP_046594139.1|	64.0	1032	1038	1037	0.0	1248
k141_20276_26	SARG|gi|817601660|ref|WP_046595348.1|	64.0	1032	1038	1037	0.0	1247
k141_20276_26	SARG|CP000647.1.gene3710.p01	64.0	1032	1038	1036	0.0	1242
k141_20276_26	SARG|gi|556290479|ref|WP_023291164.1|	64.1	1032	1038	1036	0.0	1240
k141_20276_63	SARG|gi|922960663|ref|WP_053388845.1|	40.4	223	366	648	2.82e-36	138
k141_20276_63	SARG|gi|757799695|ref|WP_043016897.1|	40.4	223	366	648	3.84e-36	137
k141_20276_63	SARG|gi|1045891604|ref|WP_065554100.1|	40.4	223	366	648	3.84e-36	137
k141_20276_63	SARG|gi|507082903|ref|WP_016153652.1|	40.4	223	366	648	3.84e-36	137
k141_20276_63	SARG|gi|491270241|ref|WP_005128370.1|	39.4	231	366	648	5.24e-36	137
k141_20276_63	SARG|gi|835233765|ref|WP_047410073.1|	40.4	223	366	648	5.24e-36	137
k141_20276_63	SARG|gi|754951242|ref|WP_042307417.1|	40.4	223	366	648	5.24e-36	137
k141_20276_63	SARG|gi|851902043|ref|WP_048212057.1|	39.4	231	366	648	5.24e-36	137
k141_20276_63	SARG|gi|992380339|ref|WP_061067665.1|	39.4	231	366	648	5.24e-36	137
k141_20276_63	SARG|gi|493734654|ref|WP_006683876.1|	40.4	223	366	648	5.24e-36	137
k141_20276_107	CARD|gb|AAC75429.1|ARO:3000833|evgS	96.8	866	867	1197	0.0	1661
k141_20276_107	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	41.9	105	867	232	1.33e-14	73.2
k141_20276_107	CARD|gb|ATC67679.1|ARO:3000838|arlR	30.5	131	867	219	9.86e-13	67.4
k141_20276_107	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	38.5	104	867	231	1.63e-12	67.0
k141_20276_107	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	29.7	111	867	225	1.01e-06	49.7
k141_20276_107	CARD|gb|AAC73788.1|ARO:3003841|kdpE	29.7	111	867	225	1.01e-06	49.7
k141_20276_107	CARD|gb|ADM92605.1|ARO:3000553|adeR	29.0	107	867	247	4.00e-06	48.1
k141_73083_7	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	37.6	218	220	219	4.82e-45	148
k141_73083_7	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	37.6	218	220	219	6.81e-45	148
k141_73083_7	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	37.6	218	220	220	7.01e-45	148
k141_73083_7	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	37.6	218	220	220	1.40e-44	147
k141_73083_7	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.2	218	220	220	3.52e-42	141
k141_73083_7	CARD|gb|AAD51348.1|ARO:3003066|smeR	36.5	219	220	229	3.49e-38	131
k141_73083_7	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	35.0	223	220	231	2.89e-37	129
k141_73083_7	CARD|gb|ADM92605.1|ARO:3000553|adeR	33.3	225	220	247	1.55e-29	109
k141_73083_8	CARD|gb|AEX49906.1|ARO:3003583|basS	30.5	456	450	477	9.04e-47	167
k141_73083_8	NCBI|WP_011461302.1|1|1|vanS-I|vanS-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-I|AMR|glycopeptide	25.7	202	450	392	1.07e-08	55.8
k141_1994_18	SARG|gb|ADZ12699.1|ARO:3005091|RanA	34.5	206	270	258	3.73e-35	125
k141_1994_18	SARG|gb|AAK76136.1|ARO:3000025|patB	24.0	221	270	588	1.64e-14	72.0
k141_1994_18	SARG|gb|AGN74946|ARO:3003749|salA	41.4	58	270	541	3.05e-07	50.1
k141_1994_18	SARG|gi|488231473|ref|WP_002302681.1|	41.5	65	270	492	3.96e-06	46.6
k141_1994_18	SARG|gi|488216250|ref|WP_002287458.1|	41.5	65	270	492	3.96e-06	46.6
k141_1994_18	SARG|gi|488247627|ref|WP_002318835.1|	41.5	65	270	492	3.96e-06	46.6
k141_1994_18	SARG|AY004350.gene.p01	41.5	65	270	492	3.96e-06	46.6
k141_1994_24	SARG|gi|500194536|ref|WP_011867743.1|	31.4	210	242	306	1.35e-27	106
k141_1994_24	SARG|gb|AGN74946|ARO:3003749|salA	25.7	187	242	541	1.09e-09	57.0
k141_1994_24	SARG|gb|SOX29786.1|ARO:3004730|tva(A)	25.4	197	242	505	3.67e-08	52.4
k141_1994_24	NCBI|WP_014936356.1|1|1|tva(B)|tva(B)|target_protection|2|TIAMULIN|PLEUROMUTILIN|ABC-F_type_ribosomal_protection_protein_Tva(B)|AMR|pleuromutilin	27.5	153	242	504	8.88e-08	51.2
k141_1994_24	SARG|gi|817536927|ref|WP_046586836.1|	20.9	196	242	492	3.96e-06	46.2
k141_1994_33	CARD|gb|AAC75429.1|ARO:3000833|evgS	26.1	651	779	1197	3.67e-49	186
k141_1994_33	SARG|ZP_02848503	34.5	113	779	221	4.37e-08	53.5
k141_1994_33	CARD|gb|ATC67679.1|ARO:3000838|arlR	31.9	91	779	219	4.59e-07	50.4
k141_1994_33	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	33.7	92	779	225	6.96e-06	47.0
k141_1994_33	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	34.6	104	779	228	9.60e-06	46.6
k141_1994_56	NCBI|WP_047693838.1|1|1|oqxA6|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA6|AMR|multidrug	38.5	161	311	391	6.24e-20	88.2
k141_1994_56	SARG|gb|AAP43109.1|ARO:3003922|oqxA	38.5	161	311	391	8.50e-20	87.8
k141_1994_56	NCBI|WP_004149398.1|1|1|oqxA10|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA10|AMR|multidrug	38.5	161	311	391	8.50e-20	87.8
k141_1994_56	NCBI|WP_004212918.1|1|1|oqxA11|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA11|AMR|multidrug	38.5	161	311	391	8.50e-20	87.8
k141_1994_56	NCBI|WP_063865373.1|1|1|oqxA5|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA5|AMR|multidrug	38.5	161	311	391	8.50e-20	87.8
k141_1994_56	NCBI|WP_063865390.1|1|1|oqxA8|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA8|AMR|multidrug	38.5	161	311	391	8.50e-20	87.8
k141_1994_56	NCBI|WP_063865399.1|1|1|oqxA9|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA9|AMR|multidrug	38.5	161	311	391	8.50e-20	87.8
k141_1994_56	NCBI|WP_004890321.1|1|1|oqxA3|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA3|AMR|multidrug	38.5	161	311	391	8.50e-20	87.8
k141_1994_56	NCBI|WP_063865358.1|1|1|oqxA2|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA2|AMR|multidrug	38.5	161	311	391	1.16e-19	87.4
k141_1994_56	NCBI|WP_063865368.1|1|1|oqxA4|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA4|AMR|multidrug	38.5	161	311	391	1.58e-19	87.0
k141_1994_73	SARG|gi|507055561|ref|WP_016126482.1|	27.6	210	500	309	2.76e-11	63.5
k141_1994_73	SARG|gi|500194536|ref|WP_011867743.1|	27.5	218	500	306	1.16e-10	61.6
k141_1994_73	SARG|gi|507050365|ref|WP_016121371.1|	28.1	210	500	309	1.58e-10	61.2
k141_1994_73	SARG|gi|542061059|gb|ERI11611.1|	27.4	215	500	316	1.66e-10	61.2
k141_1994_73	SARG|gi|445996719|ref|WP_000074574.1|	28.1	210	500	309	2.11e-10	60.8
k141_1994_73	SARG|gi|507035724|ref|WP_016107411.1|	29.2	216	500	309	2.11e-10	60.8
k141_1994_73	SARG|gi|488120365|ref|WP_002191762.1|	28.1	210	500	309	2.11e-10	60.8
k141_1994_73	SARG|gi|488053456|ref|WP_002124853.1|	27.6	210	500	309	2.11e-10	60.8
k141_1994_73	SARG|gi|507023808|ref|WP_016095885.1|	27.6	210	500	309	2.11e-10	60.8
k141_1994_73	SARG|gi|445996697|ref|WP_000074552.1|	29.2	216	500	309	2.83e-10	60.5
k141_1994_85	CARD|gb|AAC76296.1|ARO:3000656|AcrS	98.6	220	221	220	5.73e-157	432
k141_1994_85	NCBI|CAA81047.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	29.5	193	221	210	7.43e-24	93.6
k141_1994_85	NCBI|ACF30254.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	29.5	193	221	210	1.04e-23	93.2
k141_1994_86	SARG|gb|AAC76297.1|ARO:3000499|acrE	99.5	385	386	385	3.49e-268	727
k141_1994_86	SARG|CAC35724	69.6	375	386	399	8.54e-182	509
k141_1994_86	SARG|gi|928884686|ref|WP_053919771.1|	68.0	388	386	397	1.07e-179	504
k141_1994_86	SARG|YP_001879173	68.3	388	386	409	1.15e-179	504
k141_1994_86	SARG|YP_002401592	68.0	388	386	397	1.51e-179	503
k141_1994_86	SARG|CAS07946	68.0	388	386	397	2.15e-179	503
k141_1994_86	SARG|NC_002695.1.914620.p01	68.0	388	386	397	2.15e-179	503
k141_1994_86	SARG|gi|928844224|ref|WP_053895298.1|	68.0	388	386	397	3.05e-179	503
k141_1994_86	SARG|gi|928821234|ref|WP_053881997.1|	68.0	388	386	397	3.05e-179	503
k141_1994_86	SARG|gi|1000938487|ref|WP_061182054.1|	68.0	388	386	397	3.05e-179	503
k141_1994_87	SARG|gb|AAC76298.1|ARO:3000502|acrF	99.4	1034	1035	1034	0.0	1921
k141_1994_87	SARG|gi|447196024|ref|WP_001273280.1|	89.0	1033	1035	1037	0.0	1735
k141_1994_87	SARG|gi|817600095|ref|WP_046594084.1|	88.8	1033	1035	1037	0.0	1731
k141_1994_87	SARG|gi|487663012|ref|WP_001752778.1|	88.7	1033	1035	1037	0.0	1731
k141_1994_87	SARG|gi|817604860|ref|WP_046598079.1|	88.8	1033	1035	1037	0.0	1730
k141_1994_87	SARG|gi|817600173|ref|WP_046594139.1|	88.8	1033	1035	1037	0.0	1730
k141_1994_87	SARG|gi|817601660|ref|WP_046595348.1|	88.8	1033	1035	1037	0.0	1729
k141_1994_87	SARG|gi|694076105|ref|WP_032421853.1|	86.5	1032	1035	1036	0.0	1693
k141_1994_87	SARG|gi|496667122|ref|WP_009309612.1|	86.6	1032	1035	1036	0.0	1693
k141_1994_87	SARG|CP000647.1.gene3710.p01	86.5	1032	1035	1036	0.0	1692
k141_59882_7	SARG|gb|AAV85982.1|ARO:3000535|macB	34.6	205	233	644	1.02e-26	106
k141_59882_7	SARG|gb|AYV52072.1|ARO:3002882|lmrD	27.3	216	233	664	1.65e-16	77.0
k141_59882_7	SARG|gb|CDO61516.1|ARO:3003949|efrB	32.7	156	233	362	1.03e-14	71.2
k141_59882_7	SARG|gb|AAK76136.1|ARO:3000025|patB	26.3	213	233	588	2.23e-13	67.8
k141_25240_3	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	76.2	383	378	374	1.93e-205	568
k141_25240_3	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	53.7	369	378	357	4.53e-123	358
k141_25240_7	SARG|AAD41881	34.3	318	330	323	4.46e-60	194
k141_25240_7	SARG|AAD51059	34.0	318	330	323	3.50e-59	192
k141_25240_7	SARG|AAR37059	34.1	320	330	323	6.95e-59	191
k141_25240_7	NCBI|WP_063856705.1|1|1|vanH-D|vanH-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-D|AMR|glycopeptide	33.6	318	330	323	9.79e-59	191
k141_25240_7	SARG|AAD42183	34.0	318	330	322	1.48e-57	187
k141_25240_7	SARG|gi|552942232|ref|WP_023043160.1|	32.7	318	330	323	3.02e-57	187
k141_25240_7	SARG|AY082011.1.gene6.p01	32.4	318	330	323	2.36e-56	184
k141_25240_7	SARG|KF478993.1.gene2.p01	35.2	290	330	350	5.27e-55	182
k141_25240_7	NCBI|WP_063856698.1|1|1|vanH-Ac1|vanH-Ac1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ac1|AMR|glycopeptide	32.7	321	330	351	7.60e-55	181
k141_25240_7	SARG|gi|740152780|ref|WP_037997109.1|	32.2	320	330	322	5.49e-54	178
k141_56632_2	SARG|gi|542061059|gb|ERI11611.1|	26.8	213	510	316	2.39e-16	79.0
k141_56632_2	SARG|gi|488120365|ref|WP_002191762.1|	26.2	237	510	309	2.36e-15	75.9
k141_56632_2	SARG|gi|447195835|ref|WP_001273091.1|	26.8	213	510	306	5.56e-15	74.7
k141_56632_2	SARG|gi|447195836|ref|WP_001273092.1|	26.8	213	510	306	5.56e-15	74.7
k141_56632_2	SARG|ZP_04081918	26.8	213	510	306	7.47e-15	74.3
k141_56632_2	SARG|gi|488068784|ref|WP_002140181.1|	26.6	233	510	309	7.71e-15	74.3
k141_56632_2	SARG|gi|447057509|ref|WP_001134765.1|	27.0	233	510	309	1.04e-14	73.9
k141_56632_2	SARG|gi|507023808|ref|WP_016095885.1|	25.3	233	510	309	1.39e-14	73.6
k141_56632_2	SARG|gi|488067981|ref|WP_002139378.1|	26.2	233	510	309	2.51e-14	72.8
k141_56632_2	SARG|gi|500194536|ref|WP_011867743.1|	25.6	219	510	306	3.27e-14	72.4
k141_33487_1	SARG|gb|APB03219.1|ARO:3003986|TaeA	38.4	297	331	648	2.23e-59	200
k141_33487_1	SARG|X63451.gene.p01	38.3	253	331	550	4.79e-39	144
k141_33487_1	megares|MEG_6558|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SRMB_1	38.3	253	331	550	4.79e-39	144
k141_33487_1	SARG|M80346.gene.p01	36.4	236	331	551	2.29e-37	139
k141_33487_1	megares|MEG_1491|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|CARA_1	36.4	236	331	551	2.29e-37	139
k141_33487_1	SARG|gb|AVI44920.1|ARO:3004470|poxtA	33.2	205	331	542	5.92e-26	107
k141_33487_1	NCBI|WP_209691075.1|1|1|poxtA2|poxtA|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA2|AMR|multidrug	33.2	205	331	544	5.97e-26	107
k141_33487_1	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	29.3	215	331	655	1.68e-20	91.3
k141_33487_1	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	29.3	215	331	655	1.68e-20	91.3
k141_33487_1	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.8	215	331	655	2.26e-20	90.9
k141_33487_6	megares|MEG_7070|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TETD_1	60.6	104	290	138	5.03e-39	132
k141_33487_6	CARD|gb|BAA15221.2|ARO:3000263|marA	50.5	101	290	127	2.29e-29	107
k141_33487_6	CARD|gb|AFK13828.1|ARO:3000823|ramA	48.0	102	290	124	1.73e-27	102
k141_33487_8	CARD|gb|AAD51348.1|ARO:3003066|smeR	45.2	221	230	229	2.87e-57	180
k141_33487_8	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	43.2	220	230	225	1.25e-46	153
k141_33487_8	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	36.5	222	230	228	1.22e-44	148
k141_33487_8	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	37.9	227	230	232	3.03e-43	144
k141_33487_8	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	37.9	227	230	232	3.03e-43	144
k141_33487_8	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	38.9	226	230	231	2.33e-42	142
k141_33487_8	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	38.1	226	230	231	1.84e-41	140
k141_33487_8	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	35.2	230	230	233	7.71e-41	138
k141_33487_8	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	37.2	226	230	230	1.00e-40	138
k141_33487_8	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	37.6	226	230	231	1.03e-40	138
k141_33487_9	CARD|gb|AEX49906.1|ARO:3003583|basS	28.4	292	467	477	3.98e-21	94.7
k141_43464_1	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	63.8	384	374	374	6.67e-165	465
k141_43464_1	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	49.6	369	374	357	7.65e-113	332
k141_43464_5	SARG|gb|AAC75271.1|ARO:3003952|yojI	99.1	547	548	547	0.0	1054
k141_43464_5	SARG|gi|803568669|ref|WP_046077412.1|	31.2	218	548	648	1.81e-17	84.7
k141_43464_5	SARG|gi|446110352|ref|WP_000188207.1|	31.2	218	548	648	1.81e-17	84.7
k141_43464_5	SARG|YP_002382193	31.2	218	548	648	1.81e-17	84.7
k141_43464_5	SARG|gi|803575554|ref|WP_046081557.1|	31.2	218	548	648	1.81e-17	84.7
k141_43464_5	SARG|gi|446110351|ref|WP_000188206.1|	31.2	218	548	648	1.81e-17	84.7
k141_43464_5	SARG|gi|896325272|ref|WP_049294291.1|	27.8	245	548	648	9.78e-17	82.4
k141_43464_5	SARG|gi|639225329|ref|WP_024561799.1|	27.8	223	548	648	1.71e-16	81.6
k141_43464_5	SARG|gi|639218559|ref|WP_024556062.1|	27.8	223	548	648	1.71e-16	81.6
k141_43464_5	SARG|gi|757799695|ref|WP_043016897.1|	26.9	242	548	648	2.27e-16	81.3
k141_43464_16	SARG|AAA50325	32.9	164	208	569	4.37e-13	66.2
k141_43464_16	SARG|gi|514904648|ref|WP_016630030.1|	32.5	163	208	498	7.65e-13	65.5
k141_43464_16	SARG|gi|488306124|ref|WP_002376519.1|	32.5	163	208	498	1.90e-12	64.3
k141_43464_16	SARG|gi|895818174|ref|WP_048942695.1|	32.5	166	208	498	1.90e-12	64.3
k141_43464_16	SARG|gi|498528849|ref|WP_010828356.1|	31.9	163	208	498	1.90e-12	64.3
k141_43464_16	SARG|ZP_04433622	32.5	166	208	498	1.90e-12	64.3
k141_43464_16	SARG|gi|488327681|ref|WP_002397066.1|	32.5	166	208	498	1.90e-12	64.3
k141_43464_16	SARG|gi|498424272|ref|WP_010730861.1|	32.5	163	208	498	2.57e-12	63.9
k141_43464_16	SARG|gi|498517610|ref|WP_010817605.1|	32.5	163	208	498	2.57e-12	63.9
k141_43464_16	SARG|gi|498519697|ref|WP_010819589.1|	32.5	163	208	498	2.57e-12	63.9
k141_43464_24	CARD|gb|BAB36671.1|ARO:3000832|evgA	27.3	194	216	204	3.27e-22	89.0
k141_43464_24	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	33.0	115	216	228	9.97e-13	63.9
k141_43464_24	CARD|gb|ATC67679.1|ARO:3000838|arlR	31.7	205	216	219	1.46e-10	57.8
k141_43464_33	SARG|gb|ALV80601.1|ARO:3003801|bcr-1	38.9	316	397	402	1.84e-66	215
k141_43464_33	SARG|AM296481.1.gene2.p01	29.4	408	397	421	1.41e-31	123
k141_43464_33	megares|MEG_1775|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLB_1	29.4	408	397	421	1.41e-31	123
k141_43464_33	SARG|AF313472.2.gene8.p01	29.4	398	397	419	4.90e-31	121
k141_43464_33	megares|MEG_1764|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	29.4	398	397	419	4.90e-31	121
k141_43464_33	megares|MEG_1766|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	29.4	398	397	419	9.26e-31	120
k141_43464_33	SARG|AY115475.1.gene4.p01	29.4	398	397	419	9.26e-31	120
k141_43464_33	SARG|YP_001338812	29.4	398	397	435	1.14e-30	120
k141_43464_33	SARG|ABK51578	29.4	398	397	437	1.17e-30	120
k141_43464_33	megares|MEG_1772|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLA_1	29.4	398	397	437	1.17e-30	120
k141_43464_35	SARG|gi|554685678|ref|WP_023185565.1|	32.5	237	530	648	1.47e-22	100
k141_43464_35	SARG|gi|923061916|ref|WP_053445667.1|	32.3	232	530	648	2.61e-22	99.8
k141_43464_35	SARG|YP_001571041	32.8	232	530	648	3.47e-22	99.4
k141_43464_35	SARG|gi|960873409|ref|WP_058345546.1|	32.8	232	530	648	3.47e-22	99.4
k141_43464_35	SARG|gi|555268367|ref|WP_023249730.1|	31.6	237	530	648	6.13e-22	98.6
k141_43464_35	SARG|gi|1027935297|ref|WP_063809363.1|	31.6	237	530	648	6.13e-22	98.6
k141_43464_35	SARG|gi|446048048|ref|WP_000125903.1|	32.8	232	530	648	8.16e-22	98.2
k141_43464_35	SARG|gi|959109145|ref|WP_058113944.1|	32.8	232	530	648	8.16e-22	98.2
k141_43464_35	SARG|gi|446048047|ref|WP_000125902.1|	32.8	232	530	648	8.16e-22	98.2
k141_43464_35	SARG|gi|779838942|ref|WP_045343641.1|	31.9	232	530	648	1.08e-21	97.8
k141_43464_66	SARG|gi|445996710|ref|WP_000074565.1|	29.4	228	507	309	3.15e-15	75.5
k141_43464_66	SARG|gi|542061059|gb|ERI11611.1|	28.9	225	507	316	2.67e-14	72.8
k141_43464_66	SARG|gi|445996719|ref|WP_000074574.1|	28.9	228	507	309	3.34e-14	72.4
k141_43464_66	SARG|gi|814314593|emb|CKF49145.1|	28.9	228	507	309	3.34e-14	72.4
k141_43464_66	SARG|gi|507044560|ref|WP_016115614.1|	29.6	243	507	306	4.35e-14	72.0
k141_43464_66	SARG|gi|445996722|ref|WP_000074577.1|	28.9	228	507	309	4.48e-14	72.0
k141_43464_66	SARG|gi|445996709|ref|WP_000074564.1|	28.9	228	507	309	6.02e-14	71.6
k141_43464_66	SARG|gi|895736250|emb|COF64653.1|	28.5	228	507	309	6.02e-14	71.6
k141_43464_66	SARG|gi|446110087|ref|WP_000187942.1|	28.5	228	507	309	6.02e-14	71.6
k141_43464_66	SARG|gi|445996714|ref|WP_000074569.1|	28.5	228	507	309	6.02e-14	71.6
k141_43464_76	CARD|gb|WMY66391.1|ARO:3007682|MdtQ	68.9	469	479	479	8.52e-228	633
k141_43464_76	SARG|gi|554036077|gb|ESE82040.1|	37.9	464	479	485	8.90e-85	268
k141_43464_76	SARG|YP_002385300	36.5	466	479	485	1.76e-84	267
k141_43464_76	SARG|gi|554022400|gb|ESE68782.1|	37.7	464	479	484	6.73e-84	266
k141_43464_76	SARG|gi|554039504|gb|ESE85345.1|	37.5	464	479	484	7.34e-83	263
k141_43464_76	SARG|gi|693058885|ref|WP_032226462.1|	35.6	464	479	488	3.20e-82	261
k141_43464_76	SARG|ZP_03030551	35.6	464	479	488	3.20e-82	261
k141_43464_76	SARG|gi|693049450|ref|WP_032218920.1|	35.6	464	479	488	3.20e-82	261
k141_43464_76	SARG|gi|487562202|ref|WP_001717107.1|	35.6	464	479	488	6.33e-82	261
k141_43464_76	SARG|gi|446533204|ref|WP_000610550.1|	35.3	464	479	488	8.90e-82	260
k141_43464_80	NCBI|WP_049898469.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	27.2	261	311	356	1.34e-10	60.5
k141_43464_80	NCBI|WP_109545033.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	27.8	263	311	355	1.03e-09	57.8
k141_43464_80	megares|MEG_7602|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	27.8	263	311	355	1.03e-09	57.8
k141_43464_80	SARG|ACM47285	27.8	263	311	363	1.06e-09	57.8
k141_43464_85	SARG|YP_002850060	35.4	229	309	648	6.08e-31	121
k141_43464_85	SARG|gi|696368937|ref|WP_032943949.1|	35.4	229	309	648	8.27e-31	120
k141_43464_85	SARG|Q83LR7	38.8	214	309	648	8.27e-31	120
k141_43464_85	SARG|gi|851913025|ref|WP_048215946.1|	35.4	229	309	648	8.27e-31	120
k141_43464_85	SARG|gi|647325472|ref|WP_025760953.1|	38.8	214	309	648	8.27e-31	120
k141_43464_85	SARG|gi|647323678|ref|WP_025760497.1|	38.8	214	309	648	8.27e-31	120
k141_43464_85	SARG|gi|489930965|ref|WP_003834285.1|	35.4	229	309	648	8.27e-31	120
k141_43464_85	SARG|gi|936194420|ref|WP_054528571.1|	35.4	229	309	648	1.13e-30	120
k141_43464_85	SARG|gi|851922185|ref|WP_048218206.1|	35.4	229	309	648	1.13e-30	120
k141_43464_85	SARG|gi|696375069|ref|WP_032949617.1|	35.4	229	309	648	1.13e-30	120
k141_12033_5	SARG|gb|AYV52072.1|ARO:3002882|lmrD	24.9	217	249	664	3.15e-13	67.8
k141_12033_5	SARG|gi|446048013|ref|WP_000125868.1|	27.4	226	249	648	1.62e-10	59.7
k141_12033_5	SARG|gi|974588181|ref|WP_059178476.1|	27.9	197	249	646	9.56e-10	57.4
k141_12033_5	SARG|YP_001176128	27.9	197	249	646	9.56e-10	57.4
k141_12033_25	SARG|gb|APB03222.1|ARO:3003992|rphB	36.3	331	793	884	9.03e-47	178
k141_12033_25	NCBI|WP_087347987.1|1|1|rphC|rphC||2|rifamycin|rifamycin|rifamycin-inactivating_phosphotransferase_RphC|AMR|rifamycin	35.1	333	793	868	8.83e-45	172
k141_12033_25	NCBI|WP_087348261.1|1|1|rphD|rphD||2|rifamycin|rifamycin|rifamycin-inactivating_phosphotransferase_RphD|AMR|rifamycin	34.8	333	793	872	2.86e-44	171
k141_12033_25	SARG|gb|AIA08936.1|ARO:3000444|rphA	37.3	327	793	865	3.71e-44	170
k141_12033_32	SARG|gb|QNR09092.1|ARO:3007042|msr(G)	26.9	186	250	485	5.76e-06	45.8
k141_3797_1	CARD|gb|CAA79966.1|ARO:3003665|NmcR	27.3	256	312	295	7.13e-23	95.1
k141_3797_4	SARG|gb|BAA11237.1|ARO:3000254|emrY	99.8	512	513	512	0.0	990
k141_3797_4	SARG|gi|491135333|ref|WP_004993751.1|	62.2	503	513	512	1.11e-223	625
k141_3797_4	SARG|gi|823644306|ref|WP_047089196.1|	62.2	503	513	512	1.11e-223	625
k141_3797_4	SARG|gi|506355393|ref|WP_015875112.1|	62.0	508	513	511	1.51e-223	625
k141_3797_4	SARG|gi|745784185|ref|WP_039077609.1|	62.2	503	513	512	1.57e-223	625
k141_3797_4	SARG|gi|545278680|ref|WP_021565876.1|	62.2	503	513	512	2.22e-223	624
k141_3797_4	SARG|gi|928881684|ref|WP_053918316.1|	62.0	503	513	512	2.22e-223	624
k141_3797_4	SARG|gi|896057666|ref|WP_049106280.1|	61.8	508	513	512	3.16e-223	624
k141_3797_4	SARG|gi|485705201|ref|WP_001337983.1|	62.4	503	513	512	3.16e-223	624
k141_3797_4	SARG|gi|485862236|ref|WP_001461404.1|	62.2	503	513	512	3.16e-223	624
k141_3797_5	SARG|gi|545297559|ref|WP_021577764.1|	97.9	387	388	387	4.26e-270	732
k141_3797_5	SARG|gi|585367575|ref|WP_024249154.1|	97.9	387	388	387	6.06e-270	732
k141_3797_5	SARG|gi|723050633|ref|WP_033547684.1|	97.7	387	388	387	8.60e-270	731
k141_3797_5	SARG|gi|742671087|ref|WP_038976864.1|	97.9	387	388	387	8.60e-270	731
k141_3797_5	SARG|gi|486279467|ref|WP_001570159.1|	97.9	387	388	387	1.22e-269	731
k141_3797_5	SARG|gi|485667622|ref|WP_001308821.1|	97.9	387	388	387	1.22e-269	731
k141_3797_5	SARG|gi|742835557|ref|WP_038987858.1|	97.9	387	388	387	1.74e-269	731
k141_3797_5	SARG|gi|693092086|ref|WP_032250388.1|	97.7	387	388	387	1.74e-269	731
k141_3797_5	SARG|gi|485780771|ref|WP_001403742.1|	97.9	387	388	387	1.74e-269	731
k141_3797_5	SARG|gi|693139804|ref|WP_032281367.1|	97.9	387	388	387	1.74e-269	731
k141_23662_2	SARG|FR772051.1.gene9.p01	27.3	194	272	524	2.18e-09	56.6
k141_23662_2	SARG|gb|AHB37625.1|ARO:3004715|vga(E)	26.0	219	272	524	2.92e-09	56.2
k141_23662_2	CARD|gb|BAB80490.1|ARO:3007644|Cper_cplR	24.6	199	272	568	4.16e-08	52.8
k141_23662_2	SARG|gi|686386599|ref|WP_031903183.1|	22.9	188	272	488	6.98e-08	52.0
k141_23662_2	SARG|gi|686444151|ref|WP_031925491.1|	23.4	188	272	488	1.25e-07	51.2
k141_23662_2	SARG|gi|581672381|gb|EVQ77821.1|	22.9	188	272	394	1.49e-07	50.8
k141_23662_2	SARG|gi|587321226|gb|EWW03298.1|	22.9	188	272	413	1.53e-07	50.8
k141_23662_2	SARG|gi|580336413|gb|EVD62957.1|	22.9	188	272	478	1.65e-07	50.8
k141_23662_2	SARG|YP_001569068	22.9	188	272	488	1.67e-07	50.8
k141_23662_2	SARG|gi|686379454|ref|WP_031899389.1|	22.9	188	272	488	1.67e-07	50.8
k141_2077_8	CARD|gb|WP_041777404.1|ARO:3004480|Bado_rpoB_RIF	44.6	1369	1343	1186	0.0	1060
k141_2077_8	megares|MEG_8674|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB_1	44.6	1369	1343	1186	0.0	1060
k141_2077_8	CARD|gb|BAD59497.1|ARO:3000501|rpoB2	44.4	1362	1343	1162	0.0	1037
k141_2077_24	NCBI|WP_222891058.1|1|1|vanS-P|vanS-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-P|AMR|glycopeptide	24.2	227	459	359	1.72e-07	52.0
k141_2077_25	CARD|gb|AAK37618.1|ARO:3005008|TxR	39.1	317	442	318	1.13e-67	217
k141_59967_5	SARG|ZP_04615639	30.7	525	602	543	1.52e-56	198
k141_59967_5	SARG|gi|740410309|ref|WP_038243756.1|	30.7	525	602	563	2.22e-56	198
k141_59967_5	SARG|ZP_04631861	31.2	525	602	543	5.59e-56	197
k141_59967_5	SARG|YP_001401994	30.2	523	602	563	1.12e-55	196
k141_59967_5	SARG|AAS61092	30.2	523	602	563	1.12e-55	196
k141_59967_5	SARG|ZP_04612557	31.2	525	602	543	2.84e-55	195
k141_59967_5	SARG|ZP_04630103	30.9	525	602	543	3.92e-55	194
k141_59967_5	SARG|ZP_04635128	30.9	525	602	543	3.92e-55	194
k141_59967_5	SARG|YP_001605795	29.9	522	602	562	7.71e-55	194
k141_59967_5	SARG|ZP_04638974	30.9	525	602	563	1.08e-54	194
k141_59967_7	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.7	505	638	655	3.05e-88	287
k141_59967_7	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.7	505	638	655	4.27e-88	286
k141_59967_7	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.5	505	638	655	8.35e-88	286
k141_59967_7	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.5	505	638	655	1.63e-87	285
k141_59967_7	SARG|gb|AKA86814|ARO:3003746|optrA	34.5	505	638	655	1.63e-87	285
k141_59967_7	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.5	505	638	655	4.46e-87	284
k141_59967_7	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.5	505	638	655	4.46e-87	284
k141_59967_7	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.5	505	638	655	4.46e-87	284
k141_59967_7	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.5	505	638	655	4.46e-87	284
k141_59967_7	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	34.5	505	638	655	4.46e-87	284
k141_59967_12	CARD|gb|BAE77933.1|ARO:3000518|CRP	99.5	210	211	210	6.74e-151	416
k141_2082_4	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	58.4	387	363	374	3.97e-144	412
k141_2082_4	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	47.5	366	363	357	6.07e-104	309
k141_2082_6	SARG|gb|AAF89148.1|ARO:3004813|GOB-6	32.7	110	216	252	4.17e-11	59.7
k141_2082_6	ResF|blaGOB-6_1_AF189292_1	32.7	110	216	290	5.43e-11	59.7
k141_2082_6	NCBI|WP_069147617.1|1|1|blaGOB-6|blaGOB|hydrolase|2|||subclass_B3_metallo-beta-lactamase_GOB-6|AMR|beta-lactam	32.7	110	216	290	5.43e-11	59.7
k141_2082_6	SARG|gb|WP_078407131.1|ARO:3005692|GOB-43	31.8	110	216	290	1.37e-10	58.5
k141_2082_6	SARG|gb|AAF89152.1|ARO:3004809|GOB-2	31.8	110	216	252	1.45e-10	58.2
k141_2082_6	SARG|AF090141.1.gene1.p1	31.8	110	216	290	1.86e-10	58.2
k141_2082_6	SARG|gb|WP_087093762.1|ARO:3005677|GOB-28	33.3	93	216	290	1.86e-10	58.2
k141_2082_6	SARG|gb|WP_034845394.1|ARO:3005689|GOB-40	31.8	110	216	290	1.86e-10	58.2
k141_2082_6	SARG|gb|WP_078395323.1|ARO:3005690|GOB-41	31.8	110	216	290	1.86e-10	58.2
k141_2082_6	ResF|blaGOB-2_1_AF189296_1	31.8	110	216	290	1.86e-10	58.2
k141_2082_19	SARG|gb|AAC74000.1|ARO:3003950|msbA	99.7	582	583	582	0.0	1090
k141_2082_19	SARG|gi|948137056|ref|WP_056795395.1|	33.7	579	583	602	1.89e-90	290
k141_2082_19	SARG|gi|1045390184|ref|WP_065479071.1|	33.2	570	583	605	2.04e-90	290
k141_2082_19	SARG|gi|928900436|ref|WP_053931243.1|	33.2	570	583	600	1.92e-89	287
k141_2082_19	SARG|gi|664579989|ref|WP_031094015.1|	33.2	570	583	601	1.97e-89	287
k141_2082_19	SARG|gi|695865802|ref|WP_032778631.1|	33.6	571	583	605	2.18e-89	287
k141_2082_19	SARG|gi|648667297|ref|WP_026359044.1|	32.8	570	583	605	6.00e-89	286
k141_2082_19	SARG|gi|764446018|ref|WP_044369325.1|	33.0	570	583	605	8.41e-89	285
k141_2082_19	SARG|gi|695842130|ref|WP_032755430.1|	33.0	570	583	603	1.12e-88	285
k141_2082_19	SARG|gi|664317010|ref|WP_030845774.1|	33.2	570	583	605	1.18e-88	285
k141_15619_25	SARG|gi|895865878|ref|WP_048974758.1|	34.1	223	338	646	6.22e-29	116
k141_15619_25	SARG|gi|500194536|ref|WP_011867743.1|	29.9	214	338	306	4.18e-26	104
k141_15619_25	megares|MEG_4383|Drugs|Tetracycline|Tetracycline_resistance_ABC_efflux_pumps|OTRC_1	24.7	223	338	351	1.12e-12	67.0
k141_15619_25	SARG|gb|AAR96051.1|ARO:3002894|otrC	26.3	224	338	351	1.51e-12	66.6
k141_45160_13	CARD|gb|AAA99503.1|ARO:3003250|bcrC	30.2	182	199	203	2.52e-18	78.2
k141_45160_14	SARG|ZP_02775049	100	410	411	410	8.31e-291	786
k141_45160_14	SARG|NP_752857	100	410	411	420	1.21e-290	786
k141_45160_14	SARG|BAG76424	99.8	410	411	410	2.38e-290	785
k141_45160_14	SARG|gi|928824385|ref|WP_053884538.1|	99.8	410	411	410	2.38e-290	785
k141_45160_14	SARG|YP_668774	99.8	410	411	410	3.38e-290	785
k141_45160_14	SARG|Y08743.gene.p01	99.8	410	411	410	4.80e-290	785
k141_45160_14	SARG|YP_001457641	99.8	410	411	410	6.82e-290	784
k141_45160_14	SARG|ZP_03050303	99.5	410	411	410	9.69e-290	784
k141_45160_14	SARG|ACB17400	99.5	410	411	410	1.38e-289	783
k141_45160_14	SARG|ZP_03027991	99.3	410	411	410	1.95e-289	783
k141_45160_27	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	34.2	219	378	255	1.52e-35	129
k141_45160_27	SARG|gb|ADZ12699.1|ARO:3005091|RanA	32.7	214	378	258	2.44e-32	121
k141_45160_27	SARG|gi|895865878|ref|WP_048974758.1|	35.1	225	378	646	3.03e-29	118
k141_45160_27	SARG|gi|639209604|ref|WP_024547784.1|	33.8	225	378	648	1.36e-25	107
k141_45160_36	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	32.6	221	243	325	9.45e-30	112
k141_45160_36	SARG|gb|AAA26793|ARO:3003748|oleC	32.9	219	243	325	1.84e-29	111
k141_45160_36	SARG|gb|AAR96051.1|ARO:3002894|otrC	26.5	223	243	351	1.01e-13	68.6
k141_45160_36	megares|MEG_4383|Drugs|Tetracycline|Tetracycline_resistance_ABC_efflux_pumps|OTRC_1	26.5	223	243	351	1.86e-13	67.8
k141_1052_5	SARG|gi|2708772|gb|AAB96371.1|	26.1	180	465	391	1.83e-06	48.9
k141_1052_5	SARG|YP_251195	24.9	177	465	391	2.43e-06	48.5
k141_1052_5	SARG|AF024666.2.gene33.p01	24.9	177	465	391	2.43e-06	48.5
k141_1052_5	SARG|NP_044444	24.9	177	465	391	3.22e-06	48.1
k141_1052_5	SARG|gb|AAF40764.1|ARO:3003962|farB	25.3	162	465	508	6.65e-06	47.4
k141_1052_5	SARG|gi|1006695136|ref|WP_061822033.1|	23.0	161	465	388	7.43e-06	47.0
k141_68354_1	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	24.7	291	443	1024	8.33e-15	75.9
k141_68354_1	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	24.7	291	443	1024	8.33e-15	75.9
k141_68354_1	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	24.7	291	443	1024	2.58e-14	74.3
k141_68354_1	SARG|gb|CAA53189|ARO:3000521|mupA	24.7	291	443	1024	2.58e-14	74.3
k141_68354_1	megares|MEG_4091|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPB_1	22.8	298	443	1033	2.46e-13	71.2
k141_68354_1	SARG|gb|AEY83581|ARO:3000510|mupB	22.8	298	443	1033	2.46e-13	71.2
k141_63282_15	SARG|HQ451074.1.gene4.p01	100	286	287	286	1.66e-207	565
k141_63282_15	megares|MEG_6951|Drugs|beta-lactam|Class_A_betalactamases|TEM_1	100	286	287	289	1.86e-207	565
k141_63282_15	SARG|GQ149347.1.gene4.p1	99.7	286	287	286	2.36e-207	565
k141_63282_15	SARG|gi|1031626630|gb|ANG10619.1|	99.7	286	287	286	2.36e-207	565
k141_63282_15	SARG|gi|1031633182|gb|ANG13700.1|	99.7	286	287	286	2.36e-207	565
k141_63282_15	SARG|gi|1031626545|gb|ANG10578.1|	99.7	286	287	286	2.36e-207	565
k141_63282_15	SARG|gi|1031632106|gb|ANG13191.1|	99.7	286	287	286	2.36e-207	565
k141_63282_15	SARG|gi|1031631979|gb|ANG13130.1|	99.7	286	287	286	2.36e-207	565
k141_63282_15	SARG|gi|1031624195|gb|ANG09482.1|	99.7	286	287	286	2.36e-207	565
k141_63282_15	SARG|gi|1031624931|gb|ANG09825.1|	99.7	286	287	286	2.36e-207	565
k141_43657_4	SARG|gi|446669132|ref|WP_000746478.1|	100	364	366	371	5.99e-249	677
k141_43657_4	SARG|gi|26107304|gb|AAN79487.1|AE016758_91	100	364	366	380	8.38e-249	677
k141_43657_4	SARG|gi|545166026|ref|WP_021520619.1|	99.7	364	366	371	4.92e-248	675
k141_43657_4	SARG|gi|446669114|ref|WP_000746460.1|	99.2	364	366	371	2.00e-247	673
k141_43657_4	SARG|gi|766602958|ref|WP_044782102.1|	99.2	364	366	371	2.00e-247	673
k141_43657_4	SARG|gi|757742704|ref|WP_042966294.1|	99.2	364	366	371	2.00e-247	673
k141_43657_4	SARG|gi|1028099935|ref|WP_063856172.1|	98.9	364	366	371	2.84e-247	673
k141_43657_4	SARG|gi|485860031|ref|WP_001459623.1|	98.9	364	366	371	4.04e-247	672
k141_43657_4	SARG|gi|983456720|ref|WP_060617235.1|	98.9	364	366	371	5.73e-247	672
k141_43657_4	SARG|gi|545261069|ref|WP_021555171.1|	99.5	364	366	371	5.73e-247	672
k141_43657_5	SARG|gi|446110297|ref|WP_000188152.1|	100	648	649	648	0.0	1231
k141_43657_5	SARG|gi|910140813|ref|WP_050008485.1|	99.8	648	649	648	0.0	1229
k141_43657_5	SARG|gi|754732608|ref|WP_042101370.1|	99.8	648	649	648	0.0	1228
k141_43657_5	SARG|gi|446110278|ref|WP_000188133.1|	99.8	648	649	648	0.0	1226
k141_43657_5	SARG|A1A9B7	99.7	648	649	648	0.0	1225
k141_43657_5	SARG|gi|486155877|ref|WP_001519630.1|	99.7	648	649	648	0.0	1224
k141_43657_5	SARG|gi|898532714|ref|WP_049595067.1|	99.7	648	649	648	0.0	1224
k141_43657_5	SARG|gi|446110272|ref|WP_000188127.1|	99.5	648	649	648	0.0	1224
k141_43657_5	SARG|gi|486206507|ref|WP_001552670.1|	99.5	648	649	648	0.0	1224
k141_43657_5	SARG|gi|486160789|ref|WP_001524406.1|	99.7	648	649	648	0.0	1224
k141_43657_11	SARG|gb|AAC74000.1|ARO:3003950|msbA	29.1	519	574	582	7.05e-50	180
k141_43657_11	SARG|gi|928900436|ref|WP_053931243.1|	27.3	520	574	600	7.92e-48	175
k141_43657_11	SARG|gi|664579989|ref|WP_031094015.1|	27.3	520	574	601	8.03e-48	175
k141_43657_11	SARG|gi|695887424|ref|WP_032788534.1|	27.2	562	574	605	8.48e-48	175
k141_43657_11	SARG|gi|764446018|ref|WP_044369325.1|	26.6	561	574	605	1.60e-47	174
k141_43657_11	SARG|gi|664180077|ref|WP_030714054.1|	26.6	561	574	605	1.60e-47	174
k141_43657_11	SARG|gi|926294973|ref|WP_053631154.1|	27.8	564	574	620	1.95e-47	174
k141_43657_11	SARG|gi|926356413|ref|WP_053687351.1|	27.8	564	574	620	2.67e-47	174
k141_43657_11	SARG|gi|1045390184|ref|WP_065479071.1|	26.9	501	574	605	3.01e-47	173
k141_43657_11	SARG|gi|827013130|ref|WP_047175495.1|	27.7	501	574	603	4.02e-47	173
k141_43657_12	SARG|gb|AAC74000.1|ARO:3003950|msbA	26.9	432	589	582	6.88e-41	155
k141_43657_12	SARG|gi|748767925|ref|WP_040019608.1|	33.6	235	589	623	1.59e-34	137
k141_43657_12	SARG|gi|739906046|ref|WP_037756452.1|	34.4	221	589	620	2.10e-34	137
k141_43657_12	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	22.2	549	589	574	2.19e-33	133
k141_43657_12	SARG|gi|663350985|ref|WP_030349761.1|	32.5	246	589	613	2.32e-32	130
k141_43657_12	SARG|gi|1033309939|gb|OAS18676.1|	23.3	210	589	492	3.33e-07	52.0
k141_43657_12	SARG|gi|1043542993|ref|WP_065386235.1|	24.3	210	589	492	7.05e-06	47.8
k141_55204_7	SARG|gi|565651791|ref|WP_023899061.1|	40.0	255	251	647	8.29e-46	160
k141_55204_7	SARG|gi|504542119|ref|WP_014729221.1|	40.0	255	251	647	1.59e-45	160
k141_55204_7	SARG|gi|742378414|ref|WP_038857601.1|	38.8	255	251	647	3.03e-45	159
k141_55204_7	SARG|gi|696402390|ref|WP_032974230.1|	39.6	255	251	647	5.78e-45	158
k141_55204_7	SARG|gi|696423952|ref|WP_032993748.1|	39.6	255	251	647	5.78e-45	158
k141_55204_7	SARG|gi|938461734|ref|WP_054625806.1|	39.6	255	251	647	7.99e-45	158
k141_55204_7	SARG|gi|1020141879|ref|WP_063264839.1|	39.6	255	251	647	7.99e-45	158
k141_55204_7	SARG|gi|490522515|ref|WP_004387938.1|	39.6	255	251	647	7.99e-45	158
k141_55204_7	SARG|YP_001438541	39.6	255	251	647	1.10e-44	157
k141_55204_7	SARG|gi|742384718|ref|WP_038863845.1|	41.4	237	251	647	1.10e-44	157
k141_12243_10	SARG|B1LEM1	100	457	458	457	0.0	872
k141_12243_10	SARG|A1ABK4	99.8	457	458	457	0.0	871
k141_12243_10	SARG|ZP_03034990	99.8	457	458	457	0.0	871
k141_12243_10	SARG|gi|447097685|ref|WP_001174941.1|	99.8	457	458	457	0.0	871
k141_12243_10	SARG|gi|487415514|ref|WP_001682922.1|	99.6	457	458	457	0.0	871
k141_12243_10	SARG|gi|447097692|ref|WP_001174948.1|	99.8	457	458	457	0.0	870
k141_12243_10	SARG|gi|447097691|ref|WP_001174947.1|	99.8	457	458	457	0.0	870
k141_12243_10	SARG|YP_310429	99.6	457	458	457	0.0	870
k141_12243_10	SARG|gi|447097694|ref|WP_001174950.1|	99.6	457	458	457	0.0	870
k141_12243_10	SARG|gi|693048721|ref|WP_032218252.1|	99.6	457	458	457	0.0	870
k141_12243_13	SARG|gb|ALV80601.1|ARO:3003801|bcr-1	35.3	232	404	402	5.49e-36	135
k141_12243_13	megares|MEG_8019|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML_1	30.3	347	404	411	2.61e-31	122
k141_12243_13	NCBI|WP_011552636.1|1|1|cml_Myxo|cml_Myxo|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	30.3	347	404	411	2.61e-31	122
k141_12243_13	NCBI|WP_031633255.1|1|1|cmlA_floR|cmlA_floR|efflux|2|CHLORAMPHENICOL|PHENICOL|CmlA/FloR_family_phenicol_efflux_MFS_transporter|AMR|phenicol	29.0	341	404	395	1.41e-30	120
k141_12243_13	NCBI|WP_061345584.1|1|1|cml_Ochro|cml_Ochro|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	29.4	340	404	397	1.45e-30	120
k141_12243_13	NCBI|WP_115421099.1|1|1|cml_Ensi|cml_Ensi|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	28.8	344	404	400	5.40e-30	118
k141_12243_13	megares|MEG_8021|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML_1	28.8	344	404	400	5.40e-30	118
k141_12243_13	SARG|CP004022.1.gene3225.p01	26.1	341	404	394	6.30e-29	115
k141_12243_13	SARG|gi|730661043|ref|WP_034065992.1|	26.4	329	404	404	1.36e-28	114
k141_12243_13	SARG|AF034958.gene.p01	29.8	339	404	409	1.31e-27	112
k141_12243_17	NCBI|WP_063844229.1|1|1|cmlV|cmlV|efflux|2|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_MFS_transporter_CmlV|AMR|phenicol	35.3	377	390	412	2.70e-62	204
k141_12243_17	SARG|U09991.1.gene2.p01	35.3	377	390	436	4.88e-62	204
k141_12243_17	megares|MEG_1780|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	33.1	354	390	391	2.80e-48	167
k141_12243_17	SARG|AF015087.1.gene1.p01	33.2	352	390	391	5.47e-48	166
k141_12243_17	megares|MEG_1781|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	32.2	354	390	391	7.96e-47	163
k141_12243_17	SARG|AF024666.2.gene33.p01	29.9	391	390	391	7.96e-47	163
k141_12243_17	SARG|gi|2708772|gb|AAB96371.1|	29.7	391	390	391	1.11e-46	163
k141_12243_17	SARG|gb|CAA78046.1|ARO:3002701|Rfas_cmr	32.4	352	390	391	1.55e-46	162
k141_12243_17	SARG|YP_251195	29.9	391	390	391	1.55e-46	162
k141_12243_17	SARG|NP_044444	29.7	391	390	391	3.03e-46	162
k141_12243_22	SARG|YP_001126889	28.9	121	136	140	2.56e-07	45.8
k141_12243_22	SARG|gi|679859930|gb|KFX31740.1|	28.9	121	136	139	3.51e-07	45.4
k141_12243_22	SARG|gi|489443058|ref|WP_003348511.1|	28.9	121	136	140	3.56e-07	45.4
k141_12243_22	SARG|gi|670458671|ref|WP_031407470.1|	28.9	121	136	140	3.56e-07	45.4
k141_12243_22	SARG|gi|917378394|ref|WP_051985106.1|	28.9	121	136	153	4.26e-07	45.4
k141_12243_29	SARG|gi|935618129|ref|WP_054472880.1|	34.7	147	286	343	6.22e-13	67.0
k141_12243_29	SARG|gi|1027687821|ref|WP_063625584.1|	34.7	147	286	343	6.22e-13	67.0
k141_12243_29	SARG|ZP_03030547	34.7	147	286	343	6.22e-13	67.0
k141_12243_29	SARG|gi|545298014|ref|WP_021578218.1|	34.0	147	286	343	6.22e-13	67.0
k141_12243_29	SARG|gi|749012546|ref|WP_040071761.1|	34.7	147	286	343	6.22e-13	67.0
k141_12243_29	SARG|gi|896035711|ref|WP_049091836.1|	34.7	147	286	343	8.40e-13	66.6
k141_12243_29	SARG|gi|1020278005|ref|WP_063269009.1|	34.0	147	286	343	1.13e-12	66.2
k141_12243_29	SARG|gi|754690819|ref|WP_042068768.1|	34.0	147	286	343	1.13e-12	66.2
k141_12243_29	SARG|gi|754723362|ref|WP_042095437.1|	34.0	147	286	343	1.13e-12	66.2
k141_12243_29	SARG|gi|695652614|ref|WP_032619987.1|	29.8	242	286	371	1.27e-12	66.2
k141_43714_9	SARG|gb|AAC75089.1|ARO:3003577|ugd	100	388	389	388	1.15e-279	756
k141_40342_16	megares|MEG_2865|Drugs|Phenicol|Chloramphenicol_hydrolase|ESTD_1	34.6	263	303	310	1.47e-40	142
k141_40342_32	SARG|FN594949.1.gene24.p01	45.9	133	608	640	2.55e-26	112
k141_40342_32	NCBI|WP_003454408.1|1|1|tet(44)|tet(44)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(44)|AMR|tetracycline	45.9	133	608	640	2.55e-26	112
k141_40342_32	SARG|ABV82118	42.1	145	608	639	2.50e-25	109
k141_40342_32	SARG|ZP_03989103	44.4	133	608	639	4.41e-25	108
k141_40342_32	SARG|ABV82120	44.4	133	608	639	4.41e-25	108
k141_40342_35	CARD|gb|AAK37618.1|ARO:3005008|TxR	36.0	333	470	318	7.23e-57	190
k141_40342_35	SARG|ZP_02848503	33.0	103	470	221	3.47e-10	58.9
k141_40342_35	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.6	111	470	219	1.51e-09	57.0
k141_40342_35	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.6	111	470	219	1.51e-09	57.0
k141_40342_35	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.6	111	470	220	1.53e-09	57.0
k141_40342_35	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.6	111	470	220	2.07e-09	56.6
k141_40342_35	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.7	101	470	220	7.43e-08	52.0
k141_61690_4	CARD|gb|BAB36671.1|ARO:3000832|evgA	27.2	206	219	204	1.42e-20	84.7
k141_61690_4	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	29.3	116	219	228	2.84e-07	48.5
k141_61690_6	CARD|gb|AAL20862.1|ARO:3000826|sdiA	71.6	218	219	240	1.90e-111	318
k141_60358_8	SARG|gb|BAH45481.1|ARO:3002815|clbB	33.7	344	385	343	2.56e-51	174
k141_60358_8	NCBI|WP_111690898.1|1|1|cfr(C)|cfr(C)|target_modification|2|CHLORAMPHENICOL/CLINDAMYCIN/FLORFENICOL/LINEZOLID/STREPTOGRAMIN/TIAMULIN|LINCOSAMIDE/OXAZOLIDINONE/PHENICOL/PLEUROMUTILIN/STREPTOGRAMIN|23S_rRNA_(adenine(2503)-C(8))-methyltransferase_Cfr(C)|AMR|multidrug	34.6	356	385	379	3.68e-48	166
k141_60358_8	megares|MEG_1680|Drugs|MLS|23S_rRNA_methyltransferases|CFR_1	34.3	356	385	416	2.26e-47	165
k141_60358_8	SARG|CP001581.1.gene3143.p01	31.4	341	385	344	4.93e-46	160
k141_60358_8	SARG|gb|BAD63613.1|ARO:3002816|clbC	31.0	345	385	350	4.44e-44	155
k141_60358_8	SARG|gb|CAL84423.1|ARO:3004146|cfrC	30.2	344	385	344	7.56e-44	154
k141_60358_8	SARG|VXQ21601.1	31.6	348	385	344	6.03e-41	146
k141_25616_2	SARG|NP_756938	100	343	344	343	1.02e-232	634
k141_25616_2	SARG|YP_002400591	99.7	343	344	343	1.45e-232	634
k141_25616_2	SARG|gi|510912424|ref|WP_016233732.1|	99.7	343	344	343	2.92e-232	633
k141_25616_2	SARG|gi|545230232|ref|WP_021529938.1|	99.7	343	344	343	4.14e-232	632
k141_25616_2	SARG|gi|979424107|ref|WP_059320519.1|	99.7	343	344	343	4.14e-232	632
k141_25616_2	SARG|ZP_03064581	99.4	343	344	343	8.35e-232	632
k141_25616_2	SARG|gi|643436320|ref|WP_025210113.1|	99.1	343	344	343	1.19e-231	631
k141_25616_2	SARG|gi|935667920|ref|WP_054495375.1|	99.1	343	344	343	1.19e-231	631
k141_25616_2	SARG|gi|1020278005|ref|WP_063269009.1|	99.4	343	344	343	1.69e-231	631
k141_25616_2	SARG|gi|1016498541|ref|WP_063085435.1|	99.1	343	344	343	2.39e-231	630
k141_25616_3	SARG|gi|545240861|ref|WP_021539663.1|	99.3	683	684	683	0.0	1320
k141_25616_3	SARG|gi|545239202|ref|WP_021538207.1|	98.7	683	684	683	0.0	1316
k141_25616_3	SARG|gi|545269972|ref|WP_021560171.1|	98.7	683	684	683	0.0	1315
k141_25616_3	SARG|gi|545262088|ref|WP_021555845.1|	98.8	683	684	683	0.0	1315
k141_25616_3	SARG|YP_002394084	98.5	683	684	683	0.0	1314
k141_25616_3	SARG|gi|545301439|ref|WP_021581233.1|	98.5	683	684	683	0.0	1313
k141_25616_3	SARG|gi|447197906|ref|WP_001275162.1|	98.4	683	684	683	0.0	1313
k141_25616_3	SARG|YP_672169	98.4	683	684	683	0.0	1313
k141_25616_3	SARG|gi|545242743|ref|WP_021541510.1|	98.2	683	684	683	0.0	1313
k141_25616_3	SARG|gi|331067220|gb|EGI38628.1|	98.4	683	684	683	0.0	1312
k141_25616_4	SARG|gi|486401891|ref|WP_001606632.1|	100	488	489	488	0.0	920
k141_25616_4	SARG|gi|446533219|ref|WP_000610565.1|	99.8	488	489	488	0.0	918
k141_25616_4	SARG|gi|446533207|ref|WP_000610553.1|	99.8	488	489	488	0.0	917
k141_25616_4	SARG|gi|446533218|ref|WP_000610564.1|	99.6	488	489	488	0.0	917
k141_25616_4	SARG|gi|446533220|ref|WP_000610566.1|	99.6	488	489	488	0.0	917
k141_25616_4	SARG|gi|487510558|ref|WP_001706701.1|	99.6	488	489	488	0.0	916
k141_25616_4	SARG|ACB17556	99.6	488	489	488	0.0	916
k141_25616_4	SARG|YP_002394083	99.4	488	489	488	0.0	916
k141_25616_4	SARG|gi|693171998|ref|WP_032304306.1|	99.6	488	489	488	0.0	916
k141_25616_4	SARG|gi|727760155|ref|WP_033865893.1|	99.4	488	489	488	0.0	916
k141_25616_11	SARG|gb|APB03219.1|ARO:3003986|TaeA	27.5	244	235	648	2.15e-14	70.9
k141_25616_11	NCBI|AJP12342.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	25.3	221	235	550	4.02e-10	58.2
k141_25616_11	NCBI|AKC61310.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	24.4	221	235	552	9.82e-10	57.0
k141_25616_11	ResF|poxtA-Ef_1_WP094899500.1_1	24.1	199	235	538	4.58e-08	52.0
k141_25616_11	megares|MEG_8639|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT_1	24.1	199	235	543	4.59e-08	52.0
k141_25616_11	NCBI|WP_094899500.1|1|1|poxtA-Ef|poxtA-Ef|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA-Ef|AMR|multidrug	24.1	199	235	543	4.59e-08	52.0
k141_25616_11	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	33.9	62	235	461	8.57e-06	45.1
k141_25616_29	CARD|gb|AAG05661.1|ARO:3004107|Paer_soxR	62.4	141	155	156	2.02e-61	185
k141_25616_30	CARD|gb|AFK13828.1|ARO:3000823|ramA	47.0	100	108	124	8.82e-32	107
k141_25616_34	SARG|gi|446048013|ref|WP_000125868.1|	33.7	104	941	648	8.64e-11	64.7
k141_25616_34	SARG|gi|654544841|ref|WP_028012549.1|	35.4	99	941	646	4.48e-10	62.4
k141_25616_34	SARG|gi|829908959|ref|WP_047362283.1|	35.4	99	941	646	4.48e-10	62.4
k141_25616_34	SARG|gi|1015876944|ref|WP_062856780.1|	35.4	99	941	646	4.48e-10	62.4
k141_25616_34	SARG|gi|504644166|ref|WP_014831268.1|	35.4	99	941	646	4.48e-10	62.4
k141_25616_34	SARG|gi|522181382|ref|WP_020689930.1|	35.4	99	941	646	4.48e-10	62.4
k141_25616_34	SARG|gi|896106549|ref|WP_049136608.1|	35.4	99	941	646	4.48e-10	62.4
k141_25616_34	SARG|gi|829942568|ref|WP_047368199.1|	35.4	99	941	646	4.48e-10	62.4
k141_25616_34	SARG|gi|1006477526|ref|WP_061771940.1|	35.4	99	941	646	4.48e-10	62.4
k141_25616_34	SARG|gi|742827468|ref|WP_038984467.1|	35.4	99	941	646	4.48e-10	62.4
k141_25616_39	CARD|gb|AAK37618.1|ARO:3005008|TxR	39.4	297	453	318	1.51e-59	196
k141_25616_39	CARD|gb|ATC67679.1|ARO:3000838|arlR	32.2	118	453	219	2.86e-08	53.1
k141_25616_50	NCBI|WP_063856758.1|1|1|vanTc2|vanTc2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT|AMR|glycopeptide	33.5	370	360	706	1.68e-44	161
k141_25616_50	NCBI|WP_063856759.1|1|1|vanTc3|vanTc3|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT|AMR|glycopeptide	33.8	370	360	700	2.21e-44	161
k141_25616_50	NCBI|WP_063856756.1|1|1|vanT-C|vanT-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-C|AMR|glycopeptide	33.5	367	360	700	7.85e-44	159
k141_25616_50	SARG|gb|ABA71733.1|ARO:3002972|vanTG	31.1	363	360	712	2.19e-43	158
k141_25616_50	NCBI|WP_063856755.1|1|1|vanT-C|vanT-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-C|AMR|glycopeptide	33.1	369	360	700	5.22e-43	157
k141_25616_50	SARG|JF802084.2.gene3.p01	30.6	359	360	700	3.46e-42	155
k141_25616_50	SARG|gb|ABX54690.1|ARO:3002974|vanTrL	32.0	362	360	366	1.43e-41	148
k141_25616_50	SARG|FJ872411.1.gene43.p01	32.1	364	360	702	5.27e-40	149
k141_25616_50	SARG|AF162694.1.gene4.p01	31.3	361	360	698	7.05e-40	148
k141_25616_50	SARG|gi|657686198|ref|WP_029487032.1|	31.3	361	360	698	7.05e-40	148
k141_40470_6	CARD|gb|BAA15221.2|ARO:3000263|marA	100	126	128	127	5.97e-91	258
k141_1366_19	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	38.1	425	441	429	2.13e-86	269
k141_1366_21	CARD|gb|ALH22601.1|ARO:3000620|adeL	37.2	288	324	337	3.49e-61	197
k141_17368_5	megares|MEG_3295|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|ILES_1	22.3	988	861	1107	9.21e-15	77.8
k141_17368_5	SARG|gb|ADP36409.1|ARO:3003730|Bifidobacteria	22.3	988	861	1107	9.21e-15	77.8
k141_17368_12	megares|MEG_5400|Drugs|beta-lactam|Penicillin_binding_protein|PBP2_1	100	633	634	633	0.0	1280
k141_17368_12	SARG|gi|2791908|emb|CAA73538.1|	28.4	511	634	666	8.43e-43	162
k141_17368_12	megares|MEG_3792|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	28.4	511	634	666	1.55e-42	162
k141_17368_12	megares|MEG_3799|Drugs|beta-lactam|Penicillin_binding_protein|MECC_1	27.4	566	634	664	2.06e-42	161
k141_17368_12	NCBI|WP_128268231.1|1|1|mecC2|mecC2|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecC2|AMR|beta-lactam	26.6	572	634	665	2.08e-42	161
k141_17368_12	SARG|gb|CCC86795.1|ARO:3001209|mecC	27.3	567	634	665	7.02e-42	160
k141_17368_12	NCBI|WP_069996660.1|1|1|mecC3|mecC3|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecC3|AMR|beta-lactam	28.3	438	634	665	2.17e-39	152
k141_17368_12	megares|MEG_3800|Drugs|beta-lactam|Penicillin_binding_protein|MECC_1	27.9	438	634	665	1.06e-37	147
k141_17368_15	NCBI|WP_063856871.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	29.4	252	404	346	8.27e-16	77.0
k141_17368_15	NCBI|WP_063856854.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	28.8	295	404	356	1.27e-14	73.6
k141_17368_15	megares|MEG_7603|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	28.6	290	404	355	7.35e-14	71.2
k141_17368_15	SARG|BAE96115	28.6	290	404	355	7.35e-14	71.2
k141_17368_15	NCBI|WP_109545033.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	27.6	290	404	355	5.69e-13	68.6
k141_17368_15	megares|MEG_7602|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	27.6	290	404	355	5.69e-13	68.6
k141_17368_15	SARG|ACM47285	27.6	290	404	363	5.94e-13	68.6
k141_17368_15	NCBI|WP_049898469.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	27.8	295	404	356	2.45e-12	66.6
k141_17368_15	NCBI|WP_063856862.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	28.4	268	404	356	4.38e-12	65.9
k141_17368_15	megares|MEG_7604|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_2	31.0	200	404	209	6.22e-12	63.5
k141_76877_3	CARD|gb|AAC75429.1|ARO:3000833|evgS	30.6	507	950	1197	2.58e-56	211
k141_76877_5	CARD|gb|AAK37618.1|ARO:3005008|TxR	40.1	312	462	318	4.95e-68	219
k141_76877_5	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	35.1	111	462	228	1.01e-16	78.2
k141_76877_5	CARD|gb|ATC67679.1|ARO:3000838|arlR	29.3	123	462	219	9.92e-16	75.1
k141_76877_5	CARD|gb|ADM92605.1|ARO:3000553|adeR	36.0	114	462	247	1.59e-15	75.1
k141_76877_5	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	33.9	121	462	225	5.06e-15	73.2
k141_76877_5	CARD|gb|AAC73788.1|ARO:3003841|kdpE	33.9	121	462	225	9.29e-15	72.4
k141_76877_5	CARD|gb|AAD51348.1|ARO:3003066|smeR	34.6	107	462	229	6.12e-14	70.1
k141_22473_7	SARG|gi|1004359922|gb|AMP42228.1|	27.1	436	600	639	7.73e-28	117
k141_22473_7	SARG|ABN80187	27.1	436	600	640	5.80e-27	114
k141_22473_7	SARG|gb|AMP42147.1|ARO:3004442|tet(W/N/W)	25.7	435	600	639	2.42e-26	112
k141_22473_7	SARG|AAO42740	26.0	434	600	639	7.61e-26	111
k141_22473_7	SARG|AY485126.gene.p01	26.0	434	600	639	7.61e-26	111
k141_22473_7	megares|MEG_7175|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	26.0	434	600	639	7.61e-26	111
k141_22473_7	SARG|gi|1028100280|ref|WP_063856415.1|	26.3	434	600	639	7.61e-26	111
k141_22473_7	SARG|ABN79417	27.2	438	600	639	1.01e-25	110
k141_22473_7	SARG|ACI02041	25.7	435	600	639	1.01e-25	110
k141_22473_7	SARG|gi|104303742|gb|ABF72138.1|	26.9	439	600	639	1.35e-25	110
k141_22473_25	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	28.8	420	433	429	5.61e-53	182
k141_20642_34	SARG|AXF35727.1	26.0	204	234	497	1.25e-09	56.6
k141_20642_34	CARD|gb|BAB80490.1|ARO:3007644|Cper_cplR	36.7	79	234	568	2.54e-08	52.8
k141_20642_34	NCBI|AJP12342.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	40.7	81	234	550	6.11e-08	51.6
k141_20642_34	SARG|KC539823.1.gene1.p01	42.7	82	234	522	1.08e-07	50.8
k141_20642_34	SARG|AAG08983	36.5	85	234	524	1.46e-07	50.4
k141_20642_34	NCBI|WP_063856937.1|1|1|vga(A)|vga(A)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(A)|AMR|lincosamide	40.2	82	234	522	1.95e-07	50.1
k141_20642_34	NCBI|WP_032492560.1|1|1|vga(A)|vga(A)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(A)|AMR|lincosamide	40.2	82	234	522	3.52e-07	49.3
k141_20642_34	SARG|DQ823382.1.gene1.p01	40.2	82	234	522	3.52e-07	49.3
k141_20642_34	megares|MEG_7687|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|VGA_1	40.2	82	234	522	3.52e-07	49.3
k141_20642_34	megares|MEG_7686|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|VGA_1	40.2	82	234	522	3.52e-07	49.3
k141_42093_2	SARG|gb|AAK76137.1|ARO:3000024|patA	28.7	230	379	564	1.91e-17	82.8
k141_42093_2	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	28.2	216	379	574	2.02e-13	70.5
k141_42093_2	SARG|gb|APB03219.1|ARO:3003986|TaeA	25.9	220	379	648	2.62e-09	57.8
k141_42093_6	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	35.3	224	224	225	3.20e-39	134
k141_42093_6	CARD|gb|AAC73788.1|ARO:3003841|kdpE	35.3	224	224	225	3.20e-39	134
k141_42093_6	CARD|gb|ATC67679.1|ARO:3000838|arlR	31.7	218	224	219	3.22e-34	120
k141_42093_6	CARD|gb|AAG06465.1|ARO:3005063|cprR	32.9	219	224	223	2.57e-30	110
k141_42093_6	NCBI|XSG12259.1|1|1|drcR|drcR||1|||daptomycin_efflux_response_regulator_transcription_factor_DrcR|AMR|peptide	28.1	224	224	223	5.49e-29	107
k141_42093_6	CARD|gb|AAD51348.1|ARO:3003066|smeR	30.9	230	224	229	1.75e-28	106
k141_42093_6	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.5	226	224	219	1.95e-28	105
k141_42093_6	NCBI|WP_063856729.1|1|1|vanR-O|vanR-O|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-O|AMR|glycopeptide	30.3	218	224	233	2.69e-28	105
k141_42093_6	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.5	226	224	219	2.73e-28	105
k141_42093_6	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.5	226	224	220	2.80e-28	105
k141_58764_13	SARG|WP_000345069.1	36.9	425	430	434	6.02e-84	263
k141_29229_1	CARD|gb|BAB80490.1|ARO:3007644|Cper_cplR	25.9	212	256	568	1.86e-13	68.6
k141_29229_1	SARG|gi|686386599|ref|WP_031903183.1|	31.0	171	256	488	4.94e-11	61.2
k141_29229_1	SARG|ABA02367	30.8	172	256	488	8.93e-11	60.5
k141_29229_1	SARG|gi|127359|sp|P23212.1|MSRA_STAEP	30.8	172	256	488	8.93e-11	60.5
k141_29229_1	SARG|gi|686444151|ref|WP_031925491.1|	31.4	172	256	488	8.93e-11	60.5
k141_29229_1	SARG|gb|CAA36304.1|ARO:3000251|msrA	30.8	172	256	488	8.93e-11	60.5
k141_29229_1	SARG|BAD86537	30.8	172	256	488	8.93e-11	60.5
k141_29229_1	SARG|gi|581672381|gb|EVQ77821.1|	30.8	172	256	394	1.06e-10	60.1
k141_29229_1	SARG|gi|587321226|gb|EWW03298.1|	30.8	172	256	413	1.09e-10	60.1
k141_29229_1	SARG|gi|580336413|gb|EVD62957.1|	30.8	172	256	478	1.19e-10	60.1
k141_17548_9	SARG|gb|CAA09666.1|ARO:3004122|Klebsiella	60.0	375	352	374	1.08e-155	441
k141_17548_9	megares|MEG_4285|Drugs|beta-lactam|Mutant_porin_proteins|OMPD_1	52.1	357	352	357	2.67e-115	337
k141_17548_12	SARG|YP_001444376	66.4	152	153	154	9.06e-78	226
k141_17548_12	SARG|BAB59035	66.4	152	153	154	1.50e-76	223
k141_17548_12	SARG|BAC58936	63.8	152	153	154	3.02e-76	223
k141_17548_12	SARG|ZP_02197344	64.5	152	153	154	3.02e-76	223
k141_17548_12	SARG|YP_002666586	65.1	152	153	154	4.29e-76	222
k141_17548_12	SARG|Q8DF90	62.5	152	153	154	1.74e-75	221
k141_17548_12	SARG|ZP_00990220	62.5	152	153	154	5.00e-75	219
k141_17548_12	SARG|YP_002418004	62.5	152	153	154	7.09e-75	219
k141_17548_12	SARG|ZP_01813310	62.5	152	153	154	1.01e-74	219
k141_42154_10	SARG|gb|CDO61516.1|ARO:3003949|efrB	30.5	174	218	362	9.90e-11	59.3
k141_42154_10	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	28.4	162	218	579	2.46e-09	55.5
k141_42154_10	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	28.5	158	218	579	4.48e-09	54.7
k141_25836_10	SARG|gi|447057509|ref|WP_001134765.1|	28.2	252	335	309	4.30e-21	90.9
k141_25836_10	SARG|gi|445996695|ref|WP_000074550.1|	28.2	216	335	309	1.11e-20	89.7
k141_25836_10	SARG|Q83LR7	30.8	224	335	648	1.33e-20	91.7
k141_25836_10	SARG|gi|647325472|ref|WP_025760953.1|	30.8	224	335	648	1.33e-20	91.7
k141_25836_10	SARG|gi|647323678|ref|WP_025760497.1|	30.8	224	335	648	1.33e-20	91.7
k141_25836_10	SARG|gi|488042066|ref|WP_002113463.1|	28.2	216	335	309	2.09e-20	89.0
k141_25836_10	SARG|gi|488120365|ref|WP_002191762.1|	28.5	214	335	309	2.86e-20	88.6
k141_25836_10	SARG|gi|445996698|ref|WP_000074553.1|	27.8	216	335	309	2.86e-20	88.6
k141_25836_10	SARG|gi|488068784|ref|WP_002140181.1|	28.0	214	335	309	2.86e-20	88.6
k141_25836_10	SARG|gi|488130770|ref|WP_002201978.1|	27.8	216	335	309	3.92e-20	88.2
k141_25836_11	SARG|gi|1032819400|ref|WP_064325534.1|	31.3	252	338	646	1.19e-22	97.8
k141_25836_11	SARG|gi|779861244|ref|WP_045352062.1|	32.0	241	338	646	2.16e-22	97.1
k141_25836_11	SARG|gi|983405167|ref|WP_060572706.1|	31.5	238	338	646	2.90e-22	96.7
k141_25836_11	SARG|gi|782756348|ref|WP_045630015.1|	31.8	239	338	646	3.91e-22	96.3
k141_25836_11	SARG|gi|1022688710|ref|WP_063443532.1|	33.6	217	338	648	3.92e-22	96.3
k141_25836_11	SARG|gi|505180394|ref|WP_015367496.1|	33.6	217	338	648	3.92e-22	96.3
k141_25836_11	SARG|gi|851931792|ref|WP_048222288.1|	32.0	241	338	646	5.27e-22	95.9
k141_25836_11	SARG|gi|754493745|ref|WP_041910640.1|	31.4	239	338	646	5.27e-22	95.9
k141_25836_11	SARG|gi|798937928|ref|WP_045908399.1|	32.0	241	338	646	5.27e-22	95.9
k141_25836_11	SARG|gi|823326845|ref|WP_047080664.1|	33.6	217	338	648	5.28e-22	95.9
k141_31006_12	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	27.6	217	299	346	3.74e-18	82.4
k141_38826_2	SARG|gb|AAC75314.1|ARO:3003578|pmrF	99.1	322	323	322	2.60e-229	624
k141_38826_3	SARG|gi|446783055|ref|WP_000860311.1|	100	660	661	660	0.0	1349
k141_38826_3	SARG|gi|486404556|ref|WP_001607766.1|	99.8	660	661	660	0.0	1347
k141_38826_3	SARG|gi|585342394|ref|WP_024224020.1|	99.7	660	661	660	0.0	1346
k141_38826_3	SARG|gi|545169940|ref|WP_021524378.1|	99.7	660	661	660	0.0	1346
k141_38826_3	SARG|gi|446783033|ref|WP_000860289.1|	99.5	660	661	660	0.0	1345
k141_38826_3	SARG|gi|486356316|ref|WP_001592400.1|	99.7	660	661	660	0.0	1345
k141_38826_3	SARG|gi|765471235|ref|WP_044720736.1|	99.5	660	661	660	0.0	1344
k141_38826_3	SARG|gi|487679889|ref|WP_001764755.1|	99.5	660	661	660	0.0	1344
k141_38826_3	SARG|gi|487415681|ref|WP_001683081.1|	99.5	660	661	660	0.0	1344
k141_38826_3	SARG|gi|486175290|ref|WP_001535462.1|	99.5	660	661	660	0.0	1344
k141_38826_5	SARG|gb|CDO12042.1|ARO:3005053|ArnT	63.7	551	551	551	1.94e-253	704
k141_29397_13	SARG|gb|ABX54690.1|ARO:3002974|vanTrL	26.6	357	357	366	1.00e-30	119
k141_29397_13	SARG|JF802084.2.gene3.p01	28.3	360	357	700	3.04e-29	117
k141_29397_13	megares|MEG_7535|Drugs|Glycopeptide|VanN-type_resistance_protein|VANTN_1	29.6	287	357	656	2.78e-23	100
k141_29397_22	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	27.5	222	253	579	2.09e-11	62.4
k141_29397_22	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	26.6	222	253	579	1.66e-10	59.7
k141_29397_22	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.9	218	253	655	1.37e-09	57.0
k141_29397_22	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.9	218	253	655	1.37e-09	57.0
k141_29397_22	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.4	218	253	655	1.07e-08	54.3
k141_29397_22	SARG|gb|CDO61516.1|ARO:3003949|efrB	22.9	157	253	362	1.09e-08	53.9
k141_29397_22	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.4	218	253	655	1.44e-08	53.9
k141_29397_22	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.4	218	253	655	1.44e-08	53.9
k141_29397_22	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.4	218	253	655	1.44e-08	53.9
k141_29397_22	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.4	218	253	655	1.44e-08	53.9
k141_20947_1	SARG|gb|AAK76137.1|ARO:3000024|patA	29.5	234	333	564	4.90e-16	77.8
k141_20947_2	SARG|gi|554685678|ref|WP_023185565.1|	32.5	237	328	648	1.46e-21	94.4
k141_20947_2	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	30.9	220	328	255	2.26e-21	90.5
k141_20947_2	SARG|gi|657888313|ref|WP_029592374.1|	32.1	262	328	648	2.65e-21	93.6
k141_20947_2	SARG|gi|639216333|ref|WP_024554080.1|	32.0	244	328	648	3.58e-21	93.2
k141_20947_2	SARG|gi|896325272|ref|WP_049294291.1|	31.6	244	328	648	1.18e-20	91.7
k141_20947_2	SARG|gi|507086196|ref|WP_016156937.1|	30.3	238	328	648	1.59e-20	91.3
k141_20947_2	SARG|gi|757799695|ref|WP_043016897.1|	30.3	238	328	648	2.14e-20	90.9
k141_20947_2	SARG|gi|1045891604|ref|WP_065554100.1|	30.3	238	328	648	2.14e-20	90.9
k141_20947_2	SARG|gi|639225329|ref|WP_024561799.1|	31.3	252	328	648	2.14e-20	90.9
k141_20947_2	SARG|gi|507082903|ref|WP_016153652.1|	30.3	238	328	648	2.14e-20	90.9
k141_20947_6	megares|MEG_8080|Drugs|Lipopeptide|Colistin_phosphoethanolamine_transferase|EPTB_1	81.6	553	564	574	0.0	932
k141_20947_6	SARG|gb|CCI79240.1|ARO:3005047|eptB	81.6	553	564	574	0.0	932
k141_20947_6	SARG|gb|BAE78116.1|ARO:3003576|eptA	25.1	545	564	547	2.77e-32	129
k141_20947_13	NCBI|WP_011029109.1|1|1|vanH-Sc|vanH-Sc|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Sc|AMR|glycopeptide	31.7	252	325	337	2.85e-26	105
k141_20947_13	SARG|AAY52004	29.7	276	325	322	4.30e-26	104
k141_20947_13	SARG|KF478993.1.gene2.p01	30.5	259	325	350	1.25e-25	103
k141_20947_13	NCBI|WP_063856700.1|1|1|vanH-Ao2|vanH-Ao2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao2|AMR|glycopeptide	30.5	256	325	343	4.10e-25	102
k141_20947_13	NCBI|WP_063856699.1|1|1|vanH-Ao1|vanH-Ao1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao1|AMR|glycopeptide	30.5	256	325	348	4.40e-25	102
k141_20947_13	NCBI|WP_063856698.1|1|1|vanH-Ac1|vanH-Ac1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ac1|AMR|glycopeptide	30.0	257	325	351	3.12e-24	100
k141_20947_13	megares|MEG_7399|Drugs|Glycopeptide|VanA-type_resistance_protein|VANHA_1	30.8	224	325	237	6.06e-24	97.1
k141_20947_13	SARG|gb|MBY8651254.1|ARO:3007188|vanH_in_vanP_cl	27.2	246	325	314	1.20e-16	78.2
k141_20947_29	SARG|gi|491270241|ref|WP_005128370.1|	30.7	251	514	648	7.15e-21	95.1
k141_20947_29	SARG|gi|851902043|ref|WP_048212057.1|	31.3	233	514	648	1.26e-20	94.4
k141_20947_29	SARG|gi|992380339|ref|WP_061067665.1|	31.3	233	514	648	1.26e-20	94.4
k141_20947_29	SARG|gi|851928815|ref|WP_048221086.1|	31.3	233	514	648	1.26e-20	94.4
k141_20947_29	SARG|gi|780033092|ref|WP_045444768.1|	31.3	233	514	648	1.26e-20	94.4
k141_20947_29	SARG|gi|740856590|ref|WP_038641842.1|	30.9	233	514	648	3.95e-20	92.8
k141_20947_29	SARG|gi|507086196|ref|WP_016156937.1|	31.6	228	514	648	3.95e-20	92.8
k141_20947_29	SARG|gi|757799695|ref|WP_043016897.1|	30.9	233	514	648	6.97e-20	92.0
k141_20947_29	SARG|gi|1045891604|ref|WP_065554100.1|	30.9	233	514	648	6.97e-20	92.0
k141_20947_29	SARG|gi|507082903|ref|WP_016153652.1|	30.9	233	514	648	6.97e-20	92.0
k141_20947_31	NCBI|AAD44693.1|1|1|mtrA_Ngon|mtrA_Ngon||1|EFFLUX|EFFLUX|efflux_transporter_MtrCDE_transcriptional_activator_MtrA|AMR|efflux	34.6	81	393	301	3.26e-09	56.6
k141_60826_1	NCBI|WP_000778180.1|1|1|varG|varG|hydrolase|2|CARBAPENEM|beta-lactam|VarG_family_subclass_B1-like_metallo-beta-lactamase|AMR|beta-lactam	29.9	314	341	374	1.47e-41	147
k141_60826_1	SARG|gb|AAF94716.1|ARO:3004289|Vibrio	29.9	314	341	390	2.03e-41	147
k141_60826_12	CARD|gb|AAK37618.1|ARO:3005008|TxR	39.2	306	693	318	2.86e-66	220
k141_60826_25	SARG|gb|AAG57600.1|ARO:3000318|mphB	45.0	131	137	158	5.12e-33	112
k141_60826_34	CARD|gb|AAK37618.1|ARO:3005008|TxR	40.8	316	505	318	5.21e-64	209
k141_60826_48	CARD|gb|AAC16242.1|ARO:3005069|rsmA	85.2	61	62	61	4.58e-31	101
k141_60826_56	SARG|gi|91073621|gb|ABE08502.1|	100	512	513	515	0.0	998
k141_60826_56	SARG|gi|481041940|ref|WP_001296316.1|	100	512	513	512	0.0	998
k141_60826_56	SARG|gi|485705201|ref|WP_001337983.1|	99.8	512	513	512	0.0	998
k141_60826_56	SARG|gi|979463679|ref|WP_059329539.1|	99.8	512	513	512	0.0	998
k141_60826_56	SARG|NC_002695.1.914736.p01	99.8	512	513	512	0.0	997
k141_60826_56	SARG|gi|979519371|ref|WP_059338299.1|	99.8	512	513	512	0.0	997
k141_60826_56	SARG|gi|920021424|ref|WP_052936095.1|	99.8	512	513	512	0.0	997
k141_60826_56	SARG|gi|510905729|ref|WP_016232280.1|	99.6	512	513	512	0.0	997
k141_60826_56	SARG|gi|485870866|ref|WP_001467845.1|	99.8	512	513	512	0.0	997
k141_60826_56	SARG|gi|585364441|ref|WP_024246028.1|	99.8	512	513	512	0.0	997
k141_60826_57	SARG|gi|26109487|gb|AAN81690.1|AE016765_92	100	390	391	394	3.70e-262	712
k141_60826_57	SARG|gb|BAA16547.1|ARO:3000027|emrA	99.7	390	391	390	4.52e-262	712
k141_60826_57	SARG|gi|692990270|ref|WP_032178668.1|	99.7	390	391	390	4.52e-262	712
k141_60826_57	SARG|gi|765410328|ref|WP_044688844.1|	99.7	390	391	390	4.52e-262	712
k141_60826_57	SARG|gi|723107988|ref|WP_033555625.1|	99.7	390	391	390	4.52e-262	712
k141_60826_57	SARG|gi|545159469|ref|WP_021514432.1|	99.2	390	391	390	4.52e-262	712
k141_60826_57	SARG|gi|754634482|ref|WP_042021032.1|	99.7	390	391	390	4.52e-262	712
k141_60826_57	SARG|gi|545231023|ref|WP_021530660.1|	99.7	390	391	390	4.52e-262	712
k141_60826_57	SARG|gi|510905726|ref|WP_016232279.1|	99.5	390	391	390	6.42e-262	712
k141_60826_57	SARG|gi|693139934|ref|WP_032281480.1|	99.7	390	391	390	9.12e-262	711
k141_60826_58	CARD|gb|AAC75731.1|ARO:3000516|emrR	100	176	177	176	9.92e-125	347
k141_60826_61	SARG|gb|AEV23046.1|ARO:3007019|fexB	22.5	200	395	469	3.86e-07	50.8
k141_60826_64	SARG|gi|542061059|gb|ERI11611.1|	29.8	235	401	316	1.68e-29	115
k141_60826_64	SARG|gi|500194536|ref|WP_011867743.1|	30.9	207	401	306	1.20e-26	107
k141_60826_64	SARG|gi|447057509|ref|WP_001134765.1|	30.4	207	401	309	6.23e-26	105
k141_60826_64	SARG|gi|507035724|ref|WP_016107411.1|	30.0	207	401	309	8.56e-26	105
k141_60826_64	SARG|gi|488042066|ref|WP_002113463.1|	30.0	207	401	309	8.56e-26	105
k141_60826_64	SARG|gi|445996696|ref|WP_000074551.1|	30.0	207	401	309	8.56e-26	105
k141_60826_64	SARG|gi|445996697|ref|WP_000074552.1|	30.0	207	401	309	1.18e-25	104
k141_60826_64	SARG|gi|488068784|ref|WP_002140181.1|	30.4	207	401	309	1.18e-25	104
k141_60826_64	SARG|gi|488120365|ref|WP_002191762.1|	30.7	202	401	309	1.62e-25	104
k141_60826_64	SARG|gi|507055561|ref|WP_016126482.1|	30.0	207	401	309	1.62e-25	104
k141_16297_4	SARG|AF139725.gene.p01	49.0	49	204	214	5.96e-11	58.5
k141_16297_4	SARG|AAF24171	49.0	49	204	214	5.96e-11	58.5
k141_16297_4	NCBI|WP_063856931.1|1|1|vat(E)|vat(E)|acetyltransferase|2|STREPTOGRAMIN|STREPTOGRAMIN|streptogramin_A_O-acetyltransferase_Vat(E)|AMR|streptogramin	49.0	49	204	214	5.96e-11	58.5
k141_16297_4	NCBI|WP_063856932.1|1|1|vat(E)|vat(E)|acetyltransferase|2|STREPTOGRAMIN|STREPTOGRAMIN|streptogramin_A_O-acetyltransferase_Vat(E)|AMR|streptogramin	49.0	49	204	214	5.96e-11	58.5
k141_16297_4	NCBI|WP_063856933.1|1|1|vat(E)|vat(E)|acetyltransferase|2|STREPTOGRAMIN|STREPTOGRAMIN|streptogramin_A_O-acetyltransferase_Vat(E)|AMR|streptogramin	49.0	49	204	214	5.96e-11	58.5
k141_16297_4	NCBI|WP_063856934.1|1|1|vat(E)|vat(E)|acetyltransferase|2|STREPTOGRAMIN|STREPTOGRAMIN|streptogramin_A_O-acetyltransferase_Vat(E)|AMR|streptogramin	49.0	49	204	214	5.96e-11	58.5
k141_16297_4	SARG|AAG21695	49.0	49	204	214	5.96e-11	58.5
k141_16297_4	SARG|AAK91782	49.0	49	204	214	5.96e-11	58.5
k141_16297_10	SARG|gi|544923113|ref|WP_021332509.1|	32.6	384	555	478	8.51e-37	141
k141_16297_10	NCBI|WP_015031687.1|1|1|rox_sv|rox_sv||2|rifamycin|rifamycin|rifampin_monooxygenase_Rox|AMR|rifamycin	31.5	349	555	476	8.83e-28	115
k141_16297_10	SARG|gi|754504368|ref|WP_041915032.1|	28.1	338	555	378	2.66e-09	58.2
k141_16297_16	SARG|P42670	30.6	180	404	503	4.19e-07	50.8
k141_6177_12	SARG|gi|486164692|ref|WP_001528167.1|	100	334	335	377	9.34e-244	663
k141_6177_12	SARG|gi|1033149378|ref|WP_064455171.1|	99.7	334	335	377	1.88e-243	662
k141_6177_12	SARG|gi|754635927|ref|WP_042022358.1|	99.7	334	335	377	3.80e-243	661
k141_6177_12	SARG|gi|545240884|ref|WP_021539686.1|	99.7	334	335	377	3.80e-243	661
k141_6177_12	SARG|gi|485718818|ref|WP_001350388.1|	99.7	334	335	377	3.80e-243	661
k141_6177_12	SARG|gi|485719302|ref|WP_001350795.1|	99.7	334	335	377	3.80e-243	661
k141_6177_12	SARG|gi|765472000|ref|WP_044721441.1|	99.7	334	335	377	5.40e-243	661
k141_6177_12	SARG|gi|487680418|ref|WP_001765279.1|	99.7	334	335	377	5.40e-243	661
k141_6177_12	SARG|gi|1020280296|ref|WP_063269641.1|	99.7	334	335	377	5.40e-243	661
k141_6177_12	SARG|gi|485832354|ref|WP_001445395.1|	99.4	334	335	377	1.09e-242	660
k141_6177_13	megares|MEG_497|Drugs|beta-lactam|Class_C_betalactamases|ACT_1	79.2	77	178	77	1.08e-40	131
k141_6177_14	SARG|gi|1044625135|gb|OCB99622.1|	45.7	105	106	163	8.46e-21	80.5
k141_6177_14	SARG|gi|489246603|ref|WP_003154767.1|	45.7	105	106	112	1.93e-20	78.2
k141_6177_14	SARG|gi|1036316000|gb|OAZ59366.1|	45.7	105	106	163	2.38e-20	79.3
k141_6177_14	SARG|gi|494649292|ref|WP_007407236.1|	45.7	105	106	112	2.73e-20	77.8
k141_6177_14	SARG|gi|307606148|emb|CBI42519.1|	44.8	105	106	163	3.36e-20	79.0
k141_6177_14	SARG|ABS73653	45.7	105	106	112	1.10e-19	76.3
k141_6177_14	SARG|gi|505052607|ref|WP_015239709.1|	44.8	105	106	112	1.55e-19	75.9
k141_6177_14	SARG|gi|452079515|emb|CCP21271.1|	44.8	105	106	169	6.02e-19	75.9
k141_6177_14	SARG|gi|503879533|ref|WP_014113527.1|	45.7	105	106	112	1.01e-17	71.2
k141_6177_14	SARG|gi|489311090|ref|WP_003218499.1|	45.7	105	106	112	1.01e-17	71.2
k141_48772_3	CARD|gb|TKW44661.1|ARO:3005040|YajC	46.9	113	111	112	8.79e-28	97.1
k141_48772_23	SARG|gb|AAD08227.1|ARO:3003964|hp1181	32.3	353	455	443	1.34e-41	152
k141_48772_23	megares|MEG_6987|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TET39_1	29.4	255	455	395	6.78e-14	72.0
k141_48772_23	SARG|AY743590.gene.p01	29.4	255	455	395	6.78e-14	72.0
k141_48772_23	ResF|tet(39)_2_CP044518_1	29.4	255	455	395	6.78e-14	72.0
k141_48772_23	SARG|AAR14158	29.8	141	455	392	8.91e-14	71.6
k141_48772_23	SARG|CAQ51492	29.8	141	455	393	8.96e-14	71.6
k141_48772_23	SARG|gi|505141122|ref|WP_015328224.1|	29.8	141	455	393	8.96e-14	71.6
k141_48772_23	SARG|CAA76069	29.8	141	455	400	9.26e-14	71.6
k141_48772_23	SARG|Y15510.gene.p01	29.8	141	455	400	9.26e-14	71.6
k141_48772_23	SARG|BAC67142	28.2	174	455	401	1.65e-13	70.9
k141_48772_44	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	35.1	569	591	579	1.10e-105	329
k141_48772_44	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	35.0	569	591	579	3.07e-105	328
k141_48772_44	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	31.9	562	591	574	6.28e-90	288
k141_48772_44	SARG|gi|944152509|ref|WP_055644808.1|	33.0	497	591	616	5.56e-66	225
k141_48772_44	SARG|gb|AYV52072.1|ARO:3002882|lmrD	30.8	490	591	664	9.44e-64	220
k141_48772_44	SARG|gb|AAK76136.1|ARO:3000025|patB	29.7	489	591	588	6.00e-60	208
k141_48772_44	SARG|gb|AET10445.1|ARO:3004033|tetB(46)	31.0	384	591	578	8.77e-46	169
k141_48772_44	SARG|gb|CDO61516.1|ARO:3003949|efrB	36.7	281	591	362	6.80e-44	159
k141_48772_45	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	34.5	579	594	579	8.81e-93	295
k141_48772_45	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	32.6	579	594	579	7.12e-86	277
k141_48772_45	SARG|gb|AAC74000.1|ARO:3003950|msbA	30.0	580	594	582	1.42e-71	239
k141_48772_45	SARG|gi|663330365|ref|WP_030329892.1|	28.8	573	594	607	4.93e-63	217
k141_48772_45	SARG|gi|928900436|ref|WP_053931243.1|	28.9	582	594	600	8.31e-63	216
k141_48772_45	SARG|gi|664579989|ref|WP_031094015.1|	28.9	582	594	601	8.47e-63	216
k141_48772_45	SARG|gi|663155409|ref|WP_030194633.1|	28.8	573	594	605	9.14e-63	216
k141_48772_45	SARG|gi|664538723|ref|WP_031054357.1|	28.8	573	594	605	9.14e-63	216
k141_48772_45	SARG|gi|664317010|ref|WP_030845774.1|	28.8	573	594	605	1.76e-62	216
k141_48772_45	SARG|gi|663286402|ref|WP_030292859.1|	28.8	573	594	605	1.76e-62	216
k141_48772_54	NCBI|WP_031281281.1|1|1|catB|catB|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_B_phenicol_O-acetyltransferase|AMR|phenicol	45.1	51	184	210	3.13e-08	50.4
k141_48772_54	SARG|M58472.1.gene1.p01	47.1	51	184	209	5.82e-08	49.7
k141_48772_54	SARG|ABF20240	39.2	74	184	210	5.87e-08	49.7
k141_48772_54	SARG|ACA48664	39.2	74	184	210	5.87e-08	49.7
k141_48772_54	SARG|ACD03314	39.2	74	184	210	5.87e-08	49.7
k141_48772_54	SARG|AF445082.1.gene5.p01	39.2	74	184	210	5.87e-08	49.7
k141_48772_54	SARG|AY259086.1.gene4.p01	39.2	74	184	210	5.87e-08	49.7
k141_48772_54	NCBI|WP_071846350.1|1|1|catB3|catB3|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_B-3_phenicol_O-acetyltransferase_CatB3|AMR|phenicol	39.2	74	184	210	5.87e-08	49.7
k141_48772_54	NCBI|WP_071846363.1|1|1|catB3|catB3|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_B-3_phenicol_O-acetyltransferase_CatB3|AMR|phenicol	39.2	74	184	210	5.87e-08	49.7
k141_48772_54	SARG|ABC69169	39.2	74	184	210	5.87e-08	49.7
k141_48772_57	CARD|gb|AAC73564.1|ARO:3000216|acrB	99.7	1049	1050	1049	0.0	1971
k141_48772_57	SARG|gi|817600095|ref|WP_046594084.1|	80.6	1038	1050	1037	0.0	1612
k141_48772_57	SARG|gi|817601660|ref|WP_046595348.1|	80.7	1038	1050	1037	0.0	1612
k141_48772_57	SARG|gi|447196024|ref|WP_001273280.1|	80.6	1038	1050	1037	0.0	1612
k141_48772_57	SARG|gi|817604860|ref|WP_046598079.1|	80.6	1038	1050	1037	0.0	1612
k141_48772_57	SARG|gi|817600173|ref|WP_046594139.1|	80.6	1038	1050	1037	0.0	1611
k141_48772_57	SARG|gi|487663012|ref|WP_001752778.1|	80.4	1038	1050	1037	0.0	1609
k141_48772_57	SARG|gi|694076105|ref|WP_032421853.1|	81.4	1038	1050	1036	0.0	1608
k141_48772_57	SARG|gi|496667122|ref|WP_009309612.1|	81.5	1038	1050	1036	0.0	1607
k141_48772_57	SARG|CP000647.1.gene3710.p01	81.4	1038	1050	1036	0.0	1607
k141_48772_58	SARG|CAS07946	100	397	398	397	1.23e-274	744
k141_48772_58	SARG|ACB17731	100	397	398	409	1.94e-274	744
k141_48772_58	SARG|YP_002396538	99.7	397	398	397	3.53e-274	743
k141_48772_58	SARG|gi|1000938487|ref|WP_061182054.1|	99.7	397	398	397	5.02e-274	743
k141_48772_58	SARG|NC_002695.1.914620.p01	99.7	397	398	397	5.02e-274	743
k141_48772_58	SARG|YP_002269113	99.7	397	398	409	7.88e-274	743
k141_48772_58	SARG|YP_309461	99.5	397	398	397	1.44e-273	742
k141_48772_58	SARG|gi|928884686|ref|WP_053919771.1|	99.5	397	398	397	1.44e-273	742
k141_48772_58	SARG|gi|928821234|ref|WP_053881997.1|	99.5	397	398	397	2.04e-273	741
k141_48772_58	SARG|YP_001879173	99.5	397	398	409	2.26e-273	742
k141_48772_59	CARD|gb|AAC76296.1|ARO:3000656|AcrS	37.7	204	216	220	3.81e-37	128
k141_48772_59	NCBI|CAA81047.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	34.6	208	216	210	2.22e-33	118
k141_48772_59	NCBI|ACF30254.1|1|1|mtrR|mtrR|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_system_transcriptional_repressor_MtrR|AMR|efflux	34.6	208	216	210	4.40e-33	117
k141_48772_71	NCBI|WP_011906899.1|1|1|estDL136|estDL136||2|CHLORAMPHENICOL/FLORFENICOL|PHENICOL|phenicol_hydrolase|AMR|phenicol	28.9	225	320	308	8.51e-28	108
k141_48772_71	megares|MEG_2865|Drugs|Phenicol|Chloramphenicol_hydrolase|ESTD_1	30.1	246	320	310	6.27e-27	106
k141_48772_73	SARG|gi|1001786599|ref|WP_061324791.1|	81.0	554	559	563	2.74e-303	831
k141_48772_73	SARG|gi|896190680|ref|WP_049199932.1|	80.3	554	559	563	5.52e-303	830
k141_48772_73	SARG|YP_001477377	80.1	548	559	563	4.29e-300	823
k141_48772_73	SARG|ZP_04638974	80.7	548	559	563	2.35e-297	816
k141_48772_73	SARG|YP_001007250	80.3	548	559	563	3.33e-297	815
k141_48772_73	SARG|YP_001401994	79.9	548	559	563	1.82e-294	808
k141_48772_73	SARG|AAS61092	79.9	548	559	563	2.59e-294	808
k141_48772_73	SARG|gi|740410309|ref|WP_038243756.1|	78.2	554	559	563	1.05e-293	806
k141_48772_73	SARG|YP_001605795	79.7	548	559	562	9.60e-292	801
k141_48772_73	SARG|gi|544012122|gb|ERK10884.1|	80.0	526	559	541	3.59e-284	781
k141_48772_74	SARG|YP_001477378	79.3	386	407	406	1.42e-213	591
k141_48772_74	SARG|ZP_04621517	77.2	390	407	404	3.24e-207	575
k141_48772_74	SARG|ZP_04631862	77.7	390	407	404	6.53e-207	574
k141_48772_74	SARG|ZP_04612558	76.5	392	407	404	3.76e-206	572
k141_48772_74	SARG|ZP_04638972	74.5	404	407	404	5.34e-206	572
k141_48772_74	SARG|YP_001605796	77.5	386	407	404	5.34e-206	572
k141_48772_74	SARG|YP_001401993	77.2	386	407	404	1.53e-205	570
k141_48772_74	SARG|ZP_04623896	78.2	380	407	380	2.59e-205	569
k141_48772_74	SARG|YP_001871501	77.2	386	407	404	4.37e-205	569
k141_48772_74	SARG|AAC60781	73.2	388	407	410	3.15e-185	519
k141_19471_4	CARD|gb|BAB38260.1|ARO:3000830|cpxA	30.3	274	451	457	2.03e-34	132
k141_19471_5	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	45.7	232	240	252	2.65e-63	197
k141_19471_5	CARD|gb|AAG05188.1|ARO:3005068|ParR	42.0	231	240	235	9.71e-57	179
k141_19471_5	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	40.4	225	240	232	4.57e-54	172
k141_19471_5	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	40.4	225	240	232	4.57e-54	172
k141_19471_5	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	39.8	226	240	231	1.60e-51	166
k141_19471_5	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	39.8	226	240	231	1.60e-51	166
k141_19471_5	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	40.3	226	240	231	9.06e-51	164
k141_19471_5	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	40.3	226	240	231	1.28e-50	164
k141_19471_5	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	39.4	226	240	231	2.56e-50	163
k141_19471_5	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	39.9	228	240	225	1.21e-49	161
k141_19471_50	SARG|gi|507086196|ref|WP_016156937.1|	29.6	206	238	648	9.72e-22	92.4
k141_19471_50	SARG|gi|922960663|ref|WP_053388845.1|	29.6	206	238	648	9.72e-22	92.4
k141_19471_50	SARG|gi|491270241|ref|WP_005128370.1|	29.1	206	238	648	2.42e-21	91.3
k141_19471_50	SARG|gi|740856590|ref|WP_038641842.1|	29.1	206	238	648	2.42e-21	91.3
k141_19471_50	SARG|gi|851902043|ref|WP_048212057.1|	29.1	206	238	648	2.42e-21	91.3
k141_19471_50	SARG|gi|992380339|ref|WP_061067665.1|	29.1	206	238	648	2.42e-21	91.3
k141_19471_50	SARG|gi|695840638|ref|WP_032753940.1|	29.4	211	238	646	3.28e-21	90.9
k141_19471_50	SARG|gi|757799695|ref|WP_043016897.1|	29.1	206	238	648	3.29e-21	90.9
k141_19471_50	SARG|gi|1045891604|ref|WP_065554100.1|	29.1	206	238	648	3.29e-21	90.9
k141_19471_50	SARG|gi|507082903|ref|WP_016153652.1|	29.1	206	238	648	3.29e-21	90.9
k141_19471_51	SARG|gb|AYV52072.1|ARO:3002882|lmrD	24.7	231	256	664	2.87e-12	65.1
k141_19471_51	SARG|gb|CDO61516.1|ARO:3003949|efrB	25.3	174	256	362	4.01e-11	61.2
k141_19471_51	SARG|gb|AAK76136.1|ARO:3000025|patB	20.9	225	256	588	3.59e-07	49.7
k141_19471_51	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	27.3	110	256	461	4.38e-07	49.3
k141_19471_51	NCBI|WP_172065992.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	26.4	110	256	461	1.05e-06	48.1
k141_19471_61	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	36.3	201	223	255	1.10e-40	138
k141_19471_61	SARG|gi|694064328|ref|WP_032410816.1|	37.3	204	223	646	2.75e-37	136
k141_19471_61	SARG|gi|447195835|ref|WP_001273091.1|	29.6	216	223	306	2.31e-21	89.0
k141_19471_61	SARG|gi|507055561|ref|WP_016126482.1|	28.2	216	223	309	2.40e-21	89.0
k141_19471_61	SARG|gi|488053456|ref|WP_002124853.1|	28.2	216	223	309	3.32e-21	88.6
k141_19471_61	SARG|gi|488068784|ref|WP_002140181.1|	27.8	216	223	309	3.32e-21	88.6
k141_19471_61	SARG|gi|447057510|ref|WP_001134766.1|	27.8	216	223	309	3.32e-21	88.6
k141_19471_61	SARG|gi|500194536|ref|WP_011867743.1|	28.1	221	223	306	4.43e-21	88.2
k141_19471_61	SARG|gi|488067981|ref|WP_002139378.1|	27.8	216	223	309	4.60e-21	88.2
k141_19471_61	SARG|gi|487936534|ref|WP_002010000.1|	27.8	216	223	309	4.60e-21	88.2
k141_19471_72	NCBI|AKA30736.1|1|1|cxpE|cxpE||1|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_transporter_CxpE|AMR|phenicol	29.1	127	350	397	2.75e-08	53.9
k141_19471_77	SARG|gi|504542119|ref|WP_014729221.1|	29.9	224	255	647	5.45e-11	61.2
k141_19471_77	SARG|gi|506220920|ref|WP_015740695.1|	30.1	206	255	647	1.32e-10	60.1
k141_19471_77	SARG|gi|742378414|ref|WP_038857601.1|	30.1	206	255	647	1.32e-10	60.1
k141_19471_77	SARG|gi|498115003|ref|WP_010429159.1|	29.1	230	255	646	1.78e-10	59.7
k141_19471_77	SARG|YP_001438541	30.1	206	255	647	1.78e-10	59.7
k141_19471_77	SARG|gi|938461734|ref|WP_054625806.1|	30.1	206	255	647	1.78e-10	59.7
k141_19471_77	SARG|gi|938460528|ref|WP_054624864.1|	30.1	206	255	647	1.78e-10	59.7
k141_19471_77	SARG|gi|1020141879|ref|WP_063264839.1|	30.1	206	255	647	1.78e-10	59.7
k141_19471_77	SARG|gi|490522515|ref|WP_004387938.1|	30.1	206	255	647	1.78e-10	59.7
k141_19471_77	SARG|gi|655997348|ref|WP_029038923.1|	30.1	206	255	647	1.78e-10	59.7
k141_19471_78	SARG|gi|446048013|ref|WP_000125868.1|	31.9	254	269	648	1.10e-21	93.2
k141_19471_78	SARG|gb|AAK76137.1|ARO:3000024|patA	27.6	210	269	564	1.32e-16	78.2
k141_19471_78	SARG|gi|493394434|ref|WP_006350564.1|	26.7	236	269	602	5.78e-13	67.4
k141_19471_78	SARG|gi|860594225|ref|WP_048475168.1|	28.6	220	269	620	5.84e-13	67.4
k141_19471_78	SARG|gb|WP_104671188.1|ARO:3003948|efrA	28.2	213	269	575	1.38e-12	66.2
k141_19471_78	SARG|gi|695842130|ref|WP_032755430.1|	28.2	220	269	603	1.41e-12	66.2
k141_19471_78	SARG|gi|505420018|ref|WP_015607120.1|	28.2	220	269	603	1.41e-12	66.2
k141_19471_78	SARG|gi|926286457|ref|WP_053623344.1|	27.5	229	269	605	1.41e-12	66.2
k141_19471_78	SARG|gi|926400371|ref|WP_053728483.1|	28.6	213	269	603	1.89e-12	65.9
k141_19471_78	SARG|gi|496018010|ref|WP_008742581.1|	27.6	217	269	623	1.92e-12	65.9
k141_38869_2	SARG|gi|851928815|ref|WP_048221086.1|	30.8	237	624	648	1.23e-15	79.3
k141_38869_2	SARG|gi|780033092|ref|WP_045444768.1|	30.8	237	624	648	1.23e-15	79.3
k141_38869_2	SARG|Q83LR7	30.8	237	624	648	1.62e-15	79.0
k141_38869_2	SARG|gi|740856590|ref|WP_038641842.1|	30.4	237	624	648	1.62e-15	79.0
k141_38869_2	SARG|gi|647325472|ref|WP_025760953.1|	30.8	237	624	648	1.62e-15	79.0
k141_38869_2	SARG|gi|647323678|ref|WP_025760497.1|	30.8	237	624	648	1.62e-15	79.0
k141_38869_2	SARG|gi|1035686596|ref|WP_064530178.1|	30.4	237	624	648	1.62e-15	79.0
k141_38869_2	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	28.1	217	624	255	2.84e-15	75.1
k141_38869_2	SARG|gi|835233765|ref|WP_047410073.1|	28.3	269	624	648	3.73e-15	77.8
k141_38869_2	SARG|gi|754964360|ref|WP_042320280.1|	28.2	245	624	648	3.73e-15	77.8
k141_38869_10	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.3	532	531	655	2.52e-82	268
k141_38869_10	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.3	532	531	655	2.52e-82	268
k141_38869_10	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.1	532	531	655	9.65e-82	266
k141_38869_10	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.1	532	531	655	1.35e-81	266
k141_38869_10	SARG|gb|AKA86814|ARO:3003746|optrA	32.1	532	531	655	1.35e-81	266
k141_38869_10	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.1	532	531	655	3.70e-81	265
k141_38869_10	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.1	532	531	655	3.70e-81	265
k141_38869_10	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.1	532	531	655	3.70e-81	265
k141_38869_10	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.1	532	531	655	3.70e-81	265
k141_38869_10	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	32.0	532	531	655	1.42e-80	263
k141_38869_21	SARG|gi|896325272|ref|WP_049294291.1|	44.7	219	241	648	6.05e-46	160
k141_38869_21	SARG|gi|639216333|ref|WP_024554080.1|	44.5	209	241	648	8.07e-45	157
k141_38869_21	SARG|gi|639225329|ref|WP_024561799.1|	45.0	209	241	648	1.12e-44	157
k141_38869_21	SARG|gi|639218559|ref|WP_024556062.1|	45.0	209	241	648	1.12e-44	157
k141_38869_21	SARG|gi|657888313|ref|WP_029592374.1|	44.5	209	241	648	2.94e-44	156
k141_38869_21	SARG|gi|516510995|ref|WP_017899433.1|	39.7	237	241	646	2.76e-43	153
k141_38869_21	SARG|gi|490306253|ref|WP_004201358.1|	39.7	237	241	646	5.26e-43	152
k141_38869_21	SARG|gi|950164608|ref|WP_057214157.1|	39.7	237	241	646	5.26e-43	152
k141_38869_21	SARG|gi|896073592|ref|WP_049116987.1|	39.7	237	241	646	5.26e-43	152
k141_38869_21	SARG|gi|556468297|ref|WP_023320056.1|	39.7	237	241	646	5.26e-43	152
k141_38869_36	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	40.8	228	579	343	1.08e-50	177
k141_38869_36	SARG|P42332	34.1	255	579	306	5.35e-43	155
k141_38869_36	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	34.1	255	579	306	5.35e-43	155
k141_38869_36	SARG|gi|510143239|gb|AGN36970.1|	34.1	255	579	313	6.37e-43	155
k141_38869_36	SARG|ABB80128	34.1	255	579	306	7.41e-43	154
k141_38869_36	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	35.7	224	579	307	2.78e-42	153
k141_38869_36	SARG|gi|445996719|ref|WP_000074574.1|	35.4	226	579	309	5.59e-42	152
k141_38869_36	SARG|gi|542061059|gb|ERI11611.1|	34.4	224	579	316	9.17e-42	152
k141_38869_36	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	37.1	229	579	325	4.14e-41	150
k141_38869_36	SARG|gi|446026113|ref|WP_000103968.1|	35.1	222	579	306	5.00e-41	149
k141_38869_42	megares|MEG_4054|Drugs|Cationic_antimicrobial_peptide|Defensin-resistant_mprF|MPRF_1	27.2	279	319	880	1.34e-12	67.4
k141_38869_42	SARG|gb|Q8FW76|ARO:3003772|Brucella	27.2	279	319	880	1.34e-12	67.4
k141_44245_2	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	28.0	429	439	429	1.07e-43	157
k141_60891_5	NCBI|WP_002382867.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	30.6	219	432	447	5.05e-23	99.8
k141_60891_5	NCBI|WP_012579101.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	30.6	219	432	447	5.05e-23	99.8
k141_60891_5	NCBI|WP_063856739.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	30.6	219	432	447	5.05e-23	99.8
k141_60891_5	CARD|gb|ABD30512.1|ARO:3000839|arlS	28.7	265	432	451	1.73e-22	98.2
k141_60891_5	NCBI|WP_063856751.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	31.3	214	432	454	1.76e-22	98.2
k141_60891_5	NCBI|WP_002368696.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	31.1	222	432	447	1.01e-21	95.9
k141_60891_5	NCBI|WP_002305818.1|1|1|vanS-A|vanS-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-A|AMR|glycopeptide	27.0	252	432	384	3.03e-20	90.9
k141_60891_5	megares|MEG_7454|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	27.0	252	432	384	3.03e-20	90.9
k141_60891_5	NCBI|WP_063856741.1|1|1|vanS-Pt|vanS-Pt|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-Pt|AMR|glycopeptide	25.9	251	432	386	3.09e-20	90.9
k141_60891_5	megares|MEG_7488|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	25.9	251	432	386	3.09e-20	90.9
k141_60891_6	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	41.8	225	230	228	5.95e-51	164
k141_60891_6	CARD|gb|ATC67679.1|ARO:3000838|arlR	36.8	220	230	219	4.14e-49	159
k141_60891_6	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	37.5	232	230	232	4.82e-45	149
k141_60891_6	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	37.1	232	230	232	1.36e-44	148
k141_60891_6	CARD|gb|AAD51348.1|ARO:3003066|smeR	38.1	223	230	229	1.77e-44	147
k141_60891_6	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	34.2	228	230	231	2.64e-44	147
k141_60891_6	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	38.5	231	230	231	1.48e-43	145
k141_60891_6	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	38.5	231	230	231	1.48e-43	145
k141_60891_6	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	36.8	223	230	225	3.53e-43	144
k141_60891_6	CARD|gb|AAC73788.1|ARO:3003841|kdpE	36.8	223	230	225	3.53e-43	144
k141_60891_9	NCBI|WP_063844229.1|1|1|cmlV|cmlV|efflux|2|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_MFS_transporter_CmlV|AMR|phenicol	27.0	389	423	412	6.99e-37	138
k141_60891_9	SARG|U09991.1.gene2.p01	27.0	389	423	436	1.04e-36	138
k141_60891_9	SARG|AF015087.1.gene1.p01	26.1	356	423	391	8.28e-34	129
k141_60891_9	megares|MEG_1780|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	26.1	352	423	391	2.17e-33	128
k141_60891_9	SARG|gb|CAA78046.1|ARO:3002701|Rfas_cmr	23.3	386	423	391	5.86e-29	115
k141_60891_9	SARG|gi|2708772|gb|AAB96371.1|	26.8	395	423	391	5.86e-29	115
k141_60891_9	megares|MEG_1781|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMRA_1	23.3	382	423	391	1.51e-28	114
k141_60891_9	SARG|NP_044444	26.8	395	423	391	1.51e-28	114
k141_60891_9	SARG|AF024666.2.gene33.p01	26.6	395	423	391	3.88e-28	113
k141_60891_9	SARG|YP_251195	26.6	395	423	391	7.28e-28	112
k141_11161_3	SARG|gi|930482089|ref|WP_054228897.1|	28.1	217	256	599	6.76e-12	63.9
k141_11161_3	SARG|gi|985844137|ref|WP_060895163.1|	28.1	217	256	599	6.76e-12	63.9
k141_11161_3	SARG|gi|655401130|ref|WP_028800283.1|	28.5	214	256	599	5.39e-11	61.2
k141_11161_3	SARG|gi|516795764|ref|WP_018105258.1|	28.2	209	256	601	7.25e-11	60.8
k141_11161_3	SARG|gi|748767925|ref|WP_040019608.1|	28.6	213	256	623	1.33e-10	60.1
k141_11161_3	SARG|gi|664458452|ref|WP_030980047.1|	27.9	208	256	601	1.76e-10	59.7
k141_11161_3	SARG|gi|517347347|ref|WP_018522839.1|	28.2	209	256	601	1.76e-10	59.7
k141_11161_3	SARG|gi|695842130|ref|WP_032755430.1|	29.0	200	256	603	1.76e-10	59.7
k141_11161_3	SARG|gi|505420018|ref|WP_015607120.1|	29.0	200	256	603	1.76e-10	59.7
k141_11161_3	SARG|gi|648667297|ref|WP_026359044.1|	28.2	209	256	605	1.77e-10	59.7
k141_75453_4	SARG|CP001581.1.gene725.p01	32.9	383	458	477	3.45e-57	195
k141_75453_4	SARG|NP_733568	31.6	405	458	536	7.05e-44	160
k141_75453_4	SARG|YP_002196817	28.8	441	458	536	8.17e-41	152
k141_75453_4	SARG|BAA07390	32.1	418	458	512	1.70e-37	142
k141_75453_4	SARG|NC_002951.3237948.p01	27.1	414	458	643	5.82e-37	142
k141_75453_4	SARG|AAD04032	30.0	420	458	563	2.47e-33	131
k141_75453_4	megares|MEG_4381|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|OTRB_1	30.0	420	458	563	2.47e-33	131
k141_75453_4	SARG|AAC15775	30.1	412	458	536	2.67e-33	130
k141_75453_4	megares|MEG_4380|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|OTRB_1	30.1	412	458	563	3.36e-33	130
k141_75453_4	SARG|gi|780037362|ref|WP_045446599.1|	28.0	422	458	512	2.59e-30	122
k141_75453_35	SARG|gi|445996719|ref|WP_000074574.1|	30.5	203	252	309	9.54e-23	93.6
k141_75453_35	SARG|gi|500448961|gb|EOP61695.1|	32.0	203	252	306	1.27e-22	93.2
k141_75453_35	SARG|gi|446026113|ref|WP_000103968.1|	32.1	193	252	306	1.27e-22	93.2
k141_75453_35	SARG|gi|500465078|gb|EOP76697.1|	32.0	203	252	306	1.27e-22	93.2
k141_75453_35	SARG|gi|447195835|ref|WP_001273091.1|	31.0	203	252	306	2.43e-22	92.4
k141_75453_35	SARG|P42332	30.5	203	252	306	4.66e-22	91.7
k141_75453_35	SARG|gi|507044560|ref|WP_016115614.1|	31.6	193	252	306	4.66e-22	91.7
k141_75453_35	SARG|gi|447195836|ref|WP_001273092.1|	30.5	203	252	306	6.45e-22	91.3
k141_75453_35	SARG|gi|445996729|ref|WP_000074584.1|	30.0	203	252	309	6.73e-22	91.3
k141_75453_35	SARG|gi|1043490477|ref|WP_065382463.1|	30.0	203	252	309	6.73e-22	91.3
k141_31219_2	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	37.1	420	439	429	2.61e-90	279
k141_31219_5	SARG|gb|AML99881.1|ARO:3001327|mdtK	82.1	470	485	474	7.93e-285	777
k141_31219_5	NCBI|AAG27731.1|1|1|norM-Burk|norM-Burk|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_MATE_transporter_NorM|AMR|efflux	26.4	444	485	462	1.54e-23	102
k141_63585_1	NCBI|WP_050824634.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	32.9	82	92	639	6.16e-08	47.4
k141_63585_2	SARG|NP_348076	27.5	699	705	652	4.80e-74	251
k141_63585_2	SARG|YP_002850805	26.4	701	705	652	6.67e-74	250
k141_63585_2	SARG|L42544.gene.p01	27.7	685	705	651	2.43e-73	249
k141_63585_2	SARG|ZP_02952732	26.2	701	705	652	9.19e-73	247
k141_63585_2	SARG|ZP_02632674	26.2	701	705	660	1.08e-72	247
k141_63585_2	SARG|L20800.gene.p01	26.2	701	705	652	2.46e-72	246
k141_63585_2	SARG|AAV80410	27.6	685	705	651	3.34e-72	246
k141_63585_2	NCBI|WP_063856409.1|1|1|tet(Q)|tet(Q)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(Q)|AMR|tetracycline	25.6	665	705	641	3.23e-65	226
k141_63585_2	SARG|AAZ79478	25.6	665	705	657	4.34e-65	226
k141_63585_2	SARG|Q52360	25.7	665	705	641	1.18e-64	225
k141_26071_22	CARD|gb|AAC75429.1|ARO:3000833|evgS	35.2	122	130	1197	7.39e-16	71.6
k141_26071_22	NCBI|WP_034872470.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	37.1	105	130	231	9.28e-12	58.9
k141_79042_26	SARG|ZP_04003442	100	110	111	117	6.87e-79	226
k141_79042_26	SARG|ZP_03048536	99.1	110	111	110	2.23e-78	224
k141_79042_26	SARG|NC_002695.1.913273.p01	98.2	110	111	110	3.17e-78	224
k141_79042_26	SARG|P23895	98.2	110	111	110	3.17e-78	224
k141_79042_26	SARG|ABG69871	100	110	111	165	3.36e-78	226
k141_79042_26	SARG|YP_002398143	100	110	111	170	3.97e-78	226
k141_79042_26	SARG|gi|641684674|emb|CDN82496.1|	100	110	111	170	3.97e-78	226
k141_79042_26	SARG|AAN80811	100	110	111	170	3.97e-78	226
k141_79042_26	SARG|gi|116668015|pdb|2I68|A	98.2	110	111	137	7.69e-78	224
k141_79042_26	SARG|gi|643599925|ref|WP_025237077.1|	97.3	110	111	110	3.05e-76	219
k141_62181_8	SARG|CAS10898	100	273	274	273	1.30e-193	529
k141_62181_8	SARG|gi|641685979|emb|CDN83808.1|	100	273	274	274	1.35e-193	529
k141_62181_8	SARG|A1AFX9	99.6	273	274	273	7.50e-193	527
k141_62181_8	SARG|ZP_03064089	99.6	273	274	274	7.78e-193	527
k141_62181_8	SARG|gi|486204699|ref|WP_001551672.1|	99.3	273	274	273	2.15e-192	526
k141_62181_8	SARG|A8A4L2	99.3	273	274	273	3.06e-192	526
k141_62181_8	SARG|B7NJS0	99.3	273	274	273	4.34e-192	525
k141_62181_8	SARG|B7LQD5	98.5	273	274	273	8.76e-192	525
k141_62181_8	SARG|YP_312012	99.3	273	274	273	1.24e-191	524
k141_62181_8	SARG|NP_289632	98.9	273	274	273	3.57e-191	523
k141_2974_2	SARG|Q83LR7	37.3	185	256	648	4.65e-30	117
k141_2974_2	SARG|gi|647325472|ref|WP_025760953.1|	37.3	185	256	648	4.65e-30	117
k141_2974_2	SARG|gi|647323678|ref|WP_025760497.1|	37.3	185	256	648	4.65e-30	117
k141_2974_2	SARG|gi|446110305|ref|WP_000188160.1|	36.8	185	256	648	1.60e-29	115
k141_2974_2	SARG|gi|654658955|ref|WP_028119847.1|	36.2	185	256	648	2.18e-29	115
k141_2974_2	SARG|gi|696368937|ref|WP_032943949.1|	33.2	205	256	648	7.49e-29	113
k141_2974_2	SARG|gi|851913025|ref|WP_048215946.1|	33.2	205	256	648	7.49e-29	113
k141_2974_2	SARG|gi|1036100176|ref|WP_064669414.1|	35.7	185	256	648	7.49e-29	113
k141_2974_2	SARG|gi|489930965|ref|WP_003834285.1|	33.2	205	256	648	7.49e-29	113
k141_2974_2	SARG|gi|545254099|ref|WP_021550525.1|	33.3	225	256	648	1.02e-28	113
k141_2974_8	megares|MEG_729|Drugs|beta-lactam|Penicillin_binding_protein|AMPH_1	99.0	385	386	385	2.24e-280	758
k141_2974_8	megares|MEG_730|Drugs|beta-lactam|Penicillin_binding_protein|AMPH_1	85.2	385	386	386	5.58e-240	656
k141_2974_8	SARG|gb|WP_109791215.1|ARO:3005183|CMY-160	24.4	377	386	381	6.36e-20	89.4
k141_2974_8	NCBI|WP_430673476.1|1|1|blaCMY-219|blaCMY|hydrolase|2|CEPHALOSPORIN|beta-lactam|class_C_beta-lactamase_CMY-219|AMR|beta-lactam	24.4	377	386	381	8.61e-20	89.0
k141_2974_8	NCBI|WP_394294891.1|1|1|blaCMY-197|blaCMY|hydrolase|2|CEPHALOSPORIN|beta-lactam|class_C_beta-lactamase_CMY-197|AMR|beta-lactam	24.4	377	386	381	8.61e-20	89.0
k141_2974_8	SARG|gb|WP_063859788.1|ARO:3003170|CMY-131	24.4	377	386	381	1.17e-19	88.6
k141_2974_8	SARG|gb|AFU25638.1|ARO:3002096|CMY-83	23.3	377	386	381	1.17e-19	88.6
k141_2974_8	SARG|AAM11668	23.9	377	386	381	1.17e-19	88.6
k141_2974_8	SARG|gb|WP_075985684.1|ARO:3005197|CMY-145	24.4	377	386	381	1.58e-19	88.2
k141_2974_8	SARG|gb|WP_094009802.1|ARO:3005200|CMY-155	23.9	377	386	381	1.58e-19	88.2
k141_2974_13	SARG|gi|752682279|ref|WP_041330231.1|	39.6	359	365	349	4.37e-86	263
k141_2974_13	SARG|DQ212986.1.gene8.p01	38.0	361	365	349	1.97e-84	259
k141_2974_13	SARG|gi|405945042|pdb|4FU0|A	38.0	361	365	357	2.51e-84	259
k141_2974_13	SARG|gi|765411304|ref|WP_044689514.1|	38.0	361	365	349	3.94e-84	258
k141_2974_13	SARG|AAF71281	37.7	361	365	349	1.11e-83	257
k141_2974_13	SARG|gi|1028100561|ref|WP_063856696.1|	39.0	359	365	349	6.27e-83	255
k141_2974_13	NCBI|PBI24747.1|1|1|vanG-Cd|vanG-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|D-alanine--D-serine_ligase_VanG-Cd|AMR|glycopeptide	36.0	369	365	366	1.05e-82	255
k141_2974_13	SARG|gb|ABX54687.1|ARO:3002910|vanL	37.6	354	365	349	3.98e-81	250
k141_2974_13	SARG|gi|1002798395|gb|AMN85478.1|	37.7	358	365	343	1.87e-80	248
k141_2974_13	SARG|AAR37060	36.6	358	365	343	2.36e-78	243
k141_57806_2	CARD|gb|VWQ00850.1|ARO:3003843|leuO	100	314	315	314	1.46e-231	629
k141_57806_9	ResF|penA_1_AF515059_1	37.5	562	589	581	2.42e-128	387
k141_57806_9	NCBI|WP_063852700.1|1|1|mecA2|mecA2|insensitivity|2|METHICILLIN|beta-lactam|PBP2a_family_beta-lactam-resistant_peptidoglycan_transpeptidase_MecA2|AMR|beta-lactam	23.1	555	589	668	7.09e-23	102
k141_57806_9	megares|MEG_3790|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	22.2	555	589	666	2.91e-22	100
k141_57806_9	megares|MEG_3793|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	22.5	529	589	668	2.92e-22	100
k141_57806_9	megares|MEG_3789|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	22.3	529	589	668	5.14e-22	99.4
k141_57806_9	SARG|gi|686322767|ref|WP_031876626.1|	22.3	529	589	668	5.14e-22	99.4
k141_57806_9	SARG|CAA70425	22.6	536	589	666	9.00e-22	98.6
k141_57806_9	SARG|gi|686288520|ref|WP_031860875.1|	22.1	529	589	668	9.04e-22	98.6
k141_57806_9	SARG|gi|686132960|ref|WP_031774065.1|	22.1	529	589	668	9.04e-22	98.6
k141_57806_9	SARG|gi|686196719|ref|WP_031807381.1|	22.3	529	589	668	9.04e-22	98.6
k141_57806_17	SARG|DQ212986.1.gene8.p01	37.6	250	307	349	1.43e-50	169
k141_57806_17	SARG|gi|405945042|pdb|4FU0|A	37.6	250	307	357	1.73e-50	169
k141_57806_17	SARG|gi|752682279|ref|WP_041330231.1|	36.8	250	307	349	2.82e-50	169
k141_57806_17	SARG|gi|765411304|ref|WP_044689514.1|	37.6	250	307	349	2.82e-50	169
k141_57806_17	SARG|AAF71281	37.2	250	307	349	7.83e-50	167
k141_57806_17	SARG|gi|257803688|gb|EEV32510.1|	34.7	343	307	344	3.80e-49	166
k141_57806_17	SARG|gi|1028100552|ref|WP_063856687.1|	34.7	340	307	343	7.33e-49	165
k141_57806_17	SARG|gi|355380870|gb|EHG28002.1|	34.7	343	307	344	7.51e-49	165
k141_57806_17	SARG|gi|751652141|ref|WP_041119007.1|	34.7	340	307	343	1.03e-48	164
k141_57806_17	SARG|AAY67968	35.0	340	307	343	1.03e-48	164
k141_77263_2	CARD|gb|ATC67679.1|ARO:3000838|arlR	40.5	215	261	219	1.40e-52	169
k141_77263_2	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	39.8	216	261	219	1.77e-50	164
k141_77263_2	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	39.4	216	261	219	7.08e-50	162
k141_77263_2	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	39.4	216	261	220	7.29e-50	162
k141_77263_2	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	39.4	216	261	220	1.03e-49	162
k141_77263_2	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	39.4	216	261	220	3.26e-48	158
k141_77263_2	SARG|ZP_02848503	37.0	216	261	221	1.32e-44	149
k141_77263_2	CARD|gb|AAG05188.1|ARO:3005068|ParR	38.0	221	261	235	1.39e-44	149
k141_77263_2	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	36.9	217	261	228	5.02e-43	145
k141_77263_2	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	38.4	224	261	231	6.04e-42	142
k141_77263_11	SARG|AF170880.4.gene1.p01	35.0	488	601	615	6.17e-74	247
k141_77263_11	SARG|gi|558888514|ref|WP_023543283.1|	34.8	488	601	615	8.60e-74	246
k141_77263_11	SARG|gi|501350226|ref|WP_012381861.1|	34.3	487	601	603	1.35e-71	240
k141_77263_11	SARG|gi|505420018|ref|WP_015607120.1|	33.9	487	601	603	3.66e-71	239
k141_77263_11	SARG|gi|1045390184|ref|WP_065479071.1|	33.9	487	601	605	3.81e-71	239
k141_77263_11	SARG|gi|664170108|ref|WP_030704355.1|	34.0	486	601	603	5.09e-71	239
k141_77263_11	SARG|gi|490068471|ref|WP_003970646.1|	34.1	487	601	603	9.89e-71	238
k141_77263_11	SARG|gi|917166849|ref|WP_051773561.1|	34.3	487	601	620	1.01e-70	238
k141_77263_11	SARG|gi|917155568|ref|WP_051762280.1|	34.3	487	601	620	1.41e-70	238
k141_77263_11	SARG|gi|517347347|ref|WP_018522839.1|	34.1	487	601	601	1.84e-70	237
k141_77263_12	SARG|gi|947982677|ref|WP_056642336.1|	32.1	548	571	626	8.32e-66	224
k141_77263_12	SARG|gi|639892676|ref|WP_024755698.1|	32.1	524	571	631	1.77e-65	224
k141_77263_12	SARG|gi|1033217078|gb|OAR27197.1|	31.5	524	571	601	3.72e-64	219
k141_77263_12	SARG|gi|944009777|ref|WP_055601444.1|	31.9	527	571	628	4.46e-64	220
k141_77263_12	SARG|gi|944152509|ref|WP_055644808.1|	31.4	525	571	616	4.94e-63	217
k141_77263_12	SARG|gi|948137056|ref|WP_056795395.1|	31.4	542	571	602	1.96e-62	215
k141_77263_12	SARG|gi|827013130|ref|WP_047175495.1|	31.1	547	571	603	3.85e-62	214
k141_77263_12	SARG|gi|662129758|ref|WP_030081404.1|	31.1	544	571	605	7.70e-62	213
k141_77263_12	SARG|gi|664556405|ref|WP_031071225.1|	31.1	544	571	602	1.01e-61	213
k141_77263_12	SARG|gi|664085850|ref|WP_030624018.1|	31.1	544	571	605	1.07e-61	213
k141_32584_25	CARD|gb|AAD51347.1|ARO:3003067|smeS	25.4	311	919	467	2.93e-19	90.9
k141_32584_25	CARD|gb|AAC75429.1|ARO:3000833|evgS	26.3	255	919	1197	2.76e-13	73.2
k141_32584_25	CARD|gb|ATC67679.1|ARO:3000838|arlR	28.2	142	919	219	1.44e-09	58.2
k141_32584_25	CARD|gb|AAD51348.1|ARO:3003066|smeR	29.4	126	919	229	7.89e-08	53.1
k141_32584_25	CARD|gb|AAG06465.1|ARO:3005063|cprR	30.4	161	919	223	3.23e-07	51.2
k141_32584_25	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	32.0	103	919	225	1.45e-06	49.3
k141_32584_25	CARD|gb|AAC73788.1|ARO:3003841|kdpE	32.0	103	919	225	1.45e-06	49.3
k141_36204_33	CARD|gb|AAL19308.1|ARO:3000504|golS	36.4	129	142	154	5.60e-18	74.3
k141_36204_38	SARG|B1LLK9	31.1	302	316	660	3.86e-38	142
k141_36204_38	SARG|gi|550713000|ref|WP_022645909.1|	31.1	302	316	660	5.29e-38	141
k141_36204_38	SARG|gi|757799830|ref|WP_043017032.1|	31.1	302	316	660	1.86e-37	140
k141_36204_38	SARG|gi|507086291|ref|WP_016157032.1|	30.7	309	316	660	2.54e-37	139
k141_36204_38	SARG|gi|693171092|ref|WP_032303433.1|	30.8	302	316	660	3.48e-37	139
k141_36204_38	SARG|gi|487375894|ref|WP_001649055.1|	30.1	302	316	660	4.75e-37	139
k141_36204_38	SARG|gi|1002399350|ref|WP_061382108.1|	30.5	302	316	660	4.75e-37	139
k141_36204_38	SARG|gi|851935911|ref|WP_048224705.1|	30.5	302	316	660	6.50e-37	138
k141_36204_38	SARG|gi|851917461|ref|WP_048217311.1|	30.5	302	316	660	8.89e-37	138
k141_36204_38	SARG|gi|486161502|ref|WP_001525103.1|	30.5	302	316	660	8.89e-37	138
k141_77275_6	SARG|gb|ABO11759.2|ARO:3004573|Acinetobacter	32.8	439	456	429	3.85e-59	199
k141_77275_6	SARG|YP_001419960	28.2	170	456	510	1.21e-06	49.7
k141_77275_6	SARG|CAB12101	28.8	170	456	512	2.12e-06	48.9
k141_77275_24	SARG|gi|299882142|gb|EFI90353.1|	26.5	219	418	443	2.71e-11	63.9
k141_77275_24	SARG|gi|391256340|gb|EIQ15472.1|	26.9	212	418	410	3.30e-11	63.5
k141_77275_24	SARG|AF034958.gene.p01	27.5	229	418	409	5.82e-11	62.8
k141_77275_24	megares|MEG_1774|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CMLB_1	27.5	229	418	409	5.82e-11	62.8
k141_77275_24	SARG|gi|693117414|ref|WP_032267527.1|	27.4	212	418	410	7.77e-11	62.4
k141_77275_24	SARG|gi|447059751|ref|WP_001137007.1|	26.9	212	418	410	1.03e-10	62.0
k141_77275_24	SARG|gi|490068104|ref|WP_003970282.1|	26.9	212	418	410	1.03e-10	62.0
k141_77275_24	SARG|ZP_03044758	26.9	212	418	410	1.03e-10	62.0
k141_77275_24	SARG|YP_001882916	26.9	212	418	410	1.03e-10	62.0
k141_77275_24	SARG|gi|487412532|ref|WP_001680159.1|	26.9	212	418	410	1.03e-10	62.0
k141_77275_27	CARD|gb|BAH63252.1|ARO:3004583|Kpne_KpnF	84.4	109	110	109	3.87e-65	191
k141_77275_27	SARG|gb|AEH26330.1|ARO:3005009|qacE	36.7	98	110	110	1.76e-16	68.2
k141_77275_28	CARD|gb|BAH63251.1|ARO:3004580|Kpne_KpnE	82.2	118	122	120	6.47e-58	174
k141_77275_28	SARG|gb|AEH26330.1|ARO:3005009|qacE	30.6	98	122	110	1.74e-10	53.1
k141_77275_28	SARG|gb|AAC44316.1|ARO:3005010|qacEdelta1	29.4	109	122	115	5.37e-10	52.0
k141_77275_28	SARG|gb|AAZ42322.1|ARO:3003836|qacH	28.7	101	122	110	4.00e-08	47.0
k141_77275_29	NCBI|AKA30736.1|1|1|cxpE|cxpE||1|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_transporter_CxpE|AMR|phenicol	22.1	317	345	397	2.00e-08	54.3
k141_77275_36	CARD|gb|AAG05188.1|ARO:3005068|ParR	45.2	239	240	235	4.60e-68	208
k141_77275_36	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	38.3	235	240	252	1.47e-48	159
k141_77275_36	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	34.9	232	240	228	2.72e-36	127
k141_77275_36	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	29.8	235	240	225	9.98e-32	115
k141_77275_36	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	32.0	231	240	231	8.87e-31	112
k141_77275_36	CARD|gb|AAD51348.1|ARO:3003066|smeR	31.5	232	240	229	2.52e-29	108
k141_77275_36	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	30.3	231	240	231	2.82e-28	106
k141_77275_36	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	30.3	231	240	231	2.82e-28	106
k141_77275_36	CARD|gb|ADM92605.1|ARO:3000553|adeR	30.6	232	240	247	6.24e-26	100
k141_77275_36	CARD|gb|BAB36671.1|ARO:3000832|evgA	26.2	103	240	204	8.31e-06	44.3
k141_77275_37	SARG|gb|AAG05187.1|ARO:3005067|ParS	34.0	430	434	428	3.43e-67	219
k141_77275_37	CARD|gb|BAB38260.1|ARO:3000830|cpxA	32.7	294	434	457	3.70e-38	142
k141_77275_37	NCBI|WP_063856734.1|1|1|vanS-E|vanS-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-E|AMR|glycopeptide	27.6	214	434	357	4.22e-17	81.3
k141_77275_37	megares|MEG_7511|Drugs|Glycopeptide|VanE-type_regulator|VANSE_1	27.6	214	434	357	4.22e-17	81.3
k141_65779_5	SARG|gb|AEA37904.1|ARO:3003112|lsaC	26.8	209	242	492	1.21e-11	62.8
k141_65779_43	CARD|gb|AAC73788.1|ARO:3003841|kdpE	99.6	224	226	225	1.58e-161	444
k141_65779_43	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	99.1	224	226	225	6.43e-161	442
k141_65779_43	CARD|gb|ATC67679.1|ARO:3000838|arlR	39.4	221	226	219	3.69e-46	151
k141_65779_43	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	35.8	226	226	232	8.45e-45	148
k141_65779_43	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	35.8	226	226	232	8.45e-45	148
k141_65779_43	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	33.3	225	226	229	9.76e-43	143
k141_65779_43	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	32.7	226	226	231	1.43e-39	135
k141_65779_43	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	33.9	227	226	235	1.59e-39	135
k141_65779_43	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	32.7	226	226	233	1.18e-38	132
k141_65779_43	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	31.4	226	226	230	4.32e-38	131
k141_65779_44	CARD|gb|CYF42523.1|ARO:3004047|kdpD	25.7	806	806	885	1.69e-76	265
k141_65779_44	NCBI|WP_063856732.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	29.0	224	806	367	2.53e-17	83.6
k141_65779_44	NCBI|WP_021418927.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	29.0	224	806	368	2.56e-17	83.6
k141_65779_44	NCBI|WP_063856734.1|1|1|vanS-E|vanS-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-E|AMR|glycopeptide	28.8	226	806	357	3.30e-14	73.9
k141_65779_44	megares|MEG_7511|Drugs|Glycopeptide|VanE-type_regulator|VANSE_1	28.8	226	806	357	3.30e-14	73.9
k141_65779_44	megares|MEG_7486|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	27.8	245	806	382	3.99e-14	73.9
k141_65779_44	NCBI|WP_063856731.1|1|1|vanS-A|vanS-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-A|AMR|glycopeptide	27.8	245	806	382	3.99e-14	73.9
k141_63784_2	megares|MEG_7070|Drugs|Tetracycline|Tetracycline_resistance_MFS_efflux_pumps|TETD_1	44.3	106	286	138	1.79e-26	100
k141_63784_2	CARD|gb|BAA15221.2|ARO:3000263|marA	37.8	98	286	127	1.82e-18	78.6
k141_63784_2	NCBI|AAD44693.1|1|1|mtrA_Ngon|mtrA_Ngon||1|EFFLUX|EFFLUX|efflux_transporter_MtrCDE_transcriptional_activator_MtrA|AMR|efflux	25.5	102	286	301	2.49e-06	47.0
k141_32638_1	SARG|gi|542061059|gb|ERI11611.1|	37.1	221	607	316	9.72e-43	155
k141_32638_1	SARG|P42332	36.7	229	607	306	1.90e-41	151
k141_32638_1	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	36.7	229	607	306	1.90e-41	151
k141_32638_1	SARG|gi|510143239|gb|AGN36970.1|	36.7	229	607	313	2.26e-41	151
k141_32638_1	SARG|ABB80128	36.2	229	607	306	9.50e-41	149
k141_32638_1	SARG|AAD21213	36.2	229	607	306	1.31e-40	149
k141_32638_1	SARG|YP_001373621	36.0	211	607	318	1.19e-39	146
k141_32638_1	SARG|gi|447195835|ref|WP_001273091.1|	35.5	211	607	306	4.14e-38	142
k141_32638_1	SARG|gi|447057509|ref|WP_001134765.1|	37.1	213	607	309	4.44e-38	142
k141_32638_1	SARG|gi|447057510|ref|WP_001134766.1|	36.6	213	607	309	6.10e-38	141
k141_21232_1	SARG|NP_878015	29.6	179	313	322	6.09e-12	64.3
k141_21232_1	SARG|gb|MBY8651254.1|ARO:3007188|vanH_in_vanP_cl	30.6	121	313	314	1.91e-11	62.8
k141_21232_1	NCBI|WP_063856710.1|1|1|vanH-Pt2|vanH-Pt2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Pt2|AMR|glycopeptide	28.6	161	313	322	2.00e-11	62.8
k141_21232_1	NCBI|WP_063856700.1|1|1|vanH-Ao2|vanH-Ao2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao2|AMR|glycopeptide	27.2	180	313	343	2.98e-11	62.4
k141_21232_1	NCBI|WP_063856699.1|1|1|vanH-Ao1|vanH-Ao1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao1|AMR|glycopeptide	27.8	158	313	348	5.47e-11	61.6
k141_21232_20	CARD|gb|ABV18113.1|ARO:3001329|mdtG	99.8	408	409	408	4.59e-287	777
k141_21232_20	SARG|WP_000136147.1	45.2	387	409	399	1.15e-110	329
k141_21232_20	NCBI|EHE72460.1|1|1|pmrA|pmrA|efflux|1|quinolone|quinolone|multidrug_efflux_MFS_transporter_PmrA|AMR|quinolone	42.9	387	409	371	2.66e-99	299
k141_21232_20	SARG|gi|446964071|ref|WP_001041327.1|	24.2	385	409	388	6.96e-19	86.7
k141_21232_20	SARG|gi|514074859|ref|WP_016528694.1|	24.4	385	409	388	9.38e-19	86.3
k141_21232_20	SARG|gi|486852995|ref|WP_001622527.1|	24.4	385	409	388	1.26e-18	85.9
k141_21232_20	SARG|NC_007622.3793623.p01	24.2	363	409	388	2.30e-18	85.1
k141_21232_20	SARG|gi|446964073|ref|WP_001041329.1|	24.2	385	409	388	2.30e-18	85.1
k141_21232_20	SARG|gi|446964072|ref|WP_001041328.1|	24.2	363	409	388	3.09e-18	84.7
k141_21232_20	SARG|gi|757462838|ref|WP_042744224.1|	24.2	385	409	388	4.17e-18	84.3
k141_21232_32	SARG|A1A9W0	100	402	403	402	3.00e-289	782
k141_21232_32	SARG|gi|486650002|ref|WP_001619313.1|	99.8	402	403	402	4.26e-289	781
k141_21232_32	SARG|gi|545230805|ref|WP_021530443.1|	99.8	402	403	402	4.26e-289	781
k141_21232_32	SARG|gi|1015950384|ref|WP_062899171.1|	99.8	402	403	402	4.26e-289	781
k141_21232_32	SARG|YP_852164	100	402	403	412	4.38e-289	782
k141_21232_32	SARG|gi|486228847|ref|WP_001558958.1|	99.5	402	403	402	8.59e-289	781
k141_21232_32	SARG|gi|972408415|ref|WP_059040274.1|	99.8	402	403	402	8.59e-289	781
k141_21232_32	SARG|gi|928811857|ref|WP_053876925.1|	99.8	402	403	402	8.59e-289	781
k141_21232_32	SARG|gi|545248523|ref|WP_021546864.1|	99.8	402	403	402	8.59e-289	781
k141_21232_32	SARG|gi|823638138|ref|WP_047085160.1|	99.8	402	403	402	8.59e-289	781
k141_34260_5	SARG|gb|AAC74000.1|ARO:3003950|msbA	29.7	232	515	582	2.64e-21	96.3
k141_34260_5	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	30.4	227	515	579	1.05e-18	88.2
k141_34260_5	megares|MEG_2670|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|DRRA_1	29.0	207	515	293	5.07e-18	83.6
k141_34260_5	SARG|gb|APB03219.1|ARO:3003986|TaeA	22.3	547	515	648	2.69e-17	84.0
k141_34260_5	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	27.9	244	515	343	7.42e-17	80.9
k141_34260_5	SARG|gb|AAA26793|ARO:3003748|oleC	25.9	228	515	325	4.00e-14	72.4
k141_34260_5	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	25.9	212	515	325	5.36e-14	72.0
k141_34260_5	SARG|gi|694064328|ref|WP_032410816.1|	27.1	236	515	646	6.15e-12	67.0
k141_34260_5	SARG|gb|AAK76137.1|ARO:3000024|patA	23.7	228	515	564	1.71e-11	65.5
k141_34260_5	ResF|poxtA-Ef_1_WP094899500.1_1	26.1	199	515	538	5.03e-11	63.9
k141_47730_32	SARG|gi|976150171|ref|WP_059308384.1|	38.9	229	258	646	1.10e-40	147
k141_47730_32	SARG|gi|992390012|ref|WP_061077002.1|	41.4	215	258	648	2.91e-40	145
k141_47730_32	SARG|gi|968563772|ref|WP_058587854.1|	41.3	213	258	648	5.51e-40	145
k141_47730_32	SARG|gi|757782629|ref|WP_043001213.1|	41.3	213	258	648	5.51e-40	145
k141_47730_32	SARG|gi|763407609|ref|WP_044264203.1|	41.3	213	258	648	5.51e-40	145
k141_47730_32	SARG|gi|817104523|ref|WP_046477871.1|	41.3	213	258	648	1.04e-39	144
k141_47730_32	SARG|gi|764278838|ref|WP_044327089.1|	41.3	213	258	648	1.04e-39	144
k141_47730_32	SARG|gi|754964360|ref|WP_042320280.1|	41.3	213	258	648	1.43e-39	144
k141_47730_32	SARG|gi|754927849|ref|WP_042284850.1|	41.5	212	258	648	2.71e-39	143
k141_47730_32	SARG|gi|749017716|ref|WP_040076354.1|	38.6	215	258	646	3.67e-39	142
k141_32655_16	SARG|gi|694064328|ref|WP_032410816.1|	31.0	216	257	646	2.73e-16	77.0
k141_32655_23	SARG|NP_756186	100	385	386	385	5.79e-267	724
k141_32655_23	SARG|gi|545237503|ref|WP_021536627.1|	99.7	385	386	385	2.36e-266	723
k141_32655_23	SARG|gi|585358425|ref|WP_024240023.1|	99.7	385	386	385	2.36e-266	723
k141_32655_23	SARG|gi|545278489|ref|WP_021565695.1|	99.7	385	386	385	2.36e-266	723
k141_32655_23	SARG|gi|545247736|ref|WP_021546171.1|	99.7	385	386	385	2.36e-266	723
k141_32655_23	SARG|gi|723045963|ref|WP_033545801.1|	99.7	385	386	385	2.36e-266	723
k141_32655_23	SARG|gi|754658818|ref|WP_042041496.1|	99.7	385	386	385	2.36e-266	723
k141_32655_23	SARG|gi|447004723|ref|WP_001081979.1|	99.7	385	386	385	3.35e-266	722
k141_32655_23	SARG|gi|585341406|ref|WP_024223032.1|	99.5	385	386	385	4.75e-266	722
k141_32655_23	SARG|YP_002400009	99.7	385	386	385	4.75e-266	722
k141_32655_24	SARG|YP_859120	99.9	1037	1038	1037	0.0	1928
k141_32655_24	SARG|Q8FCI8	99.8	1037	1038	1037	0.0	1928
k141_32655_24	SARG|YP_002409908	99.7	1037	1038	1037	0.0	1927
k141_32655_24	SARG|gi|445947051|ref|WP_000024906.1|	99.7	1037	1038	1037	0.0	1926
k141_32655_24	SARG|gi|510913720|ref|WP_016234987.1|	99.6	1037	1038	1037	0.0	1926
k141_32655_24	SARG|ZP_03032068	99.7	1037	1038	1037	0.0	1925
k141_32655_24	SARG|YP_002400010	99.7	1037	1038	1037	0.0	1925
k141_32655_24	SARG|gi|693120879|ref|WP_032269897.1|	99.7	1037	1038	1037	0.0	1925
k141_32655_24	SARG|gi|445947058|ref|WP_000024913.1|	99.8	1037	1038	1037	0.0	1925
k141_32655_24	SARG|gi|486233868|ref|WP_001560073.1|	99.5	1037	1038	1037	0.0	1924
k141_32655_25	CARD|gb|ANK04027.1|ARO:3003838|gadW	100	242	243	242	2.72e-175	480
k141_49155_11	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	48.2	228	233	225	1.12e-64	199
k141_49155_11	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	39.3	224	233	231	1.15e-49	161
k141_49155_11	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	39.6	230	233	231	9.14e-49	159
k141_49155_11	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	38.0	229	233	230	1.26e-48	158
k141_49155_11	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	39.4	226	233	232	1.88e-48	158
k141_49155_11	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	37.7	228	233	232	3.75e-48	157
k141_49155_11	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	37.7	228	233	232	3.75e-48	157
k141_49155_11	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	38.7	235	233	252	1.86e-47	156
k141_49155_11	CARD|gb|ATC67679.1|ARO:3000838|arlR	37.1	229	233	219	8.22e-47	153
k141_49155_11	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	37.0	230	233	231	3.26e-46	152
k141_49155_12	CARD|gb|BAB38260.1|ARO:3000830|cpxA	100	457	458	457	0.0	887
k141_49155_12	SARG|gb|AAG05187.1|ARO:3005067|ParS	30.7	283	458	428	2.61e-33	129
k141_49155_12	CARD|gb|ADM92606.1|ARO:3000549|adeS	29.8	272	458	361	1.20e-20	92.0
k141_49155_12	CARD|gb|CYF42523.1|ARO:3004047|kdpD	25.5	212	458	885	1.10e-13	72.4
k141_44574_2	CARD|gb|BAB35162.1|ARO:3000676|H-NS	100	137	138	137	1.36e-85	245
k141_44574_22	CARD|gb|BAB36671.1|ARO:3000832|evgA	23.8	206	217	204	1.62e-23	92.4
k141_44574_22	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	30.5	164	217	228	5.35e-13	64.7
k141_44574_22	CARD|gb|ATC67679.1|ARO:3000838|arlR	24.5	200	217	219	4.17e-11	59.3
k141_44574_22	CARD|gb|AAG05188.1|ARO:3005068|ParR	24.4	164	217	235	3.41e-08	51.2
k141_3271_6	CARD|gb|AAK37618.1|ARO:3005008|TxR	40.1	302	445	318	5.96e-72	228
k141_3271_6	CARD|gb|ATC67679.1|ARO:3000838|arlR	33.6	110	445	219	3.41e-12	64.7
k141_42458_8	CARD|gb|CAA79966.1|ARO:3003665|NmcR	33.7	291	306	295	7.63e-46	155
k141_42458_8	megares|MEG_1992|Drugs|beta-lactam|Class_C_betalactamases|CMY_1	32.2	289	306	291	8.78e-43	147
k141_41273_2	CARD|gb|ALH22601.1|ARO:3000620|adeL	36.0	286	305	337	3.82e-46	157
k141_74233_2	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	33.0	206	256	574	5.40e-20	87.8
k141_74233_2	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	34.6	211	256	343	4.79e-19	84.0
k141_74233_2	SARG|gb|AAC74000.1|ARO:3003950|msbA	32.7	202	256	582	1.26e-17	80.9
k141_74233_2	SARG|gi|953808775|ref|WP_058042812.1|	34.8	201	256	608	1.29e-17	80.9
k141_74233_2	SARG|AF170880.4.gene1.p01	33.3	201	256	615	7.87e-17	78.6
k141_74233_2	SARG|gi|558888514|ref|WP_023543283.1|	33.3	201	256	615	7.87e-17	78.6
k141_74233_2	SARG|gi|764446018|ref|WP_044369325.1|	33.3	201	256	605	1.06e-16	78.2
k141_74233_2	SARG|gi|695865802|ref|WP_032778631.1|	33.3	201	256	605	1.06e-16	78.2
k141_74233_2	SARG|gi|1045390184|ref|WP_065479071.1|	33.3	201	256	605	1.06e-16	78.2
k141_74233_2	SARG|gi|664042835|ref|WP_030582300.1|	34.0	200	256	604	1.93e-16	77.4
k141_74233_10	SARG|gb|APB03216.1|ARO:3003982|LlmA	32.1	112	703	287	1.27e-08	55.8
k141_74233_11	SARG|gb|AVI44920.1|ARO:3004470|poxtA	31.0	525	636	542	1.08e-70	237
k141_74233_11	NCBI|WP_209691075.1|1|1|poxtA2|poxtA|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA2|AMR|multidrug	31.0	525	636	544	1.13e-70	237
k141_74233_11	ResF|poxtA-Ef_1_WP094899500.1_1	30.2	523	636	538	2.72e-69	233
k141_74233_11	megares|MEG_8639|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT_1	30.2	523	636	543	3.05e-69	233
k141_74233_11	NCBI|WP_094899500.1|1|1|poxtA-Ef|poxtA-Ef|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA-Ef|AMR|multidrug	30.2	523	636	543	3.05e-69	233
k141_74233_11	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.8	507	636	655	5.95e-67	230
k141_74233_11	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.8	507	636	655	1.14e-66	229
k141_74233_11	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.6	507	636	655	2.20e-66	228
k141_74233_11	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.6	507	636	655	4.22e-66	228
k141_74233_11	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	30.6	507	636	655	4.22e-66	228
k141_74233_19	megares|MEG_8288|Drugs|beta-lactam|Mutant_porin_proteins|OMPA_1	84.6	356	351	374	4.89e-215	591
k141_74233_19	CARD|gb|CDO13836.1|ARO:3005044|OmpA	84.6	356	351	374	4.89e-215	591
k141_69370_2	SARG|M58472.1.gene1.p01	40.4	57	183	209	1.36e-10	57.0
k141_69370_2	SARG|GQ205627.2.gene3.p01	39.6	53	183	216	9.19e-09	52.0
k141_69370_2	SARG|AF015628.1.gene2.p01	39.3	56	183	212	3.83e-07	47.4
k141_66059_5	SARG|AAR29485	24.9	450	530	639	2.39e-36	142
k141_66059_5	SARG|gi|672386269|gb|AIJ27535.1|	25.1	450	530	639	2.39e-36	142
k141_66059_5	SARG|gi|544707441|ref|WP_021137831.1|	24.9	450	530	639	2.39e-36	142
k141_66059_5	megares|MEG_7165|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	24.1	448	530	639	7.35e-34	134
k141_66059_5	NCBI|WP_032490535.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	25.1	450	530	639	8.04e-33	131
k141_66059_5	SARG|WP_002857791.1	25.3	451	530	639	1.46e-32	130
k141_66059_5	SARG|ZP_04668102	24.9	450	530	639	1.46e-32	130
k141_66059_5	megares|MEG_7164|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	24.1	448	530	639	1.46e-32	130
k141_66059_5	SARG|AJ295238.gene.p01	24.8	452	530	639	2.65e-32	130
k141_66059_5	SARG|AAY54279	24.9	450	530	639	3.56e-32	129
k141_74264_28	SARG|YP_001175678	52.5	362	374	397	3.64e-110	327
k141_74264_28	SARG|ABR13270	52.5	362	374	397	1.46e-109	325
k141_74264_28	SARG|ABG77965	52.8	362	374	397	5.88e-109	323
k141_74264_28	SARG|YP_002848373	52.5	362	374	414	7.11e-109	324
k141_74264_28	SARG|gi|503835165|ref|WP_014069159.1|	53.0	362	374	397	1.67e-108	322
k141_74264_28	SARG|gi|749610452|ref|WP_040232688.1|	52.8	362	374	397	2.36e-108	322
k141_74264_28	SARG|gi|489927712|ref|WP_003831044.1|	52.2	362	374	397	4.73e-108	321
k141_74264_28	SARG|CP001918.1.gene1258.p01	52.2	362	374	397	9.47e-108	320
k141_74264_28	SARG|gi|696364907|ref|WP_032939988.1|	52.2	362	374	397	1.34e-107	320
k141_74264_28	SARG|YP_002383660	51.6	374	374	397	1.90e-107	320
k141_74264_29	SARG|gi|694076105|ref|WP_032421853.1|	57.7	1030	1036	1036	0.0	1112
k141_74264_29	SARG|CP000647.1.gene3710.p01	57.6	1030	1036	1036	0.0	1111
k141_74264_29	SARG|gi|496667122|ref|WP_009309612.1|	57.6	1030	1036	1036	0.0	1110
k141_74264_29	SARG|gi|556290479|ref|WP_023291164.1|	57.7	1030	1036	1036	0.0	1110
k141_74264_29	SARG|gi|447196024|ref|WP_001273280.1|	56.9	1031	1036	1037	0.0	1107
k141_74264_29	SARG|gi|487663012|ref|WP_001752778.1|	56.8	1031	1036	1037	0.0	1107
k141_74264_29	SARG|gi|817600095|ref|WP_046594084.1|	56.8	1031	1036	1037	0.0	1105
k141_74264_29	CARD|gb|AAC73564.1|ARO:3000216|acrB	57.0	1034	1036	1049	0.0	1104
k141_74264_29	SARG|gi|817604860|ref|WP_046598079.1|	56.8	1031	1036	1037	0.0	1104
k141_74264_29	SARG|gi|817600173|ref|WP_046594139.1|	56.8	1031	1036	1037	0.0	1103
k141_74264_30	SARG|gi|475005571|emb|CCP13702.1|	45.8	450	458	471	6.99e-104	316
k141_74264_30	CARD|gb|AAD51346.1|ARO:3003053|smeC	45.2	449	458	471	2.20e-102	312
k141_74264_30	NCBI|AAQ92182.1|1|1|emhC|emhC||1|EFFLUX|EFFLUX|efflux_RND_transporter_outer_membrane_subunit_EmhC|AMR|efflux	42.6	462	458	486	3.36e-99	305
k141_74264_30	NCBI|AAY90615.1|1|1|emhC|emhC||1|EFFLUX|EFFLUX|efflux_RND_transporter_outer_membrane_subunit_EmhC|AMR|efflux	41.4	464	458	486	2.95e-97	300
k141_74264_30	SARG|NC_008702.1.4606278.p01	40.9	467	458	467	1.34e-96	297
k141_74264_30	NCBI|AAD15665.1|1|1|tbtM|tbtM||1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_outer_membrane_channel_subunit_TbtM|AMR|efflux	41.0	466	458	476	3.73e-92	286
k141_74264_30	SARG|YP_001973746	40.1	451	458	466	6.19e-91	283
k141_74264_30	SARG|gi|491553496|ref|WP_005411087.1|	40.1	451	458	461	7.56e-91	282
k141_74264_30	SARG|CAC14596	40.4	451	458	466	8.72e-91	282
k141_74264_30	SARG|YP_002706078	40.4	451	458	481	2.64e-90	281
k141_74264_31	NCBI|WP_031633255.1|1|1|cmlA_floR|cmlA_floR|efflux|2|CHLORAMPHENICOL|PHENICOL|CmlA/FloR_family_phenicol_efflux_MFS_transporter|AMR|phenicol	28.7	279	388	395	8.18e-32	123
k141_74264_31	SARG|YP_002384997	27.0	285	388	394	5.21e-30	118
k141_74264_31	SARG|YP_002846930	25.4	386	388	394	5.21e-30	118
k141_74264_31	SARG|gi|489114053|ref|WP_003023905.1|	25.4	386	388	394	1.36e-29	117
k141_74264_31	megares|MEG_8019|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML_1	29.9	278	388	411	6.09e-29	115
k141_74264_31	NCBI|WP_011552636.1|1|1|cml_Myxo|cml_Myxo|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	29.9	278	388	411	6.09e-29	115
k141_74264_31	NCBI|WP_061345584.1|1|1|cml_Ochro|cml_Ochro|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	30.9	275	388	397	1.20e-27	111
k141_74264_31	NCBI|WP_115421099.1|1|1|cml_Ensi|cml_Ensi|efflux|2|CHLORAMPHENICOL|PHENICOL|Cml_family_phenicol_efflux_MFS_transporter|AMR|phenicol	28.6	269	388	400	2.60e-25	105
k141_74264_31	megares|MEG_8021|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|CML_1	28.6	269	388	400	2.60e-25	105
k141_74264_31	SARG|gi|695688999|ref|WP_032634100.1|	30.9	249	388	404	6.90e-25	103
k141_74264_32	SARG|gi|445996732|ref|WP_000074587.1|	27.3	245	269	309	2.29e-19	84.7
k141_74264_32	SARG|gi|507035724|ref|WP_016107411.1|	26.2	244	269	309	3.15e-19	84.3
k141_74264_32	SARG|gi|445996708|ref|WP_000074563.1|	27.7	238	269	309	5.96e-19	83.6
k141_74264_32	SARG|gi|500194536|ref|WP_011867743.1|	26.1	241	269	306	7.91e-19	83.2
k141_74264_32	SARG|gi|445996698|ref|WP_000074553.1|	25.8	244	269	309	8.19e-19	83.2
k141_74264_32	SARG|gi|445996697|ref|WP_000074552.1|	26.2	244	269	309	8.19e-19	83.2
k141_74264_32	SARG|gi|445996696|ref|WP_000074551.1|	26.2	244	269	309	1.13e-18	82.8
k141_74264_32	SARG|gi|445996719|ref|WP_000074574.1|	26.9	238	269	309	1.55e-18	82.4
k141_74264_32	SARG|gi|447057509|ref|WP_001134765.1|	26.3	255	269	309	1.55e-18	82.4
k141_74264_32	SARG|gi|445996710|ref|WP_000074565.1|	26.9	238	269	309	1.55e-18	82.4
k141_74264_33	SARG|gi|922019548|ref|WP_053299973.1|	29.7	246	331	648	4.37e-19	87.0
k141_74264_33	SARG|gi|555268367|ref|WP_023249730.1|	29.3	246	331	648	1.06e-18	85.9
k141_74264_33	SARG|gi|1027935297|ref|WP_063809363.1|	29.3	246	331	648	1.06e-18	85.9
k141_74264_33	SARG|gi|555222481|ref|WP_023215070.1|	29.3	246	331	648	1.06e-18	85.9
k141_74264_33	SARG|gi|959866458|ref|WP_058145168.1|	29.8	245	331	648	1.43e-18	85.5
k141_74264_33	SARG|gi|555246906|ref|WP_023230855.1|	29.3	246	331	648	1.92e-18	85.1
k141_74264_33	SARG|YP_002044935	29.3	246	331	648	1.92e-18	85.1
k141_74264_33	SARG|gi|835666879|ref|WP_047606339.1|	29.3	246	331	648	1.92e-18	85.1
k141_74264_33	SARG|gi|685236936|ref|WP_031605176.1|	29.3	246	331	648	1.92e-18	85.1
k141_74264_33	SARG|gi|554958661|ref|WP_023203683.1|	29.3	246	331	648	1.92e-18	85.1
k141_34526_22	SARG|gi|500448961|gb|EOP61695.1|	26.9	216	491	306	1.15e-09	58.5
k141_34526_22	SARG|gi|507044560|ref|WP_016115614.1|	24.8	210	491	306	1.15e-09	58.5
k141_34526_22	SARG|gi|542061059|gb|ERI11611.1|	23.5	213	491	316	2.91e-09	57.4
k141_34526_22	SARG|gi|447195835|ref|WP_001273091.1|	26.0	208	491	306	3.65e-09	57.0
k141_34526_22	SARG|gi|446026113|ref|WP_000103968.1|	24.8	210	491	306	4.88e-09	56.6
k141_34526_22	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	24.7	215	491	461	6.28e-09	57.0
k141_34526_22	SARG|gi|500465078|gb|EOP76697.1|	26.4	216	491	306	8.69e-09	55.8
k141_34526_22	SARG|gi|447195836|ref|WP_001273092.1|	25.5	208	491	306	8.69e-09	55.8
k141_34526_22	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	27.7	206	491	307	8.75e-09	55.8
k141_34526_22	SARG|gi|500194536|ref|WP_011867743.1|	24.0	208	491	306	1.16e-08	55.5
k141_34526_27	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	29.4	197	353	255	2.47e-22	93.6
k141_34526_27	SARG|gb|WP_104671188.1|ARO:3003948|efrA	28.5	200	353	575	8.53e-16	77.4
k141_34526_27	SARG|gb|APB03219.1|ARO:3003986|TaeA	23.8	210	353	648	6.82e-09	56.2
k141_34526_27	SARG|M80346.gene.p01	25.2	234	353	551	3.35e-07	50.8
k141_34526_27	megares|MEG_1491|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|CARA_1	25.2	234	353	551	3.35e-07	50.8
k141_34526_27	SARG|M57437.gene.p01	32.7	168	353	548	1.04e-06	49.3
k141_34526_27	SARG|X63451.gene.p01	34.8	89	353	550	9.90e-06	46.2
k141_34526_27	megares|MEG_6558|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SRMB_1	34.8	89	353	550	9.90e-06	46.2
k141_34580_2	CARD|gb|AAC75135.2|ARO:3000792|mdtA	98.6	415	416	415	1.56e-277	753
k141_34580_2	SARG|gb|AAG05916.1|ARO:3004073|MuxA	47.0	319	416	426	4.10e-91	280
k141_34580_2	SARG|gb|BAE06005.1|ARO:3003704|mexM	39.2	347	416	385	1.69e-68	221
k141_34580_2	SARG|gi|654292006|ref|WP_027806808.1|	32.6	334	416	405	3.13e-52	179
k141_34580_2	SARG|YP_001778538	32.6	334	416	405	4.38e-52	178
k141_34580_2	SARG|gi|691070849|ref|WP_032012412.1|	33.8	370	416	406	4.48e-52	178
k141_34580_2	SARG|ZP_02904981	32.9	334	416	405	1.68e-51	177
k141_34580_2	SARG|gi|491209910|ref|WP_005068241.1|	33.5	370	416	406	2.40e-51	176
k141_34580_2	SARG|YP_002100653	32.3	334	416	405	3.28e-51	176
k141_34580_2	SARG|gi|736062670|ref|WP_034206052.1|	32.0	334	416	405	3.28e-51	176
k141_34580_3	CARD|gb|AAC75136.1|ARO:3000793|mdtB	99.8	1040	1041	1040	0.0	1903
k141_34580_3	SARG|gb|AAG05915.1|ARO:3004074|MuxB	66.9	1026	1041	1043	0.0	1272
k141_34580_3	SARG|gb|AAG05914|ARO:3004075|MuxC	49.8	1019	1041	1036	9.43e-315	898
k141_34580_3	CARD|gb|AAC75137.1|ARO:3000794|mdtC	50.0	1025	1041	1025	1.49e-313	894
k141_34580_3	SARG|gb|BAE06006.1|ARO:3003705|mexN	49.5	1018	1041	1036	2.04e-308	882
k141_34580_3	CARD|gb|AAG07594.1|ARO:3000808|MexI	31.6	1013	1041	1029	7.27e-139	442
k141_34580_3	SARG|YP_350221	29.4	1007	1041	1009	3.09e-129	416
k141_34580_3	SARG|gb|AAL19305.1|ARO:3000790|mdsB	29.8	1054	1041	1055	1.19e-127	413
k141_34580_3	NCBI|AAN33534.1|1|1|bepG|bepG|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepG|AMR|efflux	30.2	1053	1041	1074	1.27e-127	414
k141_34580_3	SARG|YP_001350280	29.7	1013	1041	1018	5.44e-127	410
k141_34580_4	CARD|gb|AAC75137.1|ARO:3000794|mdtC	98.7	1025	1026	1025	0.0	1893
k141_34580_4	SARG|gb|AAG05914|ARO:3004075|MuxC	62.7	1018	1026	1036	0.0	1177
k141_34580_4	SARG|gb|AAG05915.1|ARO:3004074|MuxB	51.2	1020	1026	1043	0.0	941
k141_34580_4	CARD|gb|AAC75136.1|ARO:3000793|mdtB	49.8	1026	1026	1040	2.48e-317	904
k141_34580_4	SARG|gb|BAE06006.1|ARO:3003705|mexN	48.5	1008	1026	1036	4.47e-295	847
k141_34580_4	SARG|gb|CAH14033.1|ARO:3004100|LpeB	31.3	1015	1026	1014	1.08e-135	433
k141_34580_4	SARG|YP_350221	29.8	1002	1026	1009	2.25e-128	414
k141_34580_4	SARG|CAY51926	29.7	1010	1026	1008	4.26e-128	413
k141_34580_4	NCBI|AAN29241.1|1|1|bepE|bepE|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepE|AMR|efflux	30.2	1025	1026	1051	1.08e-127	413
k141_34580_4	CARD|gb|AAG07594.1|ARO:3000808|MexI	31.0	1027	1026	1029	3.54e-127	411
k141_34580_5	SARG|CP001918.1.gene3442.p01	81.5	455	472	457	2.23e-258	709
k141_34580_5	SARG|gb|BAA11237.1|ARO:3000254|emrY	28.9	436	472	512	2.00e-40	150
k141_34580_5	SARG|gi|692126801|ref|WP_032082759.1|	29.1	409	472	512	1.36e-39	148
k141_34580_5	SARG|NC_010410.6003262.p01	29.4	405	472	507	2.39e-39	147
k141_34580_5	SARG|gi|693264691|ref|WP_032363351.1|	29.1	409	472	512	2.56e-39	147
k141_34580_5	SARG|gi|544880697|ref|WP_021293434.1|	29.1	409	472	512	3.52e-39	147
k141_34580_5	SARG|gi|545246045|ref|WP_021544659.1|	29.1	409	472	512	3.52e-39	147
k141_34580_5	SARG|gi|817112355|ref|WP_046485582.1|	29.6	409	472	512	4.84e-39	147
k141_34580_5	SARG|gi|1016518516|ref|WP_063098254.1|	29.6	405	472	507	6.22e-39	146
k141_34580_5	SARG|gi|920021424|ref|WP_052936095.1|	28.9	409	472	512	9.13e-39	146
k141_34580_6	CARD|gb|AAD51347.1|ARO:3003067|smeS	42.4	455	468	467	3.82e-111	335
k141_34580_6	NCBI|WP_222891058.1|1|1|vanS-P|vanS-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-P|AMR|glycopeptide	25.5	216	468	359	1.86e-19	88.6
k141_34580_7	CARD|gb|AAD51348.1|ARO:3003066|smeR	57.7	222	241	229	1.04e-85	253
k141_34580_7	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	40.8	228	241	228	3.04e-51	165
k141_34580_7	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	38.8	227	241	231	1.89e-47	155
k141_34580_7	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	37.9	227	241	232	2.74e-47	155
k141_34580_7	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	37.9	227	241	232	2.74e-47	155
k141_34580_7	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	38.3	227	241	231	3.76e-47	155
k141_34580_7	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	38.3	227	241	231	1.06e-46	154
k141_34580_7	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	38.3	227	241	231	1.06e-46	154
k141_34580_7	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	38.3	227	241	231	1.06e-46	154
k141_34580_7	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	38.1	231	241	235	1.88e-45	150
k141_39378_2	SARG|gb|CDO61516.1|ARO:3003949|efrB	28.4	190	505	362	7.00e-13	68.9
k141_39378_2	SARG|gi|542061059|gb|ERI11611.1|	26.4	216	505	316	2.26e-10	60.8
k141_39378_2	SARG|gi|447057509|ref|WP_001134765.1|	25.0	208	505	309	6.85e-10	59.3
k141_39378_2	NCBI|QHA94808.1|1|1|narA|narA||1|MADURAMICIN/NARASIN/SALINOMYCIN|IONOPHORE|ionophore_ABC_transporter_ATP-binding_subunit_NarA|AMR|ionophore	26.6	203	505	293	1.09e-09	58.5
k141_39378_2	SARG|gi|500194536|ref|WP_011867743.1|	25.8	209	505	306	2.14e-09	57.8
k141_39378_2	SARG|gi|488120365|ref|WP_002191762.1|	25.0	208	505	309	5.19e-09	56.6
k141_39378_2	SARG|gi|507050365|ref|WP_016121371.1|	24.5	208	505	309	5.19e-09	56.6
k141_39378_2	SARG|P42332	23.6	216	505	306	6.80e-09	56.2
k141_39378_2	SARG|ABB80128	23.6	216	505	306	6.80e-09	56.2
k141_39378_2	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	23.6	216	505	306	6.80e-09	56.2
k141_64086_2	SARG|CP001918.1.gene3442.p01	44.5	456	476	457	1.74e-120	359
k141_64086_2	SARG|gi|757697366|ref|WP_042927333.1|	33.7	406	476	512	5.31e-45	163
k141_64086_2	SARG|gi|506355393|ref|WP_015875112.1|	33.3	403	476	511	7.22e-45	163
k141_64086_2	SARG|gi|692126801|ref|WP_032082759.1|	33.2	416	476	512	7.34e-45	163
k141_64086_2	SARG|gi|751932149|ref|WP_041146857.1|	32.9	407	476	512	7.34e-45	163
k141_64086_2	SARG|gi|491038386|ref|WP_004900055.1|	33.5	406	476	512	1.01e-44	162
k141_64086_2	SARG|gi|955473785|ref|WP_058101257.1|	33.2	416	476	512	1.40e-44	162
k141_64086_2	SARG|gi|693264691|ref|WP_032363351.1|	33.2	416	476	512	1.40e-44	162
k141_64086_2	SARG|gi|490991732|ref|WP_004853465.1|	33.7	406	476	512	1.40e-44	162
k141_64086_2	SARG|gi|647264873|ref|WP_025712752.1|	33.5	406	476	513	1.42e-44	162
k141_64086_7	SARG|gi|507055561|ref|WP_016126482.1|	29.0	210	502	309	2.98e-19	87.4
k141_64086_7	SARG|gi|445996710|ref|WP_000074565.1|	29.3	215	502	309	5.45e-19	86.7
k141_64086_7	SARG|gi|542061059|gb|ERI11611.1|	28.8	215	502	316	5.98e-19	86.7
k141_64086_7	SARG|gi|488067981|ref|WP_002139378.1|	29.0	210	502	309	7.35e-19	86.3
k141_64086_7	SARG|gi|488130770|ref|WP_002201978.1|	29.0	210	502	309	7.35e-19	86.3
k141_64086_7	SARG|gi|487936534|ref|WP_002010000.1|	29.0	210	502	309	7.35e-19	86.3
k141_64086_7	SARG|gi|447057509|ref|WP_001134765.1|	29.0	210	502	309	9.93e-19	85.9
k141_64086_7	SARG|gi|445996719|ref|WP_000074574.1|	29.5	210	502	309	1.81e-18	85.1
k141_64086_7	SARG|gi|488120365|ref|WP_002191762.1|	29.0	210	502	309	1.81e-18	85.1
k141_64086_7	SARG|gi|488068784|ref|WP_002140181.1|	28.6	210	502	309	1.81e-18	85.1
k141_64086_46	SARG|YP_671782	100	391	392	391	2.76e-268	728
k141_64086_46	SARG|gi|754720184|ref|WP_042093261.1|	99.7	391	392	391	7.91e-268	727
k141_64086_46	SARG|gi|754718028|ref|WP_042091741.1|	99.7	391	392	391	7.91e-268	727
k141_64086_46	SARG|B1LL36	99.7	391	392	391	1.12e-267	726
k141_64086_46	SARG|gi|585365886|ref|WP_024247470.1|	99.7	391	392	391	1.12e-267	726
k141_64086_46	SARG|ZP_03031860	99.7	391	392	391	1.12e-267	726
k141_64086_46	SARG|YP_002331481	99.5	391	392	391	4.57e-267	725
k141_64086_46	SARG|B7NR12	99.0	391	392	391	9.23e-267	724
k141_64086_46	SARG|A1AHP3	99.2	391	392	391	1.31e-266	724
k141_64086_46	SARG|NP_756491	99.2	391	392	391	1.86e-266	723
k141_64086_56	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	34.3	848	805	703	1.60e-136	420
k141_64086_77	SARG|gi|641686680|emb|CDN84509.1|	100	394	395	396	2.32e-278	754
k141_64086_77	SARG|YP_002393667	99.7	394	395	394	6.15e-278	753
k141_64086_77	SARG|YP_543187	99.7	394	395	396	6.64e-278	753
k141_64086_77	SARG|YP_002331449	99.5	394	395	394	5.05e-277	750
k141_64086_77	SARG|NP_756458	99.5	394	395	396	5.45e-277	750
k141_64086_77	SARG|ACB18769	99.2	394	395	394	7.18e-277	750
k141_64086_77	SARG|YP_312412	99.2	394	395	396	7.74e-277	750
k141_64086_77	SARG|ZP_02784870	99.0	394	395	394	1.02e-276	749
k141_64086_77	SARG|NC_002695.1.915420.p01	99.0	394	395	396	1.10e-276	749
k141_64086_77	SARG|ABG71850	99.2	394	395	396	2.22e-276	749
k141_64086_90	megares|MEG_2614|Drugs|Phenicol|Phenicol_resistance_MFS_efflux_pumps|DHAP_1	26.0	246	413	395	1.57e-16	79.7
k141_64239_9	SARG|ZP_04536687	100	493	494	506	0.0	918
k141_64239_9	SARG|YP_854844	100	493	494	495	0.0	918
k141_64239_9	SARG|ABG71110	100	493	494	493	0.0	918
k141_64239_9	SARG|gi|545156500|ref|WP_021511639.1|	99.8	493	494	493	0.0	917
k141_64239_9	SARG|gi|723116127|ref|WP_033560214.1|	99.8	493	494	493	0.0	917
k141_64239_9	SARG|gi|510918377|ref|WP_016239333.1|	99.8	493	494	493	0.0	917
k141_64239_9	SARG|gi|1020277983|ref|WP_063268995.1|	99.8	493	494	493	0.0	917
k141_64239_9	SARG|gi|754635104|ref|WP_042021575.1|	99.8	493	494	493	0.0	917
k141_64239_9	SARG|gi|545161615|ref|WP_021516476.1|	99.8	493	494	493	0.0	917
k141_64239_9	SARG|gi|765449509|ref|WP_044707202.1|	99.8	493	494	493	0.0	917
k141_64239_14	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	37.9	649	631	703	7.08e-116	360
k141_64239_16	SARG|gb|AEO25219.1|ARO:3004651|lin	24.0	200	270	523	2.84e-09	56.2
